Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333052-20356301	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	417	"kidney: 237.4"	"Cell line enriched"	"Detected in single"	32	"EFO-21: 3.8"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	83000000	83000000			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	349	"kidney: 70.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	207	"liver cancer: 4.0;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA024575	Enhanced									"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favourable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015839	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	341	"brain: 33.7;kidney: 127.3;retina: 93.5"	"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enriched"	"Detected in some"	25	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced									"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.0	0.1	0.1	3.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.7	0.1	0.1	1.3	33.7	0.0
TMEM174	"FLJ31268, MGC13034"	ENSG00000164325	"Transmembrane protein 174"	Q8WUU8	5	73173195-73175143	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	282	"kidney: 61.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.7;RPTEC TERT1: 1.5"	"Cancer enriched"	"Detected in single"	126	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037975	Enhanced									"HPA037975: AB_10672732"					"unprognostic (8.11e-2)"								"prognostic favourable (3.30e-6)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528717-31530232	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	188	"kidney: 63.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favourable (1.73e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"kidney: 66.5"	"Cell line enriched"	"Detected in single"	24	"NTERA-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB037267, HPA049486"	Enhanced									"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487667	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	90	"kidney: 63.5;liver: 82.6"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 6.4"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057699	Supported									"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favourable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	63.5	82.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Group enriched"	"Detected in some"	12	"HEL: 6.6;U-937: 4.3"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"kidney: 36.5;liver: 141.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;SiHa: 1.6;U-698: 2.2;U-937: 1.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	36.5	141.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.0	0.4	0.0	0.2	0.1	1.1	0.0	1.4	0.0	0.4	0.0	1.2	0.4	0.0	0.3	0.3	0.0	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.5	1.2	0.6	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	1.5	0.1	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.2	0.0	0.2	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"kidney: 143.2"	"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 23.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.0	0.0	0.3	0.0	1.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	143.2	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.0	0.3	1.0	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1
TMEM207		ENSG00000198398	"Transmembrane protein 207"	Q6UWW9	3	190428655-190449876	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	75	"kidney: 21.1"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014332	Uncertain									"HPA014332: AB_2204907"															"unprognostic (4.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"kidney: 76.1;liver: 93.4"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;Hep G2: 9.8"	"Group enriched"	"Detected in some"	450	"liver cancer: 30.9;renal cancer: 17.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA057699	Supported									"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favourable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	76.1	93.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.9	1.0	0.5	0.2	1.2	0.0	1.0	0.0	5.4	1.5	0.0	0.0	1.3	0.9	0.2	0.0	0.0	1.2	0.9	0.1	2.7	0.0	0.7	0.0	0.0	0.0	1.0	0.7	0.2	1.2	9.8	0.0	1.3	1.3	0.0	0.0	0.0	0.4	0.6	0.8	1.2	0.0	0.7	0.6	1.3	1.2	0.0	0.1	1.1	0.2	0.4	0.2	1.9	1.0	2.6	0.0	1.0	2.0	0.4	0.0	0.0	0.9	0.0	0.7	0.8	0.5	0.7	0.7	3.5	1.9	0.5	0.5	0.2	0.6	0.0	0.6	0.1	0.8	0.2	0.1	0.6	0.7	1.2	1.0	0.2	0.1	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;BJ hTERT+: 1.2;HL-60: 1.9;SiHa: 1.5;U-698: 1.2"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.5	0.0	0.6	0.8	1.9	0.4	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.2	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell line enriched"	"Detected in single"	379	"RPTEC TERT1: 37.9"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium voltage-gated channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"kidney: 123.2"	"Cell line enriched"	"Detected in some"	40	"RPTEC TERT1: 50.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.3"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced									"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.1	0.0	0.5	0.2	2.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"kidney: 136.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.3;Hep G2: 4.8;Karpas-707: 11.4;U-266/70: 6.8"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039451, HPA039562"	Enhanced									"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favourable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	136.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	2.7	0.1	0.1	0.1	0.1	1.3	0.6	3.1	0.7	0.4	1.4	0.4	0.0	0.0	0.1	0.3	0.2	0.1	1.8	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.6	0.3	0.1	0.1	0.0	0.0	21.3	0.0	0.1	0.3	4.8	2.8	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.1	11.4	0.0	1.1	0.0	0.1	0.2	0.4	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.5	0.1	0.0	6.8	0.6	0.3	0.1	0.0	0.2	3.1	0.4	0.6	0.5	0.3	0.2	1.3	0.5	1.4	0.1	0.9	0.5	0.6	1.8	0.4	0.7	0.6	0.4	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;NTERA-2: 3.5;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		9200000	9200000	Cytosol	Cytosol	"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favourable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0
DAO	DAMOX	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"brain: 37.0;kidney: 39.0;liver: 64.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.4;HL-60: 1.7;HMC-1: 1.3;RH-30: 1.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 37.0;pons and medulla: 31.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"cerebellum: 74.4;pons and medulla: 21.1"	"Low region specificity"	"Detected in many"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favourable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.3	0.2	0.0	0.2	2.7	0.2	0.2	37.0	0.7	0.2	0.9	11.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	39.0	64.2	0.3	0.2	6.4	0.5	0.2	0.3	0.2	0.0	0.2	31.2	0.2	1.1	0.0	0.2	0.2	0.2	0.2	0.2	0.3	35.9	0.2	0.2	0.2	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	37.0	0.5	0.8	0.9	6.4	0.5	31.2	0.4
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 7.7;HEL: 2.2;HMC-1: 4.7;REH: 1.2"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced									"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"kidney: 36.1;liver: 50.8;thyroid gland: 67.7"	"Group enriched"	"Detected in some"	26	"Hep G2: 16.6;SK-BR-3: 40.3"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	36.1	50.8	0.4	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	67.7	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	40.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225355-1246189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"kidney: 14.1"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.2"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced									"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.4	0.6	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.1;NB-4: 13.2;RPMI-8226: 15.2;SH-SY5Y: 13.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA002198, CAB020827"	Enhanced					930000000	930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.3	0.0	2.9	1.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.2	0.2	0.0	0.2	3.1	15.2	0.0	0.0	2.5	13.2	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.3	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"kidney: 51.2;liver: 49.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 25.9"	"Group enriched"	"Detected in some"	50	"liver cancer: 28.1;renal cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.0	51.2	49.3	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FXYD4	CHIF	ENSG00000150201	"FXYD domain containing ion transport regulator 4"	P59646	10	43371642-43376335	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	27	"kidney: 119.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;HSkMC: 1.0;hTCEpi: 1.3;RT4: 1.1;SK-BR-3: 1.0;U-266/84: 1.3"	"Group enriched"	"Detected in many"	5	"renal cancer: 10.7;urothelial cancer: 20.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA058421	Enhanced									"HPA058421: AB_2683714"	"unprognostic (2.92e-3)"	"unprognostic (5.25e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-1)"		"unprognostic (2.32e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	0.4	0.0	2.2	0.0	0.0	0.1	1.0	0.0	0.1	2.0	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.6	0.3	119.5	0.0	1.3	0.0	1.6	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.6	0.0	0.0	4.4	1.5	0.6	0.0	0.0	0.0	0.5	0.0	2.4	0.2	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.2	0.1	1.0	0.6	0.3	1.6	0.4	1.0	1.4
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"kidney: 40.1"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;SH-SY5Y: 2.6"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	7	"cerebellum: 23.5"	"Low region specificity"	"Detected in all"			HPA015278	Enhanced									"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	0.6	0.1	1.1	0.0	0.1	0.3	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.5	40.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.5	1.2	0.2	0.2	0.4	0.2	0.4	2.5	0.1	0.3	0.1	0.0	0.0	0.5	0.3	0.0	0.0	1.4	1.6	0.0	1.1	0.0	0.3	0.4	0.0	0.1	0.2	1.7	0.0	0.1	0.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.7	0.0	1.2	0.0	0.7	0.5	1.3	1.2	0.2	0.7	1.2	0.0	0.6	2.6	0.8	0.0	0.8	0.0	0.1	0.0	0.7	1.1	0.0	0.7	0.2	0.2	0.0	0.3	0.3	0.5	1.2	0.2	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.5	0.8	0.2	0.3	1.1	0.2	0.2	0.2	0.3	0.2	0.6	1.1	0.3	0.3	0.7	0.5	1.2	0.1	0.3	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.4;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.5;SK-BR-3: 1.8"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019551	Enhanced									"HPA019551: AB_2670187"	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.5	1.5	0.0	0.0	0.1	0.4	0.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"kidney: 63.2;liver: 63.3"	"Cell line enriched"	"Detected in single"	11	"T-47d: 3.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					7300	7300			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favourable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	63.2	63.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"kidney: 85.1"	"Cell line enriched"	"Detected in some"	8	"CACO-2: 45.3"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058096	Enhanced		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.0	0.1	0.1	0.6	0.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	85.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	2.0	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	3.7	1.4	1.3	0.6	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	45.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.3	4.3	0.0	2.4	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	1.4	1.3	1.0	0.4	0.2	0.4	0.4	0.4	0.5	3.7	0.9	0.5	0.5	1.0	0.6	0.2	0.6	0.4	0.4	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.1
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838547-134902034	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 44.8;liver: 64.1"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 24.2"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA010533, HPA011179"	Enhanced					11000	11000			"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	2.5	0.0	0.0	0.0	44.8	64.1	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.4	0.9	0.6	0.2	1.7	0.5	0.3	0.1	0.4	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.2	1.0	0.4	0.1	0.5	0.2	24.2	0.3	0.9	0.3	0.1	0.2	0.4	0.2	0.6	0.8	0.0	0.3	0.2	0.7	0.1	0.1	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.9	0.5	0.4	1.5	0.9	1.3	0.9	1.1	1.7	0.9	0.4	0.2	0.5	1.4	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829037	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6"	"Group enriched"	"Detected in some"	6	"U-266/70: 5.9;U-266/84: 1.7"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	6	"AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.0	25.8	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	3.2	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.8	0.6	0.0	30.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0										
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.2	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	10.7	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.0	0.7	0.6	0.3	3.5	0.2	0.4	3.6	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.6	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"kidney: 33.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;EFO-21: 1.9;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	16	"NK-cells: 1.4;T-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041603	Enhanced									"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.6	0.6	0.1	0.4	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	1.2	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.5	0.0	0.0	0.5	0.1	0.0	1.4	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412143	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"kidney: 55.9"	"Group enriched"	"Detected in some"	131	"EFO-21: 99.0;RPTEC TERT1: 34.8"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced									"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.2	0.8	0.4	0.2	0.3	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.6	0.2	0.2	0.3	0.4	55.9	1.2	0.2	0.7	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.5	0.2	1.8	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	3.4	0.2	0.4	0.3	0.2	0.5	0.4	1.4	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	1.2	0.3	0.2	0.4	0.1	0.0	0.4	0.3	0.2	0.5	0.3	0.4	0.3	0.2	0.2	0.2
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	15	"brain: 73.8;kidney: 121.9"	"Cell line enhanced"	"Detected in many"		"A-431: 39.2;EFO-21: 59.4;NTERA-2: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.4;monocytes: 2.5"	"Region enhanced"	"Detected in many"		"cerebellum: 483.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 88.7;cerebellum: 312.3"	"CAB002138, HPA023099, HPA056734"	Enhanced		Supported	Vesicles				Vesicles	Vesicles	"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	1.6	1.2	19.6	1.4	73.8	1.0	1.4	66.0	10.9	3.1	1.3	0.5	0.0	1.0	1.0	2.0	1.7	2.0	0.9	1.0	13.8	15.2	121.9	1.5	2.1	1.0	2.8	6.4	0.9	2.0	1.3	3.2	2.2	12.8	0.9	1.4	0.8	1.3	0.8	1.4	1.7	1.1	1.2	14.7	1.1	1.3	2.1	10.6	0.0	1.4	0.0	1.0	1.0	0.1	0.5	0.6	6.4	2.5	0.0	0.2	1.0	39.2	2.1	8.8	0.6	0.2	1.4	1.2	0.6	4.0	0.3	0.5	0.3	4.7	0.2	59.4	0.0	13.7	12.7	15.7	2.7	0.1	0.7	1.4	16.5	0.3	1.7	0.2	0.7	0.6	5.1	0.8	7.8	10.5	2.7	1.1	10.5	0.2	0.6	0.1	19.3	7.9	0.3	0.2	0.7	4.7	0.3	1.4	0.9	10.6	0.7	0.1	0.5	0.4	0.0	1.5	8.4	1.9	3.4	1.0	1.3	0.3	0.2	0.1	0.1	2.6	0.5	1.5	0.2	0.7	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.2	6.4	0.0	2.5	0.6	0.0	1.0	19.6	73.8	66.0	10.9	13.8	15.2	2.8	6.4	12.8	10.6
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467053	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 42.2;liver: 103.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0"	"Group enriched"	"Detected in some"	21	"liver cancer: 57.6;renal cancer: 11.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024785	Enhanced					89000	89000			"HPA024785: AB_1847856"	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	2.5	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	2.1	0.1	0.0	0.0	0.0	1.6	0.1	0.2	1.3	0.0	0.0	0.1	42.2	103.6	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.9	0.0	0.2	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.7	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.0	1.3	1.1	2.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.7	0.1	0.6	1.3	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	1.5	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 2.4;SiHa: 6.0;U-2 OS: 9.9;U-251 MG: 3.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain									"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC126283.2		ENSG00000285330			4	109713916-109801999	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	13	"kidney: 61.8;liver: 135.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.0;EFO-21: 5.1;Hep G2: 9.4;RPTEC TERT1: 9.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, HPA024061, HPA035909"	Uncertain									"HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074"																		2.4	2.3	0.4	2.0	0.4	0.0	1.6	0.0	1.3	2.6	2.2	0.1	1.3	3.8	2.2	7.6	2.4	1.8	2.5	2.6	0.5		61.8	135.8	4.3	1.5	0.6	0.0	6.6	6.5	0.7	2.0	2.2	1.1	2.0	0.7	4.0	0.5	0.7	1.4	0.0	3.9	0.8	1.4	4.7	1.3	1.8	0.4	0.0	3.0	0.9	0.4	2.6	1.8	0.2	0.8	0.2	0.3	0.2	0.7	1.2	0.0	0.5	0.0	0.3	0.2	0.1	0.0	0.4	0.9	0.0	0.1	0.1	27.0	0.1	5.1	0.2	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.4	9.4	3.2	0.3	0.0	3.4	0.0	0.0	0.1	1.8	0.3	1.5	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.1	9.5	0.8	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	4.1	0.1	1.2	0.2	0.3	0.0	0.3	0.0	0.4	0.1	0.5	0.3	0.7	0.2	0.7	0.5	0.0	0.2	0.2	0.8	0.5	1.2										
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell line enhanced"	"Detected in some"		"BJ: 2.8;BJ hTERT+: 1.7;fHDF/TERT166: 6.8;TIME: 1.5;U-2197: 2.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced									"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	1.7	1.2	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"kidney: 16.5;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;RT4: 1.2;TIME: 2.9"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.3	1.2	0.5	0.2	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in some"	6	"AF22: 12.2;Hep G2: 36.7;NTERA-2: 24.3;RH-30: 35.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									390000	390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favourable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	36.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	24.3	0.0	0.1	35.0	0.7	0.0	0.0	3.9	1.2	0.1	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	1.5	0.3	4.1	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 24.3;testis: 7.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CAPAN-2: 2.5;Daudi: 3.7;Karpas-707: 2.6;U-266/70: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	HPA053574	Uncertain									"HPA053574: AB_2682195"	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	7.5			0.4		0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.5	3.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.6	0.0	0.7	0.2	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.2										
SLC7A13	"AGT-1, XAT2"	ENSG00000164893	"Solute carrier family 7 member 13"	Q8TCU3	8	86214052-86321146	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"kidney: 31.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.34e-1)"						"unprognostic (2.62e-1)"					"unprognostic (1.12e-1)"	"unprognostic (2.96e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.9;Hep G2: 45.8;HSkMC: 19.0;RPTEC TERT1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	11000000000	11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	28.9	0.0	9.2	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	0.1	45.8	2.0	0.0	0.0	19.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		440000	440000	Mitochondria	Mitochondria	"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favourable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.6	1.3	2.3	0.0	0.1	0.0	0.4	1.7	0.0	0.1	0.0	1.8	0.3	0.0	0.0	0.0	11.3	3.1	0.0	0.0	2.7	3.3	3.5	2.5	0.0	0.0	3.6	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 19.9;HHSteC: 9.0;U-937: 28.3"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	270000	270000	"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	19.9	9.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.9;U-266/70: 6.5"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Low region specificity"	"Detected in single"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA019059: "	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	3.9	2.2	0.8	2.2	0.6	0.4	1.3	2.3	1.6	0.5	0.8	1.5	3.2	0.7	0.3	0.6	1.8	1.8	2.0	1.9	0.1	0.7	0.2	0.9	0.7	8.9	0.9	2.9	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.2	0.5	0.5	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.3	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.5	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"blood: 8.8;kidney: 4.6;skeletal muscle: 17.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;K-562: 12.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"					"Group enriched"	"Detected in some"	21	"memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	18	"B-cells: 8.8;dendritic cells: 2.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.3	0.5	0.1	0.7	0.0	0.0	0.3	0.6	0.2	0.0			0.0	0.2	0.9	0.1	0.2	0.0	0.3	0.4	0.5	4.6	0.3	0.0	0.2	0.7		0.3	0.1	0.0	0.8	0.1		0.1	0.1		0.0	0.2	17.3	0.1	0.1	0.0	0.8	0.3	0.0	0.6			0.1		0.4	0.1	0.0	8.8	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	2.5	0.7	0.3	0.0	0.3	0.1	0.3	0.1	0.4	3.3	0.2	0.1	0.2	0.0	0.1	4.8	0.0	0.1	0.6	0.5	1.1	0.0	0.0	0.2	0.5	1.8	0.2	0.5	0.1	0.2	0.0	12.6	0.3	0.4	0.3	0.8	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.8	1.1	0.2	0.2	0.2	0.2	2.0	0.5	0.3	0.8	0.7	1.0	0.9	1.9	0.1	0.2	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1										
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 45.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	26000	26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavourable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favourable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0
AC026461.4		ENSG00000275691			16	56676132-56677763	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"blood: 1.1;intestine: 2.7;kidney: 1.0;thyroid gland: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"																															"unprognostic (1.03e-1)"					"unprognostic (2.92e-2)"	"unprognostic (2.63e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	1.8			2.4	0.0	0.0	0.0	0.1	0.0	0.0			1.0	0.1	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.7		0.0	0.0	0.0	0.0	1.4	0.0		0.0	0.1	0.0			2.7		0.1	0.0		0.3	0.0	0.0	0.6	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.5	0.0	0.3	0.2	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.6	0.0	0.2	0.2										
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917390-134950122	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 26.2;liver: 90.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;RPTEC TERT1: 6.3"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026292, HPA055414"	Enhanced		Supported	Centrosome		24000	24000	Centrosome	Centrosome	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	0.3	0.3	0.8	0.3	1.0	0.6	0.3	1.9	0.9	0.3	0.6	0.3	0.3	0.2	0.3	0.6	0.3	0.1	0.3	0.3	1.4	0.6	26.2	90.1	0.3	0.3	1.1	0.4	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.2	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.8	0.3	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.3	1.5	1.1	5.9	0.9	2.3	1.3	0.6	0.2	1.0	1.5	0.8	0.5	0.2	1.4	0.4	0.5	0.1	0.9	0.5	0.7	0.4	0.5	0.0	1.1	1.1	0.0	0.8	1.2	5.5	3.6	3.8	5.2	0.6	1.4	2.0	1.5	1.8	0.4	0.9	0.4	5.3	2.2	0.2	0.0	1.7	2.3	0.3	1.1	0.1	0.5	0.5	6.3	0.8	1.6	0.5	0.3	0.1	1.3	0.9	0.3	0.4	0.8	3.1	1.2	1.5	5.5	1.7	0.9	0.7	1.4	0.5	5.9	0.9	0.9	1.3	0.3	0.5	1.0	1.2	0.7	0.1	1.5	1.1	0.9	2.4	2.3	0.4	1.1	1.2	0.6	0.8	1.0	1.9	0.9	1.4	0.6	1.1	0.4	0.3	0.3
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069717-79089466	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 87.9;liver: 122.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.9;Hep G2: 37.2;hTEC/SVTERT24-B: 22.8;U-87 MG: 9.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044573	Enhanced					1400000	1400000			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	9.3	4.4	1.7	0.9	2.0	0.2	8.2	1.1	1.0	1.7	3.4	1.1	2.9	0.6	3.2	10.5	3.5	1.4	2.9	3.3	1.5	1.5	87.9	122.9	0.6	0.4	1.6	1.0	1.9	0.5	0.5	3.2	0.3	3.5	3.0	0.8	8.2	0.8	4.0	2.2	0.4	1.3	10.5	2.2	0.3	2.4	1.4	0.9	0.0	4.6	1.9	0.4	6.4	4.4	0.9	0.5	3.2	0.4	2.4	0.7	0.3	0.0	0.0	0.0	0.0	4.3	3.1	1.4	3.7	8.9	2.1	4.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.1	37.2	3.4	0.2	0.0	3.8	0.0	22.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	0.2	0.0	2.5	0.4	0.7	0.4	0.3	0.5	0.5	0.6	0.4	0.2	0.9	0.6	0.7	3.2	2.4	0.2	0.5	0.4	0.3	1.7	2.0	1.1	1.0	1.5	1.5	1.6	1.0	3.5	0.9
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 45.7"	"Cell line enriched"	"Detected in many"	6	"RH-30: 33.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (5.67e-3)"	0.5	1.1	0.3	1.4	0.3	1.5	0.6	0.3	0.4	0.4	0.3	0.3	0.9	0.3	0.8	1.0	0.6	0.2	0.8	0.3	0.3	0.1	45.7	0.8	0.8	1.4	0.3	0.3	0.3	3.6	0.7	0.6	0.5	0.3	0.5	0.8	1.1	0.7	0.3	0.3	0.8	0.4	0.3	0.3	0.3	0.7	0.5	0.3	1.0	4.4	0.3	0.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.1	1.1	0.2	0.5	1.6	0.0	0.3	1.9	0.0	1.7	0.2	0.9	1.9	0.5	2.4	0.2	0.3	1.6	0.8	2.8	1.1	0.5	0.8	1.5	0.3	0.0	0.1	2.6	2.5	0.0	1.1	1.1	0.1	0.0	1.6	5.3	0.0	0.5	0.4	1.1	1.6	1.6	1.2	33.2	1.2	0.0	0.9	0.7	0.7	1.3	0.0	0.2	1.3	1.8	0.0	1.4	2.4	1.3	0.8	2.4	2.2	1.3	0.8	3.2	0.8	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 23.0;placenta: 63.1"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 88.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6"	HPA003336	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.1	3.2	0.2	4.4	0.1	0.3	0.2	2.0	0.2	0.1	0.7	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	2.5	0.6	23.0	0.7	0.2	0.2	1.1	0.6	1.9	0.5	0.1	0.0	63.1	0.9	0.2	0.1	0.0	0.8	1.5	0.1	0.2	0.2	0.1	0.5	0.2	0.2	1.1	0.8	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	8.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.5	0.5	0.0	3.9	0.0	1.8	9.8	0.2	0.0	0.2	1.8	0.0	0.7	88.7	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.5	0.7	0.3	0.1	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	0.2	2.0	2.5	0.6	1.1	0.6	0.9	0.8
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.1"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	380000	380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favourable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA026076	Enhanced									"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984983	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 94.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced									"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918984	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 139.7"	"Cell line enriched"	"Detected in single"	96	"RPTEC TERT1: 69.3"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB013526, HPA036260"	Enhanced									"CAB013526: , HPA036260: AB_2675027"		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favourable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.3	0.0	3.5	0.1	3.4	0.2	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.3;Hep G2: 11.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"														"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609182-54623556	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 45.8;kidney: 59.3"	"Cell line enriched"	"Detected in single"	45	"CACO-2: 40.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved									"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favourable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	45.8	0.1	0.1	0.5	0.0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	40.7	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FP565260.4		ENSG00000279493			21	5011799-5017145	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"kidney: 3.4;liver: 10.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 5.9;HeLa: 2.5;MCF7: 4.2;SiHa: 6.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.3		0.2	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			3.4	10.1	0.0	0.7			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.1	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.9	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		620000	620000	Mitochondria	Mitochondria	"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 91.2;liver: 115.1"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.7"					"HPA040251, HPA044094"	Enhanced									"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favourable (1.31e-6)"	"unprognostic (2.69e-1)"				11.1	0.0	0.1	0.1	0.1	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.5	0.1	0.0	0.1	0.2	0.1	0.0	91.2	115.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.3	1.1	0.7	2.9	0.7	0.2	0.8	0.0	1.5	0.6	1.0	3.2	3.2	2.1	2.1	0.8	0.9	1.5	0.8	0.4	2.0	2.4	1.3	1.4	1.5	2.3	2.4	1.9	0.1	0.7	3.1	0.6	3.3	2.4	1.8	1.8	2.4	7.5	2.6	2.6	2.9	0.9	1.3	3.7	1.2	2.0	3.5	2.9	1.0	1.3	2.2	0.5	6.7	1.6	0.8	2.5	1.7	1.3	1.4	2.3	1.5	1.6	1.8	1.9	2.1	1.2	1.5	2.2	1.1	0.6	4.5	2.0	1.0	0.7	0.3	0.4	0.3	0.4	0.1	0.4	0.8	0.2	1.1	0.5	0.5	2.9	0.2	0.3	0.7	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066571	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 55.4;liver: 146.5;pancreas: 80.1"	"Group enriched"	"Detected in some"	9	"EFO-21: 19.4;Hep G2: 27.5;T-47d: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					1000000	1000000			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	0.2	0.0	0.3	0.1	0.5	0.0	3.2	0.4	1.1	0.3	0.3	0.2	8.4	0.2	1.1	10.7	0.1	1.9	3.2	0.7	0.6	0.3	55.4	146.5	4.9	0.1	0.9	0.2	0.4	80.1	2.6	3.2	0.2	0.4	5.3	0.0	0.4	4.1	8.5	8.5	0.0	0.2	0.1	0.9	0.3	6.9	0.8	0.3	0.1	4.3	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.1	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.1	13.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.6	0.2	0.5	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.4	1.1	0.6	0.3	0.9	0.2	0.4	0.3
KCP	"CRIM2, FLJ33365, NET67"	ENSG00000135253	"Kielin/chordin-like protein"		7	128862451-128910719	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	9	"ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;HMC-1: 7.6;U-87 MG: 3.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (6.12e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.33e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.01e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.64e-3)"	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	30.0	0.9	0.1	1.7	0.4	0.6	2.1	0.3	0.0		11.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	28.3	0.0	0.0	2.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	13.4	0.2	2.0	0.0	1.0	0.0	0.0	0.0	1.8	0.1	0.9	0.0	1.1	0.2	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005693	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 61.3;kidney: 50.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;RPTEC TERT1: 4.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									96000	96000				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favourable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.2	0.2	0.2	5.9	0.2	0.0	0.2	0.2	0.2	0.2	23.4	0.1	0.1	11.9	0.2	1.3	0.2	0.2	2.9	0.1	0.2	0.2	50.0	0.8	0.2	0.1	0.2	0.1	0.2	0.6	0.0	0.2	0.1	0.1	0.2	17.0	0.1	0.2	0.1	0.1	0.2	61.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	2.0	0.9	1.1	0.7	0.4	0.8	0.0	2.4	0.6	0.3	0.4	0.0	0.4	0.9	0.7	0.0	0.0	0.0	0.6	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.6	1.0	0.5	0.0	0.6	0.8	0.1	0.5	0.0	0.3	0.0	0.3	1.0	0.0	0.3	0.5	1.5	1.7	1.0	0.5	0.4	0.6	4.1	0.4	0.6	0.2	1.6	0.3	0.1	0.3	0.5	1.2	0.7	0.4	1.6	0.5	0.3	0.3	0.1	0.2	0.6	0.2	1.0	0.7	0.6	0.5	0.6	0.4	0.6	0.8	0.4	0.5	2.0	0.8	0.7	1.1	0.4	0.6	0.9	0.6	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324356-89498187	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"kidney: 65.2"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 15.4;TIME: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015475			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015475: AB_1854574"	"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1.0	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1.0	0.0	0.0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	15.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.2	0.3	0.0	34.4	0.1	2.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0.0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1.0	0.0
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"kidney: 81.4;liver: 248.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"liver cancer: 162.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					5700000	5700000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favourable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4.0	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10.0	5.0	8.3	8.4	12.8	7.1	17.1	14.9	12.1	14.7	27.3	21.3	13.2	15.9	11.2	10.6	12.8	20.2	11.5	24.4	20.4	11.6	12.2	26.4	22.5	21.5	8.5	11.4	17.7	10.1	21.6	12.5	6.5	2.8	18.4	7.8	14.9	16.4	13.7	31.5	5.3	14.2	22.3	13.8	17.8	19.0	27.3	16.0	8.8	7.0	25.6	12.4	13.1	6.5	10.1	7.0	11.0	17.9	8.6	8.3	8.3	5.2	13.9	6.3	12.7	17.4	12.0	14.4	13.8	5.3	0.1	8.3	5.0	6.5	7.0	8.3	12.1	9.4	9.5	10.0	9.5	12.2	12.8	1.5	8.4	7.0	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 128.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;EFO-21: 11.2;Hep G2: 31.9;HHSteC: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	0.7	0.9	2.6	0.5	6.2	0.4	0.9	2.5	3.6	0.9	0.5	15.1	0.0	0.4	0.9	0.7	0.6	1.1	0.9	0.6	3.4	3.1	128.6	7.0	0.8	0.5	9.3	2.1	1.8	3.0	0.4	0.6	12.9	6.5	2.3	0.5	8.1	1.7	0.6	0.6	1.0	0.4	0.9	7.8	0.5	1.7	2.7	5.6	0.0	0.8	0.0	0.6	1.0	0.4	0.6	2.4	2.7	0.4	0.7	0.9	0.0	0.0	0.0	0.9	3.3	5.0	4.7	9.8	2.0	1.2	1.1	0.8	0.0	0.0	0.1	11.2	0.1	1.2	0.0	1.5	2.6	0.0	0.3	3.8	0.2	31.9	11.2	0.0	2.8	6.3	4.4	6.4	3.2	0.0	8.5	0.2	0.0	0.3	0.0	0.4	6.0	0.0	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.0	2.3	0.5	1.7	0.1	0.1	0.1	2.4	5.1	0.0	0.3	0.6	0.0	0.3	0.0	0.2	2.7	0.4	0.3	0.9	0.2	0.2	0.4	0.3	0.3	0.1	0.6	0.6	0.6	1.3	0.7	0.3	2.4	0.3	0.0	2.6	6.2	2.5	3.6	3.4	3.1	9.3	2.1	6.5	5.6
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 61.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.8;U-2197: 3.7"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 2.1"	"HPA008549, CAB068236, CAB068237"	Approved									"CAB068236: AB_2665668, CAB068237: AB_2493103, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favourable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	61.8	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	1.9	0.1	0.0	2.7	0.0	0.6	0.3	0.0	0.1	0.1	6.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	3.7	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.6	0.3	0.2	0.1	0.8	0.8	1.9	0.0
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA044002, HPA062229"	Enhanced									"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.4	0.0	0.7	0.0	1.4	1.5	0.3	0.8	0.3	0.0	1.8	0.5	0.1	0.1	0.0	0.0	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.1	0.2	0.5	0.3	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0
SMIM32		ENSG00000271824	"Small integral membrane protein 32"		5	136191468-136193134	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	9	"brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2"	"Group enriched"	"Detected in some"	7	"HaCaT: 2.2;SCLC-21H: 6.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favourable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	0.0	1.2	2.2	0.0	0.0	0.0	7.8	0.0	5.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	9.8	0.0	0.6		26.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.1	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	1.5	0.0	1.4	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	6.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"kidney: 48.1;salivary gland: 35.6"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.4"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA054059	Enhanced									"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.1	0.0	0.1	0.4	2.1	0.0	0.1	1.2	0.0	0.0	4.3	0.3	0.1	0.2	0.1	0.0	0.4	0.0	0.1	0.1	48.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	35.6	2.9	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	1.1	0.8	4.1	0.7	4.6	1.2	0.2	0.4	0.4	0.7	1.5	0.3	0.3	1.4	0.6	0.2	0.1	0.3	1.1	1.7	0.9	0.6	0.1	0.8	0.0	0.0	0.3	0.6	1.2	1.3	1.0	0.7	0.1	1.0	0.9	0.5	0.2	0.1	0.4	0.5	1.2	1.9	0.3	0.2	0.4	0.8	0.3	0.3	0.6	0.9	0.7	4.4	1.7	1.3	1.1	0.4	1.0	0.2	1.2	0.3	0.1	1.8	0.9	1.4	0.7	1.6	0.5	1.1	0.8	0.4	0.8	4.1	0.7	0.7	0.9	0.6	1.2	0.7	0.5	0.6	0.3	1.1	0.6	0.6	3.4	4.6	0.6	0.8	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	8900000	8900000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HMC-1: 1.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056505	Enhanced					3600000	3600000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.1	0.1	0.1	23.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.1	0.1	0.1	1.0	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.9	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
KRTAP5-8	"KRTAP5-2, KRTAP5.8, UHSKerB"	ENSG00000241233	"Keratin associated protein 5-8"	O75690	11	71538025-71539207	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;RT4: 4.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (9.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.92e-2)"		"unprognostic (2.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.14e-1)"		"unprognostic (3.62e-2)"	"unprognostic (2.21e-3)"	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.3	0.4	0.0	0.2			0.3	0.0	3.4	0.0	0.1	0.2	0.0	0.2	0.3	7.1	0.1	0.2	0.1	0.2		0.0	0.0	0.1	0.0	0.0		0.0	0.2		0.1	0.2	0.4	8.7	0.4	0.0	0.1	0.1	0.0	2.7			0.1		0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Group enriched"	"Detected in some"	13	"CACO-2: 45.9;Hep G2: 25.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	45.9	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	25.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.0	0.7	0.7	2.7	0.9	0.4	1.8	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"kidney: 11.2"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 3.0;Karpas-707: 2.3"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"									HPA052019	Uncertain									"HPA052019: AB_2681696"													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.4	0.0		0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.0	0.1	1.2	2.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	19.0	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.1	4.4	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.9	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	3.5	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Cell line enriched"	"Detected in single"	42	"RH-30: 24.7"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018029, HPA064555"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	2.9	0.1	0.0	0.0	0.0	35.0	1.2	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"kidney: 7.4;liver: 25.0"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 68.6"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles				Vesicles	Vesicles	"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favourable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.1	0.3	0.0	7.4	25.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.8	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.4	0.0	0.5	1.4	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.2	2.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	1.3	0.0	0.2	0.1	1.8	3.6	0.0	0.3	0.1	0.0	0.7	0.2	2.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.2	0.2	1.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in some"	8	"CACO-2: 17.4;Hep G2: 15.3;SCLC-21H: 44.0;SH-SY5Y: 45.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		380000	380000	"Actin filaments"	"Actin filaments"	"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	44.0	45.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"kidney: 22.5"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.0	0.4	1.0	1.1	1.0	0.7	2.1	2.3	1.0	1.1	1.0	1.0	1.0	1.2	1.4	1.9	1.0	0.7	1.0	1.0	1.0	0.4	22.5	3.1	1.0	1.5	1.0	1.0	1.1	1.0	0.0	1.0	1.0	1.0	1.6	1.1	1.0	1.0	1.0	2.0	1.5	1.2	1.0	1.0	2.6	0.6	2.9	1.0	1.0	1.2	1.0	1.2	1.0	1.0	1.0	0.4	1.2	0.9	0.0	2.4	0.5	0.5	3.9	3.0	4.9	6.9	4.1	3.4	1.5	1.7	1.6	2.7	0.8	3.5	0.8	2.7	0.7	1.7	4.0	0.6	1.9	2.7	2.4	2.2	2.9	1.3	1.4	0.8	5.4	3.2	4.3	2.6	1.0	0.8	1.2	2.6	1.8	0.8	2.0	6.7	0.7	3.8	4.9	1.7	1.3	6.9	1.5	1.7	1.0	0.6	1.2	1.1	0.5	0.7	2.2	2.0	2.5	3.6	1.7	3.0	1.8	0.6	0.6	4.0	1.0	0.0	0.9	1.2	1.5	0.1	1.4	0.2	0.2	0.6	0.4	1.0	1.2	0.7	0.0	0.0	0.0	0.0	2.4	0.5	1.0	1.0	2.3	1.0	1.0	0.4	1.0	1.0	1.0	1.0
OR2T2	OR2T2P	ENSG00000196240	"Olfactory receptor family 2 subfamily T member 2"	Q6IF00	1	248445512-248455725	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 14.1"	"Cell line enriched"	"Detected in single"	22	"Karpas-707: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"																																					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	1.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836885-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 65.1;liver: 220.0"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 71.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	1.3	0.5	0.0	0.5	0.0	0.1	0.2	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	20.3	0.1	0.8	0.3	65.1	220.0	0.0	0.0	0.3	0.7	0.1	1.7	0.0	1.6	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	1.0	0.8	0.3	0.3	0.7	0.8	0.4
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183593-47191044	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 281.3"	"Group enriched"	"Detected in some"	6	"EFO-21: 30.8;RPTEC TERT1: 102.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"				Cytosol	Cytosol	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0.0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0.0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9.0	1.4	0.6	1.1	1.0	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	10.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.4	0.0	30.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	102.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.1	0.2	0.0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0.0	0.6	0.5	0.6	0.6
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278315	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 16.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;hTERT-HME1: 1.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.3"					"Low region specificity"	"Detected in all"			"HPA035603, HPA035962"	Enhanced									"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.3	0.0	2.3	0.0	0.2	0.5	0.1	0.6	0.4	0.5	0.1	0.3	0.0	0.2	0.3	0.0	0.5	0.9	0.2	0.1	0.8	0.4	0.7	0.1	0.4	0.1	0.0	2.2	0.0	0.1	0.0	0.8	0.0	0.5	0.1	1.5	0.0	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360202-140375143	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;Karpas-707: 1.0;U-266/70: 1.2;U-698: 2.6"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Low region specificity"	"Detected in all"			HPA051307	Uncertain									"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	26.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.7	0.2	0.3	0.0	0.8	0.1	0.3	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.3	0.1	0.0	1.2	0.6	2.6	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
SMIM35	TMPRSS4-AS1	ENSG00000255274	"Small integral membrane protein 35"		11	118003634-118088299	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	7	"blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.3;RPMI-8226: 8.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.1;olfactory region: 4.3"																	"unprognostic (8.83e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.64e-1)"		"unprognostic (1.58e-1)"		"unprognostic (3.04e-4)"		"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"			"unprognostic (1.64e-1)"			"unprognostic (1.88e-1)"	0.0	0.0		1.2		3.1	0.4		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.4	0.0			3.4	0.1	0.0	1.7			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		1.4	0.0	0.0			0.0		1.5	0.0		1.7	0.8	0.1	0.5	1.2	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.9	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.7	0.7	1.1	0.7	0.4	0.0	0.6	0.1	1.2	0.5	0.8	4.6	0.4										
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933808	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.0"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063175	Uncertain									"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.1	0.0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26.0	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 20.5"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"									HPA045108	Supported									"HPA045108: AB_2679218"			"prognostic favourable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favourable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003695, HPA036174, HPA036175"	Enhanced					28000000	28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: "	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.9	9.0	12.2	12.9	4.2	7.9	9.3	5.1	12.5	20.9	2.5	3.6	7.3	4.9	4.0	25.7	3.7	7.0	5.1	9.0	4.6	38.5	16.7	6.0	5.8	14.0	21.3	8.2	22.2	3.5	13.5	8.0	9.1	11.2	0.0	11.0	5.7	13.6	3.1	3.3	22.6	24.4	15.1	5.5	5.0	5.3	17.6	9.3	14.2	7.9	1.7	6.7	6.4	8.3	5.0	21.0	4.9	3.8	7.9	12.6	8.1	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7
C9orf66	FLJ31158	ENSG00000183784	"Chromosome 9 open reading frame 66"	Q5T8R8	9	212824-215741	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 20.9;kidney: 17.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;MCF7: 3.7;RT4: 3.5;THP-1: 7.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 20.9;monocytes: 6.0"									HPA035652	Uncertain									"HPA035652: AB_10601151"	"unprognostic (1.24e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.65e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.66e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.10e-3)"	0.5	3.1	0.3	0.3	0.9	1.7	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.1	0.3	0.3	0.3	0.1	17.8	0.5	0.3	0.3	0.3	0.3	0.5	1.3	1.9	0.3	0.3	0.3	0.7	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	1.4	0.2	0.7	0.8	0.3	1.3	0.3	0.3	0.4	0.3	2.0	3.0	20.9	6.0	1.6	0.6	0.6	0.1	0.4	0.3	0.4	0.1	0.1	3.5	0.1	0.0	0.2	0.1	0.7	2.1	0.4	1.0	0.3	0.6	0.1	0.0	0.0	0.2	1.1	0.3	0.5	0.3	0.1	0.8	1.1	0.2	0.1	0.1	0.0	0.0	1.9	0.8	0.0	3.7	0.2	2.4	0.4	0.8	0.4	0.3	2.1	0.1	3.5	0.6	0.4	0.0	0.2	0.5	1.6	7.6	1.1	0.3	0.8	0.5	0.2	0.9	0.4	0.1	0.2	1.3	0.6	7.0	4.9	8.0	0.3	3.3	0.1	1.8	0.6	0.4	3.0	2.0	0.1	0.2	20.9	1.6	6.0	0.7	0.1	0.6	0.3	0.9	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.8
CD24	CD24A	ENSG00000272398	"CD24 molecule"		6	106969831-106975627	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	6	"kidney: 383.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 65.1;RPTEC TERT1: 307.7;SK-BR-3: 89.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	26	"eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0"	"Group enriched"	"Detected in many"	202	"B-cells: 23.4;granulocytes: 30.4"									"HPA045879, CAB078471"			Enhanced	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavourable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	0.5	0.5	12.8	2.4	9.9	17.9	25.5	0.5	2.9	69.5	30.6	0.7	1.6	1.2	34.5	5.9	38.1	6.0	25.1	4.2	22.7		383.7	0.8	0.7	0.9	4.8	7.2	15.6	40.0	0.0	5.7	48.2	13.0	3.2	21.2	0.7	15.9	16.6	0.4	0.5	0.8	2.2	4.9	0.7	16.4	0.5	6.5	0.4	48.8	1.2	11.3	4.0	8.1	23.4	0.0	30.4	0.1	0.0	0.0	0.6	22.9	14.2	0.2	1.8	0.0	0.0	27.0	0.0	0.1	0.1	0.0	0.2	0.1	2.2	7.1	0.0	47.5	8.1	17.9	0.1	0.0	0.1	0.0	17.6	1.0	0.0	0.3	0.1	0.1	20.7	0.2	1.2	0.1	0.5	0.0	0.4	28.8	0.1	0.1	65.1	5.5	53.8	0.0	0.2	307.7	59.3	40.3	29.7	16.3	89.5	0.0	41.3	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.1	30.4	0.3	0.1	0.1	0.1	0.0	30.4	0.0	0.0	0.0	23.4	0.0	0.0	0.0	15.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6										
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112995-55173175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.4;T-47d: 3.3;U-87 MG: 1.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 0.4"					HPA053900	Uncertain									"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.1	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.3	3.3	0.0	0.4	0.0	0.2	0.7	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 19.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;BEWO: 3.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"					"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.1	1.3	0.3	0.0	0.8	0.3	0.1	0.1	0.1	0.1	0.2			0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.5	19.6	0.1	0.1	0.1	0.3		0.1	0.3	0.0	0.1	0.0		0.1	0.1		0.7	0.1	0.0	0.1	0.5	0.0	1.0	0.7	0.5	3.4			0.1		0.1	0.4	0.0	0.9	0.3	1.6	0.0	0.5	0.1	0.0	0.3	0.3	2.7	0.2	0.0	0.7	3.5	0.0	0.0	0.6	0.2	0.6	0.1	0.5	0.3	0.0	0.0	0.0	0.4	0.3	0.6	0.9	0.0	0.0	1.5	0.0	0.7	1.8	0.0	1.4	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.9	1.5	0.1	0.8	0.0	0.1	0.7	1.6	0.0	0.6	1.9	0.2	0.0	0.7	0.8	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0										
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 45.5"	"Cell line enriched"	"Detected in single"	140	"Hep G2: 28.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	8.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0										
CRYAA2		ENSG00000276076	"Crystallin alpha A2"		21	6560714-6564489	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"kidney: 34.4"	"Cell line enriched"	"Detected in single"	200	"Hep G2: 28.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			34.4	5.3	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0										
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced									"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.2	3.5	1.0	0.0	5.2	4.5	1.1	4.0	1.2	2.6	2.9	15.1	5.2	0.0	15.7	3.9	4.0	0.0	3.3	5.5	11.0	3.7	5.8	0.9	15.2	3.4	0.7	0.1	6.3	4.3	2.6	2.4	3.8	3.8	4.3	5.0	4.3	0.1	3.4	2.1	4.4	0.0	7.0	0.3	10.8	4.7	3.1	4.5	7.8	4.5	7.2	16.6	6.8	1.8	1.7	2.6	1.3	0.3	1.2	3.7	0.3	0.5	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.7;U-87 MG: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	100	"olfactory region: 45.5"	HPA000886	Uncertain									"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0										
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CACO-2: 6.2;EFO-21: 12.3;K-562: 5.2"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001220	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA001220: AB_1078933"	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.6	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.2	3.1	0.3	12.3	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	5.2	0.6	0.0	0.1	0.3	0.8	3.2	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8
HAVCR1	"CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1"	ENSG00000113249	"Hepatitis A virus cellular receptor 1"	Q96D42	5	157029413-157059119	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 37.6"	"Group enriched"	"Detected in some"	6	"A549: 35.8;CACO-2: 43.0;RPTEC TERT1: 17.1"	"Cancer enriched"	"Detected in many"	12	"renal cancer: 26.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA007173, CAB075697"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB075697: , HPA007173: "	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.46e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.20e-2)"		"unprognostic (3.21e-1)"	"unprognostic (8.70e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.10e-3)"	"prognostic unfavourable (7.81e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.32e-4)"	0.4	0.1	0.2	1.0	0.2	0.9	0.2	0.2	0.2	0.2	6.7	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.5	0.2	0.3	0.2	37.6	0.5	0.6	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	5.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.5	0.5	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.3	0.2	1.3	1.2	2.0	1.8	2.1	3.4	2.3	0.0	35.8	0.1	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	43.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.0	1.8	0.5	0.7	1.1	1.0	0.8	1.8	0.9	1.2	1.3	3.4	2.5	1.3	2.1	0.8	0.8	2.8	2.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		320000	320000	Cytosol	Cytosol	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040778-6054049	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 9.5;kidney: 13.0;lung: 36.4"	"Cell line enriched"	"Detected in some"	13	"RPTEC TERT1: 39.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									32000	32000				"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	9.5	0.1	0.0	2.4	1.1	0.1	0.1	0.0	0.2	0.7	2.2	0.0	0.0	0.1	0.1	2.8	0.1	1.5	0.1	1.1	0.0	0.2	13.0	0.4	36.4	0.1	0.0	0.0	1.6	2.6	0.1	0.0	3.4	0.0	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	39.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.4	0.2	0.9	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1, nephrin"	O60500	19	35825964-35869287	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 20.2;pancreas: 21.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced									"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	3.4	0.0		0.0	21.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4			0.0		1.9	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.8	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.0										
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278950	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 69.3;thyroid gland: 120.5"	"Group enriched"	"Detected in some"	10	"EFO-21: 26.7;RPTEC TERT1: 63.0"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.8"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: "	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	0.9	1.4	1.1	0.5	0.4	0.0	0.6	0.2	0.8	3.8	0.4	0.2	11.7	0.1	2.2	15.2	0.6	9.6	0.8	0.6	0.5	0.5	69.3	0.4	0.5	0.7	0.4	0.3	3.8	0.6	0.1	0.7	0.8	1.5	1.1	0.1	0.5	0.5	10.0	0.3	0.5	0.6	0.4	0.8	0.3	0.4	1.9	0.2	0.4	120.5	0.0	0.2	0.8	1.9	4.4	2.8	1.5	3.4	1.9	2.5	1.1	2.9	0.2	0.1	0.0	0.1	0.0	1.0	0.8	2.6	0.2	0.4	1.8	0.5	0.5	26.7	0.2	0.0	0.5	0.8	0.2	1.2	0.0	0.4	0.2	1.0	0.3	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.4	2.0	0.8	0.6	0.3	1.2	0.1	1.8	0.0	0.2	0.6	63.0	4.6	0.5	0.0	3.3	0.0	1.8	0.0	1.1	0.9	4.6	0.1	0.8	2.3	0.4	1.3	0.1	4.0	0.6	0.0	1.5	3.4	0.0	0.6	1.8	1.5	4.4	1.5	1.1	2.8	1.9	2.5	1.5	0.5	1.9	1.3	1.1	0.8	1.1	1.1	0.4	0.2	0.8	0.5	0.5	0.4	0.3	1.5	0.2
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028709-101325135	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.5;kidney: 24.4"	"Group enriched"	"Detected in some"	4	"Hep G2: 5.6;SCLC-21H: 10.3"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: "	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.8	0.9	12.6	0.7	38.5	0.7	1.4	1.7	24.4	1.0	0.9	7.6	0.0	0.8	0.8	5.2	0.8	1.0	0.9	0.8	12.7	7.0	24.4	5.0	2.8	0.7	7.5	5.5	0.7	1.1	0.7	0.1	0.8	5.3	1.0	1.0	0.1	1.1	0.8	0.8	0.8	0.8	0.8	10.2	0.7	0.9	1.5	9.3	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	10.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	38.5	1.7	6.4	12.7	7.0	7.5	5.5	5.3	9.3
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7123684-7128942	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3"	"Cell line enhanced"	"Detected in many"		"HEL: 6.8;Hep G2: 15.2;K-562: 31.3"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.3;T-cells: 2.4"					"Low region specificity"	"Detected in all"			HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favourable (3.68e-4)"	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0.0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0.0	6.2	2.0	0.7	10.1	2.3	1.4	0.1	0.0	1.3	0.0	0.0	2.4	0.1	1.8	3.1	0.0	1.0	0.0	0.0	0.7	1.1	0.0	0.0	0.2	1.7	1.9	1.1	0.5	0.0	2.2	0.1	0.0	0.0	2.7	0.0	6.8	4.9	15.2	0.0	0.4	2.0	0.3	0.1	0.0	0.0	0.0	31.3	1.4	0.0	0.0	0.1	0.4	0.4	0.1	0.4	0.0	0.1	0.1	2.6	0.1	0.3	2.7	1.1	0.0	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.4	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0.0	0.1	0.0
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 88.6"	"Group enriched"	"Detected in some"	12	"BEWO: 10.1;HAP1: 5.6;HeLa: 11.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028748	Enhanced									"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	88.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	14.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199986	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 67.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			"HPA053615, HPA062714"	Enhanced									"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favourable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.2	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 5.0;RT4: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.7"	HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.3	0.3	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.4	0.5	0.2	3.0	0.0	0.4	0.0	0.0	0.0	5.0	0.2	0.3	0.5	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.5	0.1	0.2	1.4	0.6	0.2	0.6	0.4	0.0	8.9	0.2	0.3	0.2	0.5	0.1	0.2	0.2	0.6	0.6	1.4	0.9	0.3	0.3	0.2	0.1	0.7	0.2	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell line enriched"	"Detected in some"	7	"A549: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA077996			Uncertain	Nucleoli,Centrosome				Centrosome	Centrosome	"HPA077996: AB_2686873"																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	9.9	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HUVEC TERT2: 1.9;U-266/70: 3.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"											"HPA017261, HPA045108"	Uncertain									"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.9;kidney: 24.7;liver: 59.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 13.3;MOLT-4: 15.5;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		51000	51000	Nucleoplasm	Nucleoplasm	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	1.3	3.2	11.7	1.6	16.2	1.3	0.9	7.4	26.9	0.9	1.0	8.9	0.0	6.9	1.1	0.9	1.2	0.9	2.3	1.2	12.9	8.3	24.7	59.8	1.1	1.6	9.2	9.8	0.9	1.5	0.9	7.7	0.9	4.1	1.2	0.9	1.0	2.3	0.9	1.1	1.8	2.9	0.9	5.1	1.4	1.1	1.1	6.6	1.3	1.7	0.0	0.9	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.3	0.0	0.5	3.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	1.6	15.5	0.1	0.0	0.3	0.3	0.3	1.0	0.0	0.2	1.7	9.2	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	3.7	0.7	1.9	0.2	2.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.7	16.2	7.4	26.9	12.9	8.3	9.2	9.8	4.1	6.6
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		4500000	4500000	Cytosol	Cytosol	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.6	1.1	1.3	2.2	8.8	22.5	4.2	13.9	86.6	2.7	8.4	4.9	3.2	0.0	9.4	28.6	82.0	5.7	0.5	1.9	2.0	2.6	0.0	1.8	12.7	30.7	1.7	0.1	14.8	79.7	4.4	8.0	0.1	0.4	51.7	2.7	57.6	0.6	24.3	1.8	2.5	0.1	1.5	132.8	7.6	5.8	33.4	0.5	49.5	52.2	3.9	35.8	99.5	0.0	1.1	6.9	0.2	1.2	8.6	8.2	2.9	21.8	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154228	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 56.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.2;U-87 MG: 9.5"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favourable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	6.6	0.3	0.2	1.3	0.3	0.8	0.3	0.2	0.2	0.2	1.5	0.0	11.9	0.7	0.2	1.0	0.2	0.2	0.1	0.2	0.3	0.3	56.8	0.3	12.2	1.2	0.5	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.8	2.0	5.7	1.1	1.2	0.2	0.9	1.0	0.0	0.3	0.4	0.3	0.2	0.0	1.0	0.4	0.3	0.6	0.3	0.2	2.2	1.7	4.6	1.0	2.0	1.5	0.3	0.6	1.3	0.7	0.8	0.0	0.6	2.5	0.0	0.0	1.1	0.3	0.3	0.4	0.4	0.3	0.1	2.8	0.8	1.8	0.5	0.4	0.1	0.9	1.8	0.2	0.0	0.8	1.5	0.6	0.1	1.0	0.8	0.5	0.5	0.8	0.5	1.0	0.0	0.8	0.3	0.2	0.2	0.3	0.3	0.0	1.2	3.8	0.3	0.1	0.9	6.2	2.0	0.1	0.3	0.7	0.9	0.8	0.5	0.5	0.2	0.7	9.5	0.7	0.8	2.6	1.0	0.8	1.1	0.5	0.8	1.2	1.0	0.9	0.5	2.2	1.5	1.3	4.6	2.0	1.0	1.7	0.9	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.0	0.0
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935868-70965431	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 37.9;placenta: 29.0;salivary gland: 106.9"	"Group enriched"	"Detected in some"	9	"BEWO: 13.5;HaCaT: 12.4;SK-BR-3: 30.6"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	12	"monocytes: 1.4;T-cells: 1.0"	"Not detected"	"Not detected"							"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	0.6	0.0	0.1	0.1	0.1	0.0	4.4	0.8	0.2	12.2	0.1	0.1	6.9	0.1	0.5	0.4	0.5	5.0	0.1	0.3	0.1	0.0	37.9	0.1	2.1	0.1	0.1	0.1	2.0	1.1	0.0	1.7	29.0	0.1	0.6	0.0	7.4	106.9	1.1	0.1	11.8	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.3	0.1	1.6	1.1	0.1	0.2	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.2	0.2	0.3	0.8	1.6	1.9	13.5	0.2	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.7	12.4	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.3	0.9	0.4	30.6	0.0	0.3	0.0	0.2	0.4	0.1	0.6	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.0	0.1	0.1	0.1	0.1
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 139.4;liver: 39.3"	"Group enriched"	"Detected in some"	5	"hTCEpi: 15.9;RPTEC TERT1: 9.8"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		25000	25000	Vesicles	Vesicles	"HPA007600: AB_1845284, HPA027823: "	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0.0	2.2	2.0	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0.0	8.9	1.6	0.7	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory beta subunit"	Q8WZ55	1	54998193-55011784	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 3.9;kidney: 12.3;salivary gland: 4.2"	"Cell line enriched"	"Detected in single"	20	"RPMI-8226: 12.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"					"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced									"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.0		4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.4	0.2	3.9	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.3	0.2	0.5	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.9	0.1	0.4	0.2	0.1	0.1										
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.9;parathyroid gland: 15.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 12.7"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057717	Approved									"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.2	0.7	0.2	0.2	0.2	0.0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0.0	0.2	4.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.0;K-562: 7.4;U-266/70: 2.8"	"Group enriched"	"Detected in some"	12	"glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0.0	1.0	1.0	28.1	0.1	0.0	0.1	1.0		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0.0	0.2	0.0	0.2	0.1	2.0	0.1	0.1	6.1			0.1		0.1	0.0	0.6	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	1.6	3.0	1.8	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	1.1	0.5	1.1	1.0	0.0	0.1	0.3	0.3	0.4	0.3	0.1	0.7	0.0	0.3	1.8	0.4	0.1	0.1	0.0	7.4	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.4	0.0	1.6	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.9	2.8	1.6	0.3	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0										
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10308026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 30.2;K-562: 30.7;PC-3: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					590000	590000			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	5.7	13.9	8.1	6.1	7.7	2.0	13.1	4.1	7.8	5.6	38.3	2.9	5.2	47.0	4.3	6.1	3.0	5.1	21.6	11.4	7.8	5.1	81.7	83.7	5.5	2.1	5.8	7.6	10.6	6.5	13.9	6.0	1.3	5.1	8.6	17.8	4.8	3.5	8.4	70.6	1.4	71.4	5.0	7.0	1.4	14.4	3.9	4.1	1.3	7.3	10.5	1.6	6.4	4.8	0.8	0.6	3.0	1.2	0.7	2.1	0.8	3.6	4.3	5.0	12.6	20.1	23.1	27.4	6.2	6.7	2.0	2.8	1.7	18.7	0.0	10.4	4.5	0.1	11.7	7.9	2.4	0.2	8.8	16.4	19.7	14.1	6.2	0.1	0.1	30.2	5.2	4.1	3.8	6.0	30.7	0.2	7.0	0.7	0.1	0.6	7.7	29.6	3.6	0.0	0.4	18.5	2.3	4.0	6.2	14.8	1.3	0.4	10.3	0.6	1.7	3.0	3.9	4.8	0.0	0.1	0.0	0.0	4.9	0.0	0.0	2.1	1.2	0.5	1.5	0.5	2.1	0.3	1.7	0.7	0.6	0.8	0.8	1.6	3.0	0.7	0.3	0.5	0.2	0.8	8.1	7.7	4.1	7.8	7.8	5.1	5.8	7.6	5.1	4.1
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823964-17129831	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 28.9;kidney: 79.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 17.8;ASC TERT1: 4.5;SK-MEL-30: 3.3;WM-115: 6.7"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	240000	240000			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.3	0.3	0.3	0.3	0.6	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.3	0.0	0.4	11.5	0.3	1.6	0.3	0.3	0.3	0.3	79.7	0.3	0.3	0.4	0.3	0.3	2.0	0.3	0.6	1.7	1.1	0.3	0.6	0.1	0.3	0.3	0.3	0.3	0.3	28.9	0.3	0.3	0.5	0.1	1.2	0.3	0.3	3.1	0.3	0.3	0.3	0.3	0.8	1.2	0.9	0.2	0.6	1.4	0.0	0.0	0.1	1.8	17.8	0.6	4.5	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.6	0.2	1.8	0.1	0.3	0.2	0.0	0.3	0.2	0.3	0.1	0.1	0.4	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.1	1.8	0.1	0.2	0.3	0.2	0.6	0.1	0.0	0.5	0.1	6.7	0.9	0.2	0.0	0.8	0.0	1.0	0.4	0.4	0.2	0.0	0.8	0.8	1.4	0.6	0.6	0.0	1.2	0.7	0.0	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152003	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 65.9;liver: 80.5;testis: 45.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.4;MCF7: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdTCR: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 1.5;T-cells: 4.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 24.7"	HPA057167	Enhanced									"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favourable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	3.3	2.3	4.0	0.8	4.7	0.9	6.3	0.9	4.0	5.1	1.6	1.9	6.5	0.8	3.1	11.0	8.3	4.9	1.9	2.6	2.6	2.5	65.9	80.5	1.2	2.0	2.7	1.9	13.1	4.3	6.2	8.8	2.3	2.7	3.8	0.9	4.8	7.6	7.8	0.6	5.1	0.8	2.4	1.5	2.4	1.1	45.0	1.9	1.1	4.0	3.9	12.9	3.8	6.2	0.2	0.0	0.2	0.2	1.5	4.8	1.0	5.2	1.8	5.3	10.1	2.0	0.6	5.3	5.4	12.0	7.5	3.3	9.0	2.6	0.2	9.1	1.3	4.7	9.3	7.6	5.2	0.2	8.4	0.1	1.0	13.8	8.0	0.2	0.3	2.7	26.4	1.6	0.3	5.4	0.7	0.2	0.9	25.5	1.5	0.1	11.1	4.0	0.4	6.3	0.2	6.5	2.0	1.4	7.6	3.4	16.1	2.5	15.6	0.3	0.3	2.1	11.7	0.4	3.9	0.2	0.1	0.2	0.1	0.2	3.0	0.1	0.2	0.0	4.8	0.0	4.6	0.0	1.3	2.9	0.0	0.2	2.9	3.6	0.2	1.5	0.1	0.0	0.7	1.0	4.0	4.7	0.9	4.0	2.6	2.5	2.7	1.9	2.7	1.9
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 65.0;heart muscle: 35.5;kidney: 41.5"	"Cell line enhanced"	"Detected in some"		"BJ: 19.3;BJ hTERT+: 14.4;BJ hTERT+ SV40 Large T+: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 28.8;hTEC/SVTERT24-B: 20.1;LHCN-M2: 13.4;U-2 OS: 14.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (3.45e-5)"	"unprognostic (3.01e-4)"	7.3	3.5	44.2	2.0	43.1	1.5	9.7	10.5	59.9	1.8	1.7	65.0	0.0	1.6	3.1	8.7	2.3	2.1	2.7	35.5	47.4	33.0	41.5	2.0	2.9	1.4	62.6	13.8	1.5	1.4	3.4	1.6	2.3	36.3	2.2	1.8	0.8	5.8	2.6	2.3	2.0	1.7	2.6	57.7	5.5	1.1	2.2	48.6	0.0	4.9	0.8	2.2	1.7	0.4	1.2	1.0	1.8	0.6	0.1	2.3	0.2	2.3	0.1	0.1	0.7	0.5	1.5	0.8	19.3	14.4	16.0	20.2	0.1	0.1	0.5	1.4	6.6	0.3	0.0	1.5	28.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.2	0.7	0.5	20.1	1.2	0.0	0.0	0.7	13.4	0.3	0.0	0.4	0.6	0.6	0.1	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.4	0.2	0.0	0.1	0.4	2.6	14.4	0.3	9.1	0.3	0.1	0.1	3.6	0.1	0.7	0.3	0.3	1.8	2.3	0.1	1.8	0.4	0.8	0.9	0.2	1.2	0.9	1.9	1.7	0.1	0.6	1.0	0.5	0.2	44.2	43.1	10.5	22.6	47.4	33.0	62.6	13.8	36.3	48.6
FMO1		ENSG00000010932	"Flavin containing monooxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 70.4"	"Cell line enriched"	"Detected in some"	7	"HSkMC: 21.5"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	36	"naive B-cell: 3.5"	"Lineage enriched"	"Detected in single"	36	"B-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023680	Uncertain									"HPA023680: AB_1848966"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	3.4	3.6	0.1	0.1	0.3	0.0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0.0	2.5	3.0	5.0	3.3	1.8	0.9	0.1	0.0	70.4	1.0	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0.0	4.0	4.2	1.5	0.1	4.0	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.2	0.1
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686432-37745247	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.7;kidney: 66.2;pancreas: 18.6"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"					"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Group enriched"	"Detected in some"	5	"basal ganglia: 0.7;hypothalamus: 2.3"	"Low region specificity"	"Detected in some"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (2.51e-6)"	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.1	4.5	0.0	4.8	3.8	0.9	7.8	0.0	2.8	34.7	0.0	0.0		66.2	7.7	3.7	0.0	0.0	0.0	0.8	18.6	1.6	0.0	0.6	0.0	1.6	3.4	0.0	0.0	3.8	0.0	0.0	5.5	0.3	0.0	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	52.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621159-48626356	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031463			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031463: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	0.8	0.1	1.9	0.2	0.0	0.4	0.1	0.3	5.3	16.6	0.1	27.3	0.0	1.4	42.8	0.1	0.4	0.1	0.1	0.1	0.1	15.3	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.2	1.1	10.4	0.1	0.1	23.5	0.2	0.2	11.3	1.0	3.5	0.2	0.2	2.0	0.1	0.1	0.1	0.1	0.1	2.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	1.3	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	1.6	0.0	8.3	0.2	0.0	1.3	0.0	0.0	77.4	29.8	13.5	0.5	0.0	0.5	0.2	30.6	0.0	0.0	0.0	0.8	0.0	32.8	0.0	1.3	0.0	0.0	0.1	0.0	1.2	0.0	5.2	0.4	13.5	0.0	0.0	0.0	1.0	0.0	8.5	0.1	0.0	0.1	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1
KCNE1B		ENSG00000276289	"Potassium voltage-gated channel subfamily E regulatory subunit 1B"	A0A087WTH5	21	7816675-7829926	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.9;SK-MEL-30: 2.5;U-266/70: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.0;eosinophil: 4.0"	"Group enriched"	"Detected in many"	17	"granulocytes: 4.0;monocytes: 1.6"																				"unprognostic (5.41e-4)"	"unprognostic (8.78e-2)"		"unprognostic (7.14e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.34e-2)"		"unprognostic (1.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.24e-1)"		"unprognostic (1.73e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.49e-1)"			0.0	0.0		0.0		0.0	1.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	8.2	0.0	8.3			3.8	0.4	1.2	0.0			0.0	0.0	0.8		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.9		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	4.0	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.7	0.5	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	3.0	1.6	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.2										
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.4;SK-MEL-30: 3.6;U-266/70: 3.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced									"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.6	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.7	1.7	0.0	0.2	0.2	1.7	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Group enriched"	"Detected in some"	5	"HMC-1: 5.0;SK-BR-3: 9.4"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480982-18486126	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 36.4"	"Cell line enhanced"	"Detected in some"		"A549: 5.2;CAPAN-2: 10.2;EFO-21: 5.2;NTERA-2: 5.7;RPTEC TERT1: 11.6;RT4: 9.2;T-47d: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favourable (1.88e-4)"	0.6	0.0	0.0	0.3	0.2	0.0	5.0	0.5	0.5	2.5	0.6	0.7	2.6	0.3	0.0	2.6	1.8	0.8	7.4	0.3	0.0	0.0	36.4	6.9	1.4	0.0	0.1	0.6	0.2	5.7	0.0	0.3	0.3	2.9	0.5	0.7	2.8	2.2	1.2	0.0	0.1	0.4	1.0	0.1	0.0	4.8	0.2	0.0	0.0	1.6	0.3	0.8	5.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	5.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.0	10.2	0.0	5.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.2	0.0	0.0	11.6	9.2	2.8	0.0	0.0	0.8	0.0	10.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.6	2.9	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.0;kidney: 5.7;seminal vesicle: 7.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 8.1"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 21.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 20.4"	"HPA044307, HPA073521, HPA074382"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	15.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1		5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.9	0.0	1.5	0.0	0.0	0.0	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1										
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.6	0.1	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.5	34.8	0.0	0.0	0.0	0.1	9.9	5.8	0.0	3.1	0.4	0.0	0.1	0.1	0.0	15.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	152.3	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968632-84002776	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.6;brain: 42.5;kidney: 12.4;liver: 15.1"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;SCLC-21H: 28.6;U-87 MG: 10.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 30.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA013998, HPA014144, CAB068211"	Enhanced	Supported								"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	1.8	1.1	34.1	1.3	42.5	1.3	0.9	0.2	35.2	0.7	1.1	2.2	0.0	1.9	2.2	0.9	0.7	0.7	1.3	1.0	9.5	21.7	12.4	15.1	1.0	0.8	5.0	14.0	0.7	2.1	1.6	3.3	0.9	7.4	0.8	0.9	0.1	0.6	0.8	0.5	0.7	1.7	1.2	1.9	1.1	2.8	5.4	5.9	0.0	0.8	0.0	0.5	1.1	0.0	0.0	0.0	30.6	0.4	0.0	0.0	0.0	0.1	3.7	7.5	0.0	0.0	1.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.2	0.1	0.0	1.3	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.1	0.0	1.2	0.4	0.1	0.2	0.2	0.1	0.1	0.1	0.0	4.3	0.0	0.0	3.9	0.5	0.0	0.0	0.4	0.0	0.0	28.6	1.2	0.0	0.1	2.2	3.8	1.3	0.2	0.1	2.2	0.3	0.0	0.1	0.0	0.0	10.1	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	34.1	42.5	0.2	21.2	9.5	21.7	5.0	14.0	7.4	5.9
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1, fibrocystin/polyductin"	P08F94	6	51615300-52087625	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 19.8;kidney: 49.4;pancreas: 32.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 15.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced									"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favourable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	5.6	0.0	0.1	19.8	0.1	0.1	6.3	0.1	0.1	0.1	49.4	2.5	0.1	0.0	0.1	0.0	0.1	32.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.1	0.5	1.4	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	15.4	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell line enriched"	"Detected in single"	18	"HEL: 13.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015095, HPA056839"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877746-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 90.4"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 50.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007978	Approved									"HPA007978: AB_1854967"	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favourable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	8.5	17.9	4.2	1.4	5.9	0.8	5.0	3.7	5.0	6.2	2.3	5.2	1.1	1.5	4.5	2.5	2.3	3.8	2.8	4.3	5.5	3.9	90.4	13.4	4.1	6.9	6.0	5.0	5.4	1.6	1.0	0.9	10.1	4.7	3.2	1.2	3.4	1.5	3.0	4.0	2.6	1.8	4.6	4.1	9.6	1.5	2.2	5.7	0.0	1.2	0.6	1.0	2.8	5.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.3	0.0	50.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	5.9	3.7	5.0	5.5	3.9	6.0	5.0	4.7	5.7
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 25.6;brain: 54.9;kidney: 23.5"	"Cell line enriched"	"Detected in some"	5	"AF22: 9.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA055868, HPA059112"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			1.1	25.6	14.0	1.1	23.0	1.2	1.1	54.9	38.2	0.9	1.3	1.1	0.0	1.4	1.1	1.8	0.9	1.7	7.1	3.7	14.9	22.6	23.5	1.3	1.1	1.0	14.7	20.0	1.0	3.7	1.0	7.6	2.4	9.8	1.2	1.5	0.4	1.1	3.4	1.1	1.2	1.8	1.1	4.6	3.8	1.6	1.4	3.5	0.0	1.1	0.0	1.0	1.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	1.1	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.6	0.1	0.2	0.1	0.5	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.4	0.4	0.0	1.0	0.0	0.0	0.0	1.8	0.3	0.2	0.5	0.2	0.2	0.0	0.9	0.4	0.2	0.4	0.2	0.5	0.5	0.2	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	14.0	23.0	54.9	23.0	14.9	22.6	14.7	20.0	9.8	3.5
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Group enriched"	"Detected in some"	65	"CACO-2: 4.7;Hep G2: 5.6;RT4: 9.7"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favourable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced									"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.8;U-251 MG: 8.3;U-937: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favourable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.5	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.3	6.1	0.1	0.4	3.3	2.3	0.0	16.4	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.8	0.1	0.3	0.0	2.7	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 62.3"	"Cell line enriched"	"Detected in single"	217	"RPTEC TERT1: 50.6"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdTCR: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 10.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain									"HPA045015: AB_2679183"							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	2.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 70.6"	"Cell line enriched"	"Detected in some"	5	"U-937: 10.7"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.0;non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 7.9"	"Not detected"	"Not detected"							HPA052014	Uncertain									"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.1	0.1	0.1	0.5	0.1	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.1	0.0	70.6	0.4	0.3	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.1	0.1	0.1	0.1	0.7	1.1	0.1	0.2	3.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	1.2	0.1	7.9	0.0	0.6	0.5	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.1	0.0	0.0	0.1	3.0	0.0	0.4	0.3	0.0	1.2	0.3	0.6	0.2	0.0	0.0	7.9	0.0	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210407	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2"	"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 8.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.8	0.0	1.9	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	1.4	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.6	0.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296549	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 55.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.4	0.3	0.7	0.7	5.4	0.3	0.2	1.8	0.3	1.9	0.0	5.2	1.4	0.2	0.6	0.3	0.3	1.6	1.1	0.3	0.4	55.9	5.2	11.0	0.2	0.3	1.0	0.3	0.9	0.0	0.7	0.1	0.2	0.4	0.5	0.0	3.2	11.8	0.3	0.6	2.1	0.0	0.3	1.6	0.4	1.3	0.0	1.5	1.0	0.3	0.1	0.7	1.1	0.1	0.4	10.0	1.1	2.6	4.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.5	44.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	11.3	0.0	7.9	1.1	7.5	4.3	0.0	0.4	0.0	0.7	2.3	0.4	0.1	0.2	1.5	10.0	2.6	0.0	0.3	0.0	1.0	0.3	0.7	0.2	1.8	0.3	0.4	0.3	1.0	0.2	0.0
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;HEL: 9.2;hTCEpi: 10.6;RPTEC TERT1: 26.2;RT4: 18.9;SCLC-21H: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favourable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.2	2.7	2.6	0.0	0.0	1.9	9.2	0.0	0.0	0.0	0.0	0.3	0.0	10.6	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	26.2	18.9	8.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540867	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 16.0;kidney: 64.2"	"Group enriched"	"Detected in some"	15	"EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.3;SK-BR-3: 3.6"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favourable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	0.5	2.0	0.4	0.6	0.4	0.0	0.4	0.9	0.4	0.6	5.6	0.4	0.4	1.0	4.3	0.8	4.3	2.7	0.7	3.0	0.4	0.0	64.2	0.9	0.4	0.4	0.4	0.4	0.6	0.4	0.0	0.4	2.6	0.4	1.8	0.0	0.4	0.4	0.4	0.7	0.2	16.0	0.9	0.4	0.4	1.7	0.6	0.4	0.4	0.4	0.4	0.5	6.0	0.6	0.0	0.1	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	1.9	0.0	6.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.9	0.4	0.4	0.0	0.4	0.4	0.4	0.4
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911200-44937002	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.5;retina: 17.1"	"Group enriched"	"Detected in some"	118	"RPMI-8226: 25.5;U-937: 15.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.2;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039894, HPA062907"	Enhanced									"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favourable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.1	0.0	0.1	0.9	0.2	0.1	0.0	0.3	0.2	0.0	4.2	1.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.3	46.5	0.1	0.0	0.0	0.4	0.0	0.0	5.7	0.1	0.3	0.0	4.9	0.0	4.9	17.1	2.7	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.9	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	1.2	0.3	0.4	0.0	4.9	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;EFO-21: 20.8;HaCaT: 74.4;RT4: 37.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009819, HPA054065"	Enhanced									"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.4	0.0	20.8	0.0	74.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	37.6	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in some"	5	"EFO-21: 20.5;RPTEC TERT1: 81.6"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain									"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favourable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	81.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;REH: 1.5"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.1	1.2	1.3	1.5	0.3	0.0	0.3	0.6	0.7	0.4	0.5	0.5	0.0	0.8	0.2	0.0	0.2	0.3	0.0	0.0	1.3	0.1	0.4	0.4	1.3	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Group enriched"	"Detected in some"	5	"HHSteC: 56.9;HSkMC: 38.0"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdTCR: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"		960000000	960000000	"Cell Junctions"	"Cell Junctions"	"CAB000154: , HPA034796: AB_2674333, HPA069867: "	"unprognostic (2.96e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.2	0.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	38.0	0.0	10.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6
AC117457.1		ENSG00000275163			3	178419123-178843300	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 5.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.0	11.8	0.0	12.2	0.3	0.2	0.3		5.2	0.2	1.5	0.0	0.0	0.0	2.6	2.9	0.0	19.9	0.0	11.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041458	Enhanced		Supported	Mitochondria		63000	63000	Mitochondria	Mitochondria	"HPA041458: AB_2677491"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favourable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.5	6.8	5.1	9.3	7.0	8.7	4.5	5.9	12.0	5.9	6.0	6.0	3.1	10.0	4.1	5.0	4.0	7.9	4.1	9.9	6.5	8.2	5.2	2.1	34.6	4.9	7.3	5.0	6.4	4.2	3.7	3.4	5.7	5.0	7.4	7.4	4.4	7.0	6.1	3.1	4.3	8.3	10.7	3.1	8.5	10.6	1.0	5.9	9.1	2.7	9.3	8.3	3.6	6.0	3.2	2.9	7.4	7.1	8.3	9.4	5.3	5.0	7.0	2.4	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		9100	9100	Mitochondria	Mitochondria	"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.8	10.2	9.2	3.2	6.1	3.5	6.0	9.0	5.2	5.4	7.2	6.9	2.7	12.9	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.7	1.3	1.2	15.0	6.5	4.5	11.4	6.1	4.0	7.5	2.4	17.7	3.7	2.0	4.5	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	29.6	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.1	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.8;K-562: 7.1"									"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"														"Secreted - unknown location"																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	2.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTXN3		ENSG00000205279	"Cortexin 3"	Q4LDR2	5	127649044-127658630	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 21.9;kidney: 58.1"	"Group enriched"	"Detected in some"	4	"AF22: 4.4;NTERA-2: 1.4"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory region: 50.2"																"unprognostic (7.32e-2)"	"unprognostic (9.88e-2)"		"unprognostic (1.19e-1)"				"unprognostic (1.29e-1)"	"unprognostic (6.20e-3)"					0.6	0.6	2.2	0.5	9.4	0.5	0.6	0.2	19.1	0.6	0.6	0.7	0.0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	7.9	4.8	58.1	0.6	0.6	0.6	12.6	4.6	0.5	0.5	0.5	5.9	0.5	21.9	0.9	0.6	0.0	0.7	0.6	9.1	0.5	0.5	0.5	0.5	0.5	0.6	0.6	1.0	0.0	0.5	0.3	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.4	0.2	19.1	7.9	4.8	12.6	4.6	21.9	1.0
CYS1		ENSG00000205795	"Cystin 1"	Q717R9	2	10056780-10080944	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 75.1"	"Cell line enriched"	"Detected in some"	18	"RPTEC TERT1: 49.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 46.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.48e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (1.27e-5)"	"unprognostic (2.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.20e-2)"	1.4	0.8	3.2	3.2	1.6	0.0	0.9	2.8	2.6	8.1	4.5	2.1	2.7	1.2	5.5	6.6	3.3	3.4	14.9	2.8	2.0	1.9	75.1	0.4	3.1	0.5	1.4	3.1	6.9	17.1	0.2	3.2	0.0	2.4	2.6	0.9	5.9	1.4	3.9	0.5	0.7	1.7	3.1	1.5	1.3	1.9	1.4	0.9	0.1	7.8	2.4	1.0	2.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.2	0.2	0.1	0.0	0.9	0.1	0.0	2.7	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.6	2.8	2.6	2.0	1.9	1.4	3.1	2.4	0.9
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Mitotic spindle, Cytosol"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"					"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favourable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.2	0.5	27.2	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933682-48944969	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 32.4;kidney: 18.0"	"Cell line enhanced"	"Detected in many"		"U-266/70: 6.7;U-266/84: 5.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 5.8;T-cells: 4.8"					"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"	"Nucleoplasm, Actin filaments"	"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favourable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2.0	18.0	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0.0	5.8	0.0	0.0	4.8	0.5	2.9	0.0	0.2	1.5	0.8	0.7	1.2	0.0	0.4	0.5	1.4	2.8	2.3	0.0	0.6	0.0	0.8	1.0	2.1	1.0	1.1	2.3	4.1	0.9	1.1	0.0	0.0	1.0	0.6	0.2	1.1	0.0	0.0	1.3	0.4	0.0	0.6	0.0	0.3	0.6	1.9	1.5	0.2	2.1	0.4	0.9	4.5	2.4	0.5	0.3	0.9	2.0	0.1	0.0	0.0	1.8	0.7	0.1	6.7	5.3	1.7	1.4	0.0	0.4	5.8	0.0	0.9	1.6	0.0	0.8	0.0	1.6	0.7	0.0	0.1	4.8	3.1	0.1	0.0	0.0	0.0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2.0	0.4	0.4	0.6	0.1
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Cell line enriched"	"Detected in some"	7	"BEWO: 30.6"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912884-110012266	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;SK-BR-3: 14.6;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"									25000	25000				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.8	0.1	0.4	0.0	0.4	0.0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0.0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0.0	0.6	0.0	1.2	0.7	0.0	41.2	0.0	0.4	0.0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0.0	0.2	0.2	0.0	1.2	4.5	0.4	0.4	0.5	0.0	0.4	1.7	0.0	0.0	0.0	2.6	0.2	0.3	2.4	0.1	0.0	0.1	0.0	0.6	1.5	0.8	0.5	0.1	0.0	0.0	8.0	0.8	0.0	0.3	0.0	0.6	0.1	0.4	0.1	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.8	0.1	0.0	0.0	2.9	0.5	0.2	0.1	0.6	0.6	0.2	0.0	0.0	0.0	14.6	0.5	3.5	0.0	0.0	1.2	2.0	0.0	4.6	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 42.7"	"Cell line enhanced"	"Detected in many"		"A549: 12.9;RPMI-8226: 14.9;RPTEC TERT1: 22.0;RT4: 16.3"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		9400	9400	"Golgi apparatus"	"Golgi apparatus"	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	1.5	0.9	3.7	4.3	1.1	1.8	9.6	1.4	0.6	1.8	0.3	0.6	0.6	1.0	10.2	1.1	3.7	0.4	1.6	1.5	42.7	1.2	0.6	2.6	1.2	2.3	0.9	2.7	7.6	5.7	0.2	0.9	1.7	0.2	2.1	1.7	0.2	0.4	1.9	3.1	0.7	0.8	1.8	0.6	1.6	0.3	0.1	1.1	1.0	4.2	2.0	1.4	1.4	0.0	10.6	0.0	0.0	0.0	0.1	10.9	12.9	0.0	0.0	0.0	0.0	0.0	3.6	1.9	2.4	0.3	0.0	0.0	10.2	3.7	0.2	0.0	0.4	0.5	0.4	0.3	1.3	5.7	0.0	0.0	0.0	8.2	0.0	0.0	2.3	0.0	8.5	0.0	0.0	9.1	0.0	5.0	0.0	0.0	6.1	0.0	7.1	0.0	14.9	22.0	16.3	12.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.9	2.8	0.0	0.0	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	1.5	3.7	1.8	9.6	1.6	1.5	1.2	2.3	0.9	0.3
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		570000	570000	Mitochondria	Mitochondria	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.5	7.0	0.0	0.1	65.3	0.0	0.0	0.0	0.0	15.5	0.1	0.1	1.5	0.0	0.1	0.0	0.1	0.0	0.3	3.7	0.0	0.0	10.3	0.0	0.0	14.2	0.0	0.0	0.5	0.0	2.7	0.0	0.1	0.3	0.3	0.2	0.0	7.6	1.2	0.3	0.0	0.1	27.0	0.3	6.2	3.2	0.0	6.0	0.0	1.4	0.0	0.9	0.1	0.2	0.7	0.3	0.3	8.9	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.2;skeletal muscle: 53.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.4;ASC diff: 22.6;ASC TERT1: 20.8;fHDF/TERT166: 17.6;T-47d: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	8.0	0.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.5	0.3	0.0	0.4	0.0	1.6	6.8	0.1	2.5	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.3	53.2	6.8	0.8	0.5	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	76.4	22.6	20.8	0.1	2.6	6.4	3.6	3.4	0.1	0.2	0.1	0.7	17.6	8.2	1.1	0.0	1.7	3.8	1.4	0.7	9.5	0.0	0.1	0.0	0.9	9.8	0.1	0.2	0.0	0.0	0.5	0.0	2.5	0.4	0.0	1.9	0.0	0.3	0.0	0.1	0.0	8.1	0.0	0.0	1.0	1.8	2.6	3.9	26.0	0.5	0.0	2.1	2.7	0.0	3.4	0.3	0.0	0.0	0.0	0.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	1700000	1700000	"Plasma membrane"	"Plasma membrane"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 63.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.3;BJ: 4.8;HMC-1: 6.3;RT4: 1.8;SK-BR-3: 4.5"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Region enriched"	"Detected in single"	12	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005131, CAB025903"	Approved				"Secreted to blood"					"CAB025903: , HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	0.4	0.3	0.0	0.0	1.2	0.0	0.5	0.0	0.0	3.1	0.2	0.0	0.8	0.1	4.4	13.5	0.1	0.3	0.0	0.6	0.0	0.0	63.6	0.4	0.3	0.0	0.0	0.0	11.6	0.0	0.0	0.4	14.4	0.0	0.3	0.1	0.4	0.3	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.2	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.9	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	6.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	4.5	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 55.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HaCaT: 1.9;HeLa: 1.4;hTCEpi: 6.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.2	0.3	3.0	0.1	4.4	0.1	0.3	0.2	0.4	0.1	0.2	10.3	0.6	0.2	0.2	6.5	0.2	8.6	0.1	0.3	6.2	5.5	55.5	0.1	0.1	0.1	1.1	0.1	0.6	0.1	0.1	0.0	0.1	12.8	0.1	0.1	0.7	0.1	0.3	0.7	1.8	0.4	0.2	2.0	0.1	0.1	0.2	2.8	0.0	0.3	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	1.2	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.0	0.1	0.3	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.0	4.4	0.2	0.4	6.2	5.5	1.1	0.1	12.8	2.8
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.1;NTERA-2: 4.4;T-47d: 3.3;U-266/70: 2.7"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA060904	Enhanced									"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.5	0.1	0.3	0.7	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.3	0.7	1.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.5	6.1	0.1	0.3	0.2	0.6	4.4	0.1	0.1	0.0	0.7	0.1	1.3	2.3	0.4	2.0	0.3	0.0	3.3	0.6	0.7	0.5	0.2	0.5	0.3	2.7	0.8	0.3	0.3	0.1	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Group enriched"	"Detected in some"	17	"BEWO: 4.8;CACO-2: 11.1;Hep G2: 10.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced									"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Group enriched"	"Detected in some"	5	"Daudi: 62.1;U-698: 27.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	8.9	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153919	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.9;kidney: 3.7;pancreas: 11.1"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.6;WM-115: 14.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 27.9;olfactory region: 87.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles				Vesicles	Vesicles	"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.3	2.2	2.6	0.8	6.5	0.3	2.1	0.2	10.4	0.4	0.3	5.1	0.0	0.9	0.4	0.2	0.2	0.3	0.5	0.3	2.3	14.9	3.7	0.3	0.4	0.3	2.8	1.3	2.3	11.1	0.7	0.3	1.4	3.9	1.5	0.6	0.9	1.1	0.2	0.4	0.4	0.5	0.3	4.2	0.3	0.3	0.9	3.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.6	6.5	0.2	9.3	2.3	14.9	2.8	1.3	3.9	3.3
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Group enriched"	"Detected in some"	20	"A549: 4.8;RT4: 3.9"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavourable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Group enriched"	"Detected in some"	9	"A-431: 26.2;CAPAN-2: 49.1;EFO-21: 41.0;HaCaT: 35.8;RPTEC TERT1: 38.1"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"					"Group enriched"	"Detected in many"	13	"basal ganglia: 10.7;hypothalamus: 32.7;midbrain: 14.3;pons and medulla: 12.8;thalamus: 8.5"	HPA042302	Enhanced				"Secreted in other tissues"	1300000	1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	49.1	0.0	41.0	0.0	35.8	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.6	4.3	0.0	0.0	0.0	0.0	38.1	0.3	1.2	0.2	2.4	0.0	0.2	0.7	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		1500000	1500000	Mitochondria	Mitochondria	"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.36e-5)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	11.8	6.7	1.9	0.6	0.5	1.4	0.8	0.7	0.2	4.4	0.3	1.4	0.5	0.8	3.0	0.7	2.8	0.9	0.8	0.6	1.9	0.0	44.3	3.1	0.4	3.0	2.5	1.2	1.2	0.5	0.2	0.3	1.0	0.2	28.5	0.7	0.2	1.0	0.1	3.4	25.1	0.6	0.4	7.0	1.9	5.7	0.6	0.4	0.0	15.6	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.0	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Group enriched"	"Detected in some"	5	"A549: 59.0;Hep G2: 58.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004860, CAB037271"	Enhanced									"CAB037271: AB_2221326, HPA004860: AB_1844433"	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	59.0	0.9	2.9	4.5	3.5	1.0	0.1	0.3	0.1	0.2	12.6	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	58.8	0.1	0.0	0.2	0.5	4.1	0.4	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.3	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.0	4.8	0.9	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
AC012531.3		ENSG00000273049			12	53985845-54034888	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.6;kidney: 24.3;skeletal muscle: 10.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.3;fHDF/TERT166: 3.2;HDLM-2: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.5"	"Lineage enriched"	"Detected in single"	26	"T-cells: 2.5"																																					8.6	0.9	0.1	0.1	0.2	0.0	1.2	0.1	0.1	1.0	0.4	0.0	0.0	0.2	2.0	4.5	0.8	2.8	0.0	0.4	0.1	0.1	24.3	0.3	0.3	1.2	0.1	0.0	3.2	0.5	0.8	0.2	1.1	0.1	0.7	0.0	0.0	0.3	0.0	10.3	0.8	1.2	1.3	0.4	0.3	0.7	1.1	0.0	0.0	0.4	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.6	0.8	0.0	13.3	1.1	0.0	0.0	0.2	0.2	0.6	0.2	0.0	1.2	0.0	0.3	3.2	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.4	0.0	0.4	0.4	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.7	0.1	0.3	1.3	2.4	0.1	0.0	0.8	1.8	1.2	0.3	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660723	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 35.0;liver: 42.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced									"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	10.0	7.6	4.9	2.6	9.6	6.3	5.2	5.4	8.0	7.4	9.8	7.2	6.8	11.1	7.2	8.3	3.2	6.4	4.2	8.8	6.6	3.9	35.0	42.7	4.9	3.2	12.9	3.8	7.6	5.9	3.8	13.9	5.9	8.7	4.7	2.7	5.5	4.7	7.4	3.7	6.9	18.8	4.9	12.6	4.5	4.0	5.3	10.2	4.0	5.5	2.3	3.3	5.4	4.7	1.9	2.3	0.2	0.8	2.4	3.7	0.9	3.9	4.0	5.8	8.0	6.1	6.4	7.5	8.6	12.4	4.5	5.7	11.5	1.3	2.7	5.2	3.3	3.3	3.2	5.6	4.8	4.9	4.1	3.3	3.3	8.4	8.8	2.3	2.3	4.8	3.9	5.9	11.4	4.1	1.8	5.3	4.7	5.3	2.3	2.6	3.6	4.3	2.4	4.6	4.0	7.8	2.2	3.4	5.4	7.4	3.0	17.9	8.1	2.5	4.0	3.4	1.9	2.5	3.4	5.6	1.8	3.0	4.5	0.9	2.6	0.0	0.7	0.2	1.6	0.8	1.6	1.3	1.4	0.7	0.5	1.9	3.7	1.7	0.0	2.4	0.8	2.3	0.7	0.9	4.9	9.6	5.4	8.0	6.6	3.9	12.9	3.8	8.7	10.2
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell line enriched"	"Detected in some"	5	"T-47d: 14.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"											HPA058258	Uncertain									"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.7	0.1	14.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1										
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 60.0"	"Cell line enhanced"	"Detected in many"		"RT4: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favourable (2.41e-4)"	13.2	37.6	4.8	7.7	4.4	1.1	16.3	2.0	4.0	8.4	19.1	4.0	30.3	9.2	3.5	15.4	6.7	4.3	7.2	12.9	5.6	2.0	60.0	15.0	9.0	3.7	3.7	2.8	9.4	3.4	2.6	1.7	14.1	3.9	12.4	7.4	7.6	10.1	33.3	28.4	9.7	22.4	4.5	3.5	4.5	8.0	4.5	3.6	3.5	30.6	6.6	5.9	13.0	7.6	7.8	13.8	11.9	6.2	1.2	4.3	2.1	9.6	3.1	2.6	6.2	27.4	5.0	15.3	2.3	3.4	5.0	9.8	12.2	18.4	6.0	5.1	2.8	5.8	1.8	11.3	6.0	7.5	4.4	10.3	1.5	21.7	4.6	1.3	9.6	22.1	17.4	6.4	0.8	6.8	1.2	3.4	5.4	11.6	3.1	4.1	0.4	4.6	7.8	1.9	15.1	1.6	37.5	8.5	4.6	4.5	6.8	4.7	6.0	8.8	5.1	9.1	2.8	1.3	0.7	6.1	1.2	3.1	3.8	6.5	0.5	0.0	2.5	11.9	1.8	6.2	1.6	7.8	1.3	1.8	13.8	1.9	0.6	0.8	0.4	1.2	5.4	5.2	4.3	2.1	4.8	4.4	2.0	4.0	5.6	2.0	3.7	2.8	3.9	3.6
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650659	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 72.2;kidney: 28.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.0;CAPAN-2: 9.4;Daudi: 34.2;RPMI-8226: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;monocytes: 21.1"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced									"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13.0	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0.0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0.0	4.2	0.2	0.2	1.1	5.9	0.0	21.1	2.3	0.9	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	9.4	34.2	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	1.5	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.3	0.0	0.5	0.0	0.1	4.9	0.5	1.0	0.2	0.1	2.6	1.1	0.9	0.6	0.0	2.3	21.1	5.9	0.0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997703-47042363	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.4"	"Cell line enhanced"	"Detected in some"		"A-431: 10.4;CAPAN-2: 39.1;HaCaT: 8.7;PC-3: 12.7;RPTEC TERT1: 17.9;RT4: 44.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038438	Approved				"Secreted - unknown location"					"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	6.5	6.1	0.0	3.7	0.1	1.3	4.2	15.7	0.8	10.0	0.0	0.0	0.0	27.4	0.1	5.4	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.6	0.0	7.5	0.2	0.0	3.2	1.9	0.1	0.1	5.5	2.1	0.1	0.1	1.5	1.3	0.0	0.0	11.3	5.6	12.3	16.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.7	0.0	8.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	17.9	44.8	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;kidney: 54.7;liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.6;Hep G2: 45.0;RPMI-8226: 11.2"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.6;T-cells: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA026443, HPA028321"	Enhanced					250000	250000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1.0	0.2	14.9	0.3	0.0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0.0	12.3	0.2	21.3	0.1	0.3	1.0	0.5	0.5	0.1	1.0	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	3.9	3.2	0.2	0.1	0.0	0.4	0.1	0.7	0.7	0.4	0.2	18.6	2.6	0.0	0.1	0.5	0.0	0.0	0.0	0.5	3.8	0.0	2.4	2.6	45.0	0.5	1.9	0.0	0.5	0.2	1.3	0.0	0.4	0.0	5.3	1.0	4.2	0.0	1.8	4.2	1.8	0.0	0.0	11.2	0.1	1.0	0.7	0.5	5.4	0.2	0.6	0.7	3.8	0.4	0.1	0.1	1.0	0.0	0.1	3.0	2.5	0.2	0.0	0.0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3.0	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1.0	0.6	0.8	0.7	0.3	0.6	0.1
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 128.9;lymphoid tissue: 92.1"	"Cell line enhanced"	"Detected in many"		"AF22: 34.8;MCF7: 22.9;NTERA-2: 26.2;RPTEC TERT1: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced									"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favourable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	20.5	3.1	31.4	3.3	35.4	2.2	17.4	7.7	24.9	7.6	3.6	42.9	42.1	1.9	5.5	6.1	28.2	6.3	5.1	10.4	36.9	22.4	128.9	1.9	7.0	2.0	45.3	12.4	2.9	3.4	13.2	5.5	12.4	27.3	3.4	4.0	5.9	15.2	39.4	7.4	7.4	2.6	6.1	59.9	92.1	2.8	4.2	25.4	0.0	45.0	7.7	5.2	5.8	6.9	0.1	0.0	0.0	0.0	1.8	0.4	0.2	0.1	0.5	34.8	6.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	6.2	2.7	0.0	15.8	0.0	3.3	5.1	0.3	0.2	0.0	6.7	3.5	1.8	12.3	0.0	0.0	1.8	0.3	1.6	0.1	0.1	1.6	2.3	0.0	0.0	22.9	2.1	0.4	26.2	2.4	0.0	0.4	9.6	75.1	2.0	13.2	2.1	1.8	14.8	4.9	14.0	0.2	0.2	0.9	2.6	0.1	7.1	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	31.4	35.4	7.7	24.9	36.9	22.4	45.3	12.4	27.3	25.4
AIFM1	"AIF, CMTX4, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130129362-130165887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced					160000	160000			"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favourable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	9.9	28.9	7.1	11.3	8.6	5.3	7.1	7.5	8.9	10.4	14.2	8.4	10.0	19.6	9.9	11.7	8.6	13.0	11.4	34.2	7.2	7.0	66.8	50.5	5.8	9.8	8.2	7.1	7.3	14.6	16.8	7.7	6.1	8.8	6.9	14.2	12.3	13.1	9.4	35.7	5.8	23.2	8.9	6.4	8.7	14.9	14.9	7.2	19.5	7.9	16.1	9.7	8.4	6.0	10.8	22.0	9.8	18.3	15.8	12.8	8.0	16.7	31.0	12.7	31.8	14.5	10.4	16.8	10.6	9.2	16.4	13.3	22.0	12.4	36.2	37.1	9.7	16.2	39.2	13.8	17.5	13.8	23.9	22.9	23.4	29.9	18.5	20.1	24.2	12.8	13.6	17.4	14.9	13.8	19.7	16.8	11.5	40.4	20.4	31.6	9.1	24.1	18.5	14.3	41.9	37.1	17.0	16.4	9.6	12.4	28.8	27.7	14.8	18.2	10.0	7.8	7.5	21.3	20.2	9.0	14.5	16.9	10.1	33.7	11.7	2.9	14.8	9.8	9.1	18.3	9.6	10.8	9.7	11.2	22.0	8.1	9.6	9.7	2.1	15.8	15.5	10.6	12.8	8.0	7.1	8.6	7.5	8.9	7.2	7.0	8.2	7.1	8.8	7.2
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	18000	18000	Mitochondria	Mitochondria	"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (4.36e-4)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.2	1.4	1.6	6.9	15.3	14.6	3.5	3.4	4.3	7.4	20.8	30.4	2.4	10.9	9.0	5.3	13.1	5.4	25.6	30.0	9.1	6.2	10.6	6.8	58.2	0.7	8.2	1.3	8.1	14.4	7.3	21.4	0.2	13.1	0.1	11.3	8.7	0.3	0.3	7.1	12.2	0.0	11.9	1.9	11.0	0.9	5.9	4.5	6.1	0.4	4.8	8.5	3.6	1.2	12.4	10.7	0.9	5.8	11.5	5.1	0.6	20.1	3.0	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0
AL355315.1		ENSG00000249967			10	97584374-97673910	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"kidney: 22.2;liver: 15.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;EFO-21: 3.9;HaCaT: 1.9;HBEC3-KT: 2.9;HBF TERT88: 2.0;T-47d: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.0"									HPA076857			Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076857: AB_2686817"																		2.4	1.1	1.9	0.3	2.3	0.3	1.0	4.6	3.3	1.9	0.9	5.5	0.6	0.3	1.1	2.5	0.8	2.7	2.3	4.9	2.6	1.0	22.2	15.1	0.8	0.3	6.4	3.3	0.8	2.4	5.7	0.9	0.6	4.8	0.8	0.3	2.1	0.8	3.9	2.2	0.9	0.8	0.8	5.5	0.9	0.9	0.9	4.6	0.0	0.8	2.5	0.4	1.0	0.9	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.6	3.6	0.0	1.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	3.9	0.6	1.9	0.0	2.9	2.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	2.3	4.6	2.3	2.6	1.0	6.4	3.3	4.8	4.6
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 23.4;Karpas-707: 24.1;RPMI-8226: 12.6;RT4: 64.5;U-266/70: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		640000	640000	Cytosol	Cytosol	"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.1	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.4	3.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.3	64.5	0.1	0.1	0.3	3.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.3	4.1	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9;SK-BR-3: 35.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401"	Enhanced					40000	40000			"CAB004645: AB_425775, HPA006401: AB_1844731"	"unprognostic (1.17e-1)"	"prognostic favourable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.0	7.9	4.0	11.9	17.0	2.5	9.8	4.8	3.0	5.0	4.0	5.7	3.8	3.4	6.5	6.2	13.5	6.8	14.4	1.8	1.9	6.0	1.9	1.8	33.9	5.3	1.6	6.1	6.6	8.1	2.8	2.7	5.6	7.5	2.5	3.4	12.9	1.6	8.2	1.9	4.0	10.5	3.3	3.9	5.2	12.8	7.9	3.0	8.5	35.0	6.3	15.9	2.6	4.6	4.3	5.7	5.2	1.7	2.7	6.5	0.9	1.5	13.2	5.7	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		65000	65000	"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 5.3;Hep G2: 12.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.0"	HPA043523	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043523: AB_10966687"	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.1	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		1500000000	1500000000	"Plasma membrane"	"Plasma membrane"	"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	4.9	0.0	0.0	60.1	77.0	0.5	76.7	109.7	9.4	8.3	0.5	0.0	0.0	0.9	65.8	0.0	0.5	0.0	3.7	0.0	0.0	14.5	0.4	11.4	35.4	1.0	69.8	67.4	0.1	29.7	0.0	85.8	0.4	0.1	3.6	0.0	0.0	34.1	0.2	5.2	0.0	0.0	0.8	42.9	0.0	0.1	0.7	0.0	0.1	0.0	0.0	6.7	85.8	41.4	0.0	93.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.5;HeLa: 6.9;SH-SY5Y: 7.7;U-2 OS: 9.5;WM-115: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		250000	250000	"Plasma membrane"	"Plasma membrane"	"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.5	1.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	6.9	0.0	0.4	0.1	0.0	3.2	0.0	0.1	0.0	2.8	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	5.0	0.1	0.7	0.0	0.1	7.7	1.2	0.6	0.0	0.1	0.1	0.0	0.0	9.5	0.7	0.3	0.5	0.3	0.0	0.1	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8
ARHGAP24	"DKFZP564B1162, FilGAP, FLJ33877"	ENSG00000138639	"Rho GTPase activating protein 24"	Q8N264	4	85475114-86002670	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 62.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.7;ASC TERT1: 21.6;HHSteC: 20.8;HUVEC TERT2: 38.4;RPTEC TERT1: 21.5;TIME: 27.1;U-138 MG: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5"	"Group enriched"	"Detected in many"	4	"B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014288	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA014288: AB_1844994"	"unprognostic (2.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.75e-3)"	"unprognostic (4.28e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.67e-11)"	"unprognostic (1.75e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.75e-4)"	21.3	1.9	5.3	16.4	7.9	10.7	17.6	1.8	9.4	5.8	6.2	8.4	2.4	4.8	9.2	7.3	7.7	3.9	7.1	16.8	6.3	7.3	62.5	6.0	9.9	23.8	11.0	3.3	4.1	21.5	6.9	8.2	13.9	9.0	6.7	4.3	8.7	9.0	5.8	7.6	6.2	8.7	13.2	19.8	33.6	15.9	2.8	6.7	2.1	17.8	6.5	24.2	13.0	5.2	23.1	6.5	2.8	8.0	0.0	0.0	1.4	0.9	1.9	1.4	0.0	35.7	21.6	1.5	6.7	9.0	1.6	2.7	0.0	0.0	0.8	2.4	15.1	0.0	0.0	2.8	3.5	0.0	0.3	1.1	0.2	0.0	20.8	0.1	0.0	15.8	0.3	3.3	1.5	38.4	1.9	0.1	14.6	0.0	0.0	0.0	0.1	3.5	0.1	7.1	3.6	21.5	0.0	0.7	0.7	0.7	1.1	2.4	0.1	0.0	27.1	19.3	0.4	1.4	0.1	0.1	0.0	1.1	3.3	0.7	6.2	0.0	8.0	0.0	0.0	1.5	0.0	23.1	0.0	0.0	1.9	18.4	0.0	0.0	2.8	0.0	1.1	6.5	0.0	1.4	5.3	7.9	1.8	9.4	6.3	7.3	11.0	3.3	9.0	6.7
ARHGEF28	"p190RhoGEF, RGNEF, RIP2"	ENSG00000214944	"Rho guanine nucleotide exchange factor 28"	Q8N1W1	5	73626158-73941993	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 37.8;LHCN-M2: 34.8;TIME: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.2;memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037602	Enhanced		Approved	"Plasma membrane,Microtubules,Cytosol"				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA037602: AB_10672282"	"unprognostic (1.97e-1)"	"prognostic favourable (5.31e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.91e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-2)"	"prognostic favourable (8.98e-4)"	3.4	17.7	3.0	2.7	1.4	0.0	7.7	2.3	2.3	9.7	6.7	1.1	8.6	2.3	11.9	9.7	7.1	7.5	12.0	1.5	1.4	1.9	43.0	5.5	5.5	0.3	1.7	3.2	14.5	19.2	0.2	7.0	1.1	2.5	5.1	2.8	4.3	20.0	9.5	0.9	11.1	3.9	2.7	3.3	2.0	14.8	2.0	1.0	4.1	10.5	6.0	6.0	3.4	6.2	0.0	0.0	0.0	0.0	0.6	1.2	0.1	10.9	7.8	0.0	1.0	1.0	1.4	0.0	4.0	8.1	5.1	5.1	2.3	4.8	0.0	8.6	1.4	3.7	0.5	6.5	7.8	0.0	1.1	0.2	1.2	9.9	8.2	0.0	0.0	1.3	2.6	8.0	37.8	16.7	0.0	0.0	34.8	1.0	0.0	0.0	0.1	3.2	0.0	2.1	1.3	14.0	6.7	0.7	1.5	1.9	0.3	0.2	1.7	0.0	22.3	2.5	3.5	0.2	3.8	0.4	0.0	0.0	3.9	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.1	3.0	1.4	2.3	2.3	1.4	1.9	1.7	3.2	2.5	1.0
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"											HPA000549			Uncertain	Cytosol	"Secreted in other tissues"			Cytosol	Cytosol	"HPA000549: "	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.3	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0										
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.1;ASC TERT1: 6.3;CACO-2: 5.4;HSkMC: 11.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"HPA022142: AB_1845102, HPA022145: "	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.1	6.3	0.5	0.4	0.3	0.3	0.3	5.4	0.3	1.1	0.3	1.0	0.5	0.5	0.3	0.4	2.8	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.4	0.6	0.7	0.2	0.1	0.6	1.9	0.4	0.4	0.3	0.9	0.8	0.5	0.4	0.5	0.9	0.4	1.6	0.7	0.5	1.6	0.6	1.2	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 239.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 82.1;SH-SY5Y: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 10.5;gdTCR: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					4100000	4100000			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	3.9	26.3	48.7	8.6	45.1	1.3	14.9	39.4	92.1	8.7	43.8	34.5	11.3	61.3	19.8	11.2	28.7	9.4	50.1	36.0	86.3	68.2	239.7	30.6	16.9	1.9	82.3	52.6	11.5	33.0	130.6	16.7	8.3	111.5	9.8	34.8	15.5	55.7	15.4	55.1	11.2	51.2	17.8	64.0	9.6	69.5	8.4	25.9	0.9	60.1	23.7	13.9	12.3	9.0	1.4	8.4	10.5	3.0	5.6	9.1	1.4	14.7	36.0	11.6	9.0	2.8	0.5	4.1	7.2	6.0	7.6	8.0	43.9	29.8	0.0	27.5	5.7	17.4	6.4	13.9	7.9	0.1	2.8	0.9	27.2	20.3	4.4	0.6	1.3	1.5	3.4	5.6	7.3	6.9	0.2	0.2	8.8	5.6	1.2	2.3	4.7	7.7	0.2	14.1	2.6	82.1	18.4	9.3	68.1	43.0	43.4	1.9	8.9	1.4	14.6	5.9	15.7	9.9	26.0	0.9	1.1	0.3	7.0	2.1	7.9	10.5	1.0	0.1	2.9	3.0	1.5	1.4	3.4	1.1	8.4	0.2	1.0	1.1	0.3	5.6	0.9	0.4	9.1	1.4	48.7	45.1	39.4	92.1	86.3	68.2	82.3	52.6	111.5	25.9
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809059-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 30.8;HaCaT: 62.8;SK-BR-3: 58.9;T-47d: 33.4;U-2 OS: 28.9"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Uncertain		Approved	"Nucleoli fibrillar center"		16000000	16000000	"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA005654: AB_2667378"	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.31e-4)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favourable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	28.9	7.2	4.9	8.1	5.4	1.4	33.1	3.4	8.7	33.5	8.5	4.4	17.8	5.7	24.8	26.5	15.6	46.3	23.2	23.8	4.5	4.2	101.8	13.2	41.6	5.8	4.4	6.5	30.4	17.8	5.8	9.8	28.7	7.0	42.7	2.4	21.4	17.8	27.3	16.7	12.7	7.4	12.5	3.8	14.2	9.6	13.6	2.6	5.7	93.0	23.7	8.5	14.2	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	9.2	0.2	25.6	0.1	0.1	30.8	2.8	1.3	2.3	1.5	13.8	17.6	0.0	14.2	0.3	62.8	2.2	15.7	0.7	0.0	1.6	0.0	1.9	19.1	5.2	0.0	3.4	2.5	6.1	0.8	0.9	1.4	1.4	0.1	0.3	3.6	0.0	0.2	2.9	3.2	0.1	3.0	0.7	19.2	4.5	0.0	0.1	11.4	58.9	0.6	33.4	1.0	3.7	0.6	28.9	0.7	1.3	0.1	0.2	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	5.4	3.4	8.7	4.5	4.2	4.4	6.5	7.0	2.6
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.4	10.8	10.9	9.6	1.3	13.4	10.0	6.9	6.3	8.1	2.1	6.6	11.9	17.4	6.2	3.1	24.1	9.4	10.1	2.3	20.0	6.5	3.4	22.7	1.4	27.8	6.1	7.9	2.1	20.1	25.1	6.3	41.4	5.0	3.5	12.6	11.0	5.9	7.0	5.2	5.1	12.2	7.0	3.7	4.5	2.4	6.5	6.5	11.1	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58513140-58831437	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0"	"Cell line enhanced"	"Detected in many"		"A549: 19.6;BJ hTERT+: 20.8;CACO-2: 30.8;RPTEC TERT1: 48.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"basophil: 8.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045212			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045212: AB_10959667"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	11.8	5.7	1.1	5.7	1.5	0.2	9.4	0.5	2.5	9.8	5.1	1.1	4.8	1.0	7.8	12.3	8.1	7.1	11.6	12.1	1.1	1.4	43.0	2.5	5.8	5.2	0.9	2.2	19.0	24.2	0.8	4.6	3.2	2.1	7.8	3.9	18.7	4.8	4.1	22.4	6.5	2.8	6.0	3.9	2.7	3.2	4.9	0.8	0.8	5.1	7.5	3.2	8.6	10.4	0.1	1.1	8.7	0.3	1.0	0.2	0.1	0.0	19.6	0.2	0.0	6.3	8.1	0.0	12.9	20.8	11.8	14.0	30.8	4.1	0.0	13.6	13.1	0.2	2.0	2.3	16.4	0.0	2.0	0.0	2.5	0.0	4.0	0.0	0.0	12.7	0.7	9.2	9.9	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	1.2	0.0	4.9	0.0	48.7	2.3	0.0	2.5	0.0	0.1	1.1	0.0	0.2	0.0	2.8	2.6	0.4	1.6	0.0	0.0	0.0	8.3	0.0	2.6	8.7	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.2	1.0	0.3	0.9	0.1	0.1	1.1	1.5	0.5	2.5	1.1	1.4	0.9	2.2	2.1	0.8
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.9;skin 1: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA061116: AB_2684433"	"unprognostic (2.17e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favourable (3.15e-4)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favourable (3.93e-5)"	"prognostic favourable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	4.0	0.8	2.7	3.8	2.3	0.7	0.9	11.9	6.5	0.8	0.9			1.3	0.0	16.5	7.5	0.7	1.4	0.0	3.1	5.1	29.9	0.5	0.7	8.7	1.5		0.0	1.1	1.2	18.4	0.1		0.9	1.0		1.4	0.1	0.0	20.5	1.1	0.0	0.7	2.3	8.6	8.0			6.3		6.0	1.2	3.5	0.5	0.1	0.9	0.8	0.2	3.4	0.7	1.8	5.7	0.3	0.0	0.5	0.0	7.0	0.0	0.0	0.0	0.0	5.1	3.2	9.0	2.4	0.0	4.3	0.7	0.9	0.0	0.6	0.9	0.0	2.5	9.7	0.0	1.1	9.5	0.0	27.3	0.0	0.3	0.0	0.3	1.1	0.0	14.7	6.4	0.1	11.7	2.7	0.7	0.5	2.4	3.5	4.5	17.2	1.2	2.0	5.4	1.4	12.3	4.4	0.0	0.1	1.6	0.0	0.1	2.3	8.7	3.5	0.3	1.3	0.9	0.9	0.0	0.0	3.4	0.0	1.3	0.5	3.4	2.9	0.0	0.5	2.6	2.0	0.0	0.2	0.8	0.1	0.6	0.7										
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 61.6;liver: 47.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		13000	13000	Mitochondria	Mitochondria	"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favourable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	12.8	9.8	8.4	5.1	12.1	4.0	8.1	6.0	10.1	6.7	19.4	6.3	4.5	19.8	6.1	17.8	8.8	7.1	8.2	6.8	7.5	9.6	61.6	47.9	3.8	4.9	7.8	5.9	5.1	9.8	4.8	8.4	3.7	10.3	5.9	6.4	6.4	8.4	4.1	12.0	6.4	29.1	7.0	6.9	2.7	6.5	7.0	3.8	4.9	4.6	8.8	5.6	6.2	5.6	15.8	13.1	7.3	11.2	11.1	11.7	6.5	13.7	10.9	17.8	15.8	11.2	10.4	8.5	7.0	11.8	15.7	13.8	12.8	14.8	16.4	14.1	11.5	13.6	16.0	16.2	36.5	19.4	10.3	8.0	8.2	16.6	3.6	9.9	4.3	8.4	7.5	15.4	22.8	23.0	7.1	8.3	24.1	20.2	12.0	5.9	13.2	24.3	12.6	19.9	16.3	12.7	15.6	17.1	13.4	10.4	5.6	27.1	17.2	4.8	8.1	19.6	16.3	11.6	13.0	7.0	21.3	13.5	4.3	5.7	22.0	7.3	8.7	0.1	7.7	11.2	9.9	15.8	8.9	7.6	13.1	11.8	8.5	11.7	1.0	11.1	6.3	7.3	4.7	6.5	8.4	12.1	6.0	10.1	7.5	9.6	7.8	5.9	10.3	3.8
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 123.3;liver: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		640000	640000	"Nuclear bodies"	"Nuclear bodies"	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	6.0	10.2	5.0	4.3	7.6	1.8	7.2	6.7	6.0	5.9	12.0	7.7	7.8	12.2	6.4	7.3	6.8	7.5	10.6	8.5	5.3	5.0	123.3	55.9	8.0	4.6	8.4	5.1	8.5	13.9	5.6	11.6	5.7	7.3	9.7	10.0	8.9	8.3	6.5	14.2	5.2	20.0	6.7	9.3	5.2	8.4	5.1	7.8	8.9	11.3	5.3	5.3	6.9	4.9	10.6	12.4	37.6	11.7	9.3	11.9	7.2	3.8	5.5	12.7	7.8	10.0	11.4	14.8	5.3	8.8	5.4	7.5	2.1	21.6	15.7	35.4	10.2	9.0	14.6	3.9	7.5	15.8	5.0	8.6	12.8	10.1	11.3	7.2	4.6	10.6	7.5	10.0	7.2	8.7	11.3	11.0	5.5	3.0	13.1	10.0	4.7	8.8	12.6	16.5	24.8	30.9	7.4	6.5	8.3	9.7	12.2	11.7	27.1	5.7	5.7	5.5	4.4	9.6	2.8	4.9	14.4	15.5	4.2	12.0	9.4	23.7	11.7	27.3	9.0	8.5	9.3	10.6	9.3	10.2	8.9	9.5	11.5	10.1	37.6	9.3	7.4	12.4	11.9	7.2	5.0	7.6	6.7	6.0	5.3	5.0	8.4	5.1	7.3	7.8
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in some"	11	"AF22: 7.0;RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1
C5orf67		ENSG00000225940	"Chromosome 5 open reading frame 67"	F2Z3F1	5	56511567-56606232	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;kidney: 9.3;retina: 16.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.1;EFO-21: 9.1;U-266/70: 10.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in some"	5	"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9"																				"unprognostic (7.28e-2)"	"unprognostic (1.41e-1)"		"unprognostic (2.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.69e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.62e-2)"		0.4	0.0	0.2	0.2	1.2	0.4	1.0	0.2	0.2	0.4	0.8	0.4	0.2	1.5	0.6	17.9	0.4	0.4	0.2	0.2	0.6	0.2	9.3	0.2	0.4	0.6	0.7	0.2	0.2	0.2	0.0	0.2	0.2	6.1	0.2	0.0	16.3	1.1	0.2	0.2	0.8	1.6	0.2	0.2	1.5	0.1	0.2	0.2	0.2	2.1	0.2	0.2	0.2	0.2	0.1	1.5	3.3	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	3.3	0.0	1.9	1.5	0.4	0.1	0.2	1.2	0.2	0.2	0.6	0.2	0.7	0.2	6.1	0.2
C9orf92	Em:AL513424.1	ENSG00000205549	"Chromosome 9 open reading frame 92"	A6NGG3	9	16203935-16276313	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"kidney: 3.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.7;BJ hTERT+: 4.3;HBF TERT88: 2.6;PC-3: 1.4;SH-SY5Y: 1.3;U-2197: 4.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.06e-1)"				"unprognostic (4.77e-2)"					"unprognostic (3.74e-2)"		"unprognostic (5.47e-2)"	"unprognostic (1.20e-1)"		"unprognostic (5.04e-1)"	"unprognostic (5.09e-2)"		0.6	0.0	0.3	0.5	0.3	0.0	0.6	0.0	0.5	0.5	0.6			0.5	1.7	1.2	0.0	1.2	1.4	0.0	0.6	0.5	3.3	0.4	0.0	0.1	1.3		1.2	0.0	0.0	0.0	0.0		2.5	0.0		0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.0	0.0	1.7			2.8		0.0	1.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	4.7	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63382161	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.5"	"Cell line enhanced"	"Detected in many"		"A549: 38.2;ASC TERT1: 40.3;RT4: 40.5;SK-BR-3: 32.5;T-47d: 52.3;U-138 MG: 55.8;U-87 MG: 67.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008773, CAB025181, CAB062549, CAB068179, HPA073203"	Enhanced		Approved	Nucleoplasm,Vesicles		29000	29000	Nucleoplasm	Nucleoplasm	"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: "	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	3.7	0.3	4.7	15.0	27.4	0.3	14.5	3.7	2.3	15.7	32.0	2.6	5.0	0.4	9.8	12.3	42.8	8.5	2.6	1.6	4.9	1.4	103.5	0.3	1.2	0.3	1.8	0.2	2.1	43.8	0.3	3.9	5.9	16.9	3.8	30.3	8.5	8.2	17.9	0.5	44.1	2.4	18.1	0.1	0.4	2.2	1.3	6.7	0.0	1.7	18.4	25.9	10.6	14.5	0.3	0.2	0.6	0.7	0.3	0.2	0.0	0.0	38.2	0.6	0.0	5.1	40.3	2.0	2.7	2.5	0.4	0.7	0.2	0.0	0.0	9.4	2.2	0.2	0.0	1.8	1.1	0.0	1.3	0.0	2.6	0.0	0.1	0.0	0.0	15.2	2.1	11.6	3.7	0.4	0.0	0.0	0.5	22.0	0.0	0.0	0.6	6.0	0.0	0.0	0.0	0.0	40.5	0.3	0.0	0.1	32.5	0.0	52.3	0.0	0.0	55.8	3.0	1.8	0.0	0.0	0.0	0.0	67.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.7	0.2	0.1	0.0	4.7	27.4	3.7	1.3	4.9	1.4	1.8	0.2	16.9	6.7
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424487-93574730	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 10.8;kidney: 7.5"	"Group enriched"	"Detected in some"	6	"MCF7: 2.6;RPTEC TERT1: 4.5;T-47d: 8.6"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 10.8"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;hypothalamus: 28.7"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported								"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.3	0.7	1.4	0.0	2.1	0.0	1.3	0.1	1.5	0.5	0.2	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.4	0.4	2.1	10.8	7.5	0.1	0.9	0.0	0.8	0.0	0.7	0.1	0.3	3.2	2.1	5.9	0.1	0.2	0.2	1.4	0.0	3.7	0.1	0.2	0.3	2.5	0.1	0.1	2.3	0.7	0.0	0.1	2.5	0.7	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.2	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.1	0.1	1.5	2.1	10.8	0.8	0.0	5.9	0.7
CALHM1	FAM26C	ENSG00000185933	"Calcium homeostasis modulator 1"	Q8IU99	10	103453387-103458888	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.1;U-266/70: 4.3;U-266/84: 4.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA061816	Enhanced									"HPA061816: "	"unprognostic (2.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.65e-3)"	"unprognostic (3.44e-2)"		"unprognostic (2.86e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-2)"	0.0	0.0	1.1	0.5	0.3	0.8	0.0	3.4	5.7	0.0	0.0			0.5	0.1	0.3	0.0	0.0	0.4	0.1	1.2	2.5	2.4	0.0	0.0	0.4	1.3		0.1	0.4	0.0	0.2	0.0		0.0	0.1		0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.1	0.2			0.0		2.0	0.2	0.0	1.0	1.6	0.8	1.6	1.3	1.0	0.2	0.4	0.3	0.3	0.4	0.1	0.0	0.5	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.2	0.0	0.4	0.0	0.3	0.3	0.4	0.7	0.3	0.9	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.4	0.0	0.2	1.1	0.3	0.5	0.0	0.8	0.4	0.5	0.4	0.3	4.1	0.3	0.5	0.6	0.3	0.2	1.0	0.1	0.0	0.0	1.0	0.4	0.3	0.2	0.4	4.3	4.9	0.6	0.5	1.1	0.1	0.6	0.6	0.4	1.0	1.6	0.2	0.5	0.4	1.0	1.6	1.0	0.4	0.9	0.8	1.3	1.4	0.3	0.3	0.2										
CCDC150	FLJ39660	ENSG00000144395	"Coiled-coil domain containing 150"	Q8NCX0	2	196639554-196763490	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.7;testis: 11.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 7.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048104	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA048104: AB_2680264"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.58e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.91e-4)"	"unprognostic (2.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.17e-3)"	"unprognostic (5.66e-4)"	"unprognostic (7.29e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.69e-5)"	0.5	0.4	1.0	2.9	5.2	1.5	0.5	2.6	3.1	0.4	1.0	2.4	0.0	0.6	0.5	0.6	1.6	0.6	0.6	0.5	1.3	0.5	6.7	3.4	0.5	0.8	3.1	0.3	0.5	0.5	0.5	1.0	0.7	2.9	0.4	0.9	0.1	0.4	0.2	0.6	0.6	0.8	1.2	3.1	0.6	0.6	11.9	3.9	3.9	0.4	2.9	2.1	0.6	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.6	7.1	4.6	0.2	0.4	3.2	1.6	0.8	1.3	3.3	2.4	1.5	1.2	0.9	1.3	2.1	2.8	1.2	3.3	6.6	4.1	2.5	3.5	3.9	0.0	1.3	1.1	0.0	0.2	1.5	0.9	0.8	3.2	3.0	0.9	0.7	1.2	2.1	4.0	1.6	2.7	1.1	0.9	0.5	0.6	7.8	1.4	1.1	0.7	0.3	1.1	0.8	1.4	2.5	2.1	2.3	1.4	1.3	1.3	2.1	1.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	5.2	2.6	3.1	1.3	0.5	3.1	0.3	2.9	3.9
CCDC195		ENSG00000283428	"Coiled-coil domain containing 195"	A0A1B0GUA6	2	224703764-224716365	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 1.0;lymphoid tissue: 2.1;skeletal muscle: 1.8"	"Group enriched"	"Detected in some"	7	"Daudi: 6.8;RPMI-8226: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.0	0.0	0.0	0.8			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	1.8	0.0	0.0	0.0		0.0	0.0	0.1			0.0		2.1	0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	7	"A549: 9.1;RPTEC TERT1: 27.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA029202: "		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavourable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favourable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.1	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.1	0.2	0.1	0.0	0.2	27.1	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193750-31329146	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 73.8"	"Cell line enriched"	"Detected in some"	8	"EFO-21: 104.0"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Cell Junctions"		1200000	1200000	"Cell Junctions"	"Cell Junctions"	"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	6.7	1.9	3.4	2.2	7.5	0.6	3.9	1.1	8.4	7.0	2.1	2.4	1.0	2.1	4.5	8.4	3.8	10.0	13.4	3.0	3.3	4.3	73.8	1.4	6.5	1.1	5.0	4.8	3.5	1.3	2.5	2.1	5.3	5.6	2.4	1.7	20.4	1.4	2.9	1.9	1.8	2.0	4.0	6.3	1.4	1.8	0.9	5.5	0.0	3.5	3.3	1.3	4.4	3.4	0.6	0.5	1.7	0.5	0.7	0.4	0.3	0.0	0.4	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	104.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.6	0.3	0.4	1.7	0.7	0.5	0.5	0.3	0.3	3.4	7.5	1.1	6.7	3.3	4.3	5.0	4.8	5.6	5.5
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550727	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.8;HUVEC TERT2: 31.0;TIME: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB013500: , HPA056911: AB_2683274, HPA069214: "	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	3.1	8.7	10.8	1.7	9.8	0.6	14.6	3.2	12.2	25.7	2.0	7.3	8.9	1.4	14.9	4.9	7.7	7.0	2.7	13.6	11.2	7.8	54.8	26.2	15.3	1.3	8.3	5.9	8.1	13.6	12.5	2.9	20.8	10.9	27.6	2.3	11.1	32.0	12.7	1.0	7.4	1.7	10.6	5.3	0.8	9.0	5.2	9.7	1.3	15.0	4.2	8.0	10.0	14.6	0.5	0.2	1.1	0.1	0.3	0.2	0.0	0.0	0.7	7.8	0.0	0.0	0.0	0.1	0.1	1.7	0.6	1.4	4.8	0.0	0.0	6.9	1.0	0.0	3.7	0.0	1.0	0.0	0.6	0.0	0.1	3.3	0.1	0.0	0.0	0.3	0.2	0.8	0.0	31.0	0.0	0.0	1.2	1.3	0.0	0.1	3.8	0.3	0.0	3.9	0.1	2.6	0.0	0.2	0.4	0.0	3.0	0.0	0.3	0.3	18.9	0.0	2.0	0.0	1.0	0.0	0.0	0.0	0.1	3.5	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.2	0.1	0.0	10.8	9.8	3.2	12.2	11.2	7.8	8.3	5.9	10.9	9.7
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846390	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 24.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.4;Hep G2: 25.8;T-47d: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 6.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	15	"granulocytes: 6.4;T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036633, HPA058130"	Enhanced									"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favourable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.7	2.2	11.6	2.3	9.7	0.9	7.8	12.9	10.2	4.1	8.8	8.2	0.8	8.3	3.2	3.8	1.0	2.8	5.5	3.3	13.8	4.0	36.6	24.0	2.6	1.4	11.9	6.5	1.6	15.5	8.0	5.9	0.8	10.0	5.4	9.4	3.3	13.7	1.5	3.8	1.6	14.0	1.4	6.4	0.7	8.1	4.5	13.0	0.0	4.1	0.1	1.6	0.8	1.0	0.3	0.1	6.4	0.1	0.1	2.8	0.1	0.3	3.4	0.9	0.1	0.0	0.0	3.9	0.2	0.4	0.0	0.0	8.4	0.6	0.3	0.6	0.6	0.0	5.5	0.0	0.0	0.0	3.0	0.0	1.2	25.8	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.0	0.5	0.0	5.0	0.0	0.1	5.4	0.6	0.0	1.4	5.9	3.9	3.0	2.3	3.0	1.4	0.1	0.0	8.5	0.1	0.0	0.0	0.6	0.2	0.8	0.8	1.1	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	2.8	0.1	11.6	9.7	12.9	10.2	13.8	4.0	11.9	6.5	10.0	13.0
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;RH-30: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.7	2.8	2.1	3.3	8.3	5.2	4.6	1.5	0.7	0.9	1.2	24.9	1.7	1.8	0.8	1.7	1.4	6.7	0.8	1.5	0.7	4.6	1.7	1.4	6.5	3.9	2.3	3.3	3.1	1.1	2.5	3.7	3.6	2.7	2.7	2.9	1.8	0.8	0.6	3.1	1.3	1.0	38.6	2.7	3.7	2.8	3.7	2.7	2.1	2.1	3.1	1.9	1.1	1.8	1.0	2.1	7.6	0.9	2.2	6.7	4.1	1.6	3.7	5.0	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 58.4;salivary gland: 25.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057717	Approved									"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.1	0.5	0.2	0.1	0.2	0.0	0.1	2.8	0.2	0.7	0.1	0.1	2.2	0.0	0.5	0.5	0.1	0.1	0.4	1.2	0.1	0.1	58.4	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.9	0.8	0.4	0.3	0.5	0.0	1.2	25.7	0.7	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.7	0.1	0.1	11.5	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.8	0.0	2.2	0.0	5.1	0.7	0.1	1.7	0.0	0.3	0.0	0.0	0.0	3.1	0.1	0.6	0.0	0.3	0.0	0.2	0.3	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.4	0.8	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.2	0.1	0.1	0.1	0.1	0.3	0.1
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HEL: 5.4;HUVEC TERT2: 8.2;NTERA-2: 16.2;RPTEC TERT1: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.8"	"Low region specificity"	"Detected in all"							"CAB012969, HPA042348"	Enhanced									"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (4.75e-3)"	0.8	0.5	28.3	0.5	17.1	1.9	2.6	5.9	17.7	26.0	0.6	4.3	0.0	1.4	8.1	15.4	2.6	16.0	23.1	0.6	18.1	6.2	50.5	1.7	0.8	0.5	10.8	12.0	1.1	97.3	0.8	1.1	0.7	5.7	1.4	0.6	3.4	70.0	0.6	0.5	4.5	0.5	0.7	2.8	0.7	1.0	0.9	6.3	0.0	0.5	2.1	49.4	0.6	0.2	1.2	0.6	7.8	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	0.0	0.0	33.4	0.0	0.2	0.2	0.0	0.0	0.0	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.6	0.0	0.1	28.3	17.1	5.9	17.7	18.1	6.2	10.8	12.0	5.7	6.3
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Group enriched"	"Detected in some"	20	"A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5
CLDN24	CLDN21	ENSG00000185758	"Claudin 24"	A6NM45	4	183321764-183322426	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 4.6;salivary gland: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.8;fHDF/TERT166: 3.5;HSkMC: 1.4;SCLC-21H: 1.4;SK-BR-3: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.49e-1)"				"unprognostic (9.27e-2)"		"unprognostic (1.89e-1)"					"unprognostic (4.93e-3)"					0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.1	0.1			0.0	0.1	0.0	1.0	0.1	0.0	0.2	0.0	0.0	4.6	0.4	0.6	0.0	0.0		0.2	0.3	0.5	0.1	0.0		0.1	0.0		2.1	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.2			0.2		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.3	1.8	0.7	0.0	0.3	0.0	0.4	3.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216073	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.2;kidney: 48.4"	"Cell line enriched"	"Detected in some"	18	"HaCaT: 27.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Supported									"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.6	0.6	0.6	0.1	0.6	0.0	26.2	0.7	0.6	2.5	10.0	0.0	6.9	0.0	0.7	14.0	4.2	0.8	0.0	0.7	0.6	0.6	48.4	0.9	1.7	0.0	0.6	0.0	0.6	1.5	0.0	1.3	5.9	0.0	4.6	19.5	0.0	14.2	8.7	0.6	2.2	0.8	0.0	0.6	0.6	0.7	1.0	0.0	0.0	12.2	1.2	1.8	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 10.9;lymphoid tissue: 10.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 9.0;U-937: 4.7"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.4	0.5	0.3	5.7	0.3	0.5	0.7	0.4	0.3	1.9	1.8	0.1	0.1	0.7	0.8	1.7	2.0	0.4	1.4	0.3	0.3	0.3	10.9	1.2	3.2	5.0	0.3	0.1	0.5	0.7	0.0	3.2	1.5	0.5	0.5	0.4	1.6	2.5	0.1	0.3	1.2	2.3	1.7	0.3	6.3	1.6	1.1	0.1	8.4	0.5	1.5	10.8	0.4	0.4	3.4	5.5	1.6	0.4	4.3	3.6	0.5	0.1	0.5	0.5	0.3	0.8	0.2	0.6	0.4	0.0	0.1	0.2	0.0	0.4	0.3	0.1	0.4	0.4	0.0	0.0	0.1	9.0	0.4	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.1	1.1	0.1	0.6	0.8	0.1	0.3	0.5	0.2	0.3	0.0	1.0	0.2	0.3	0.6	0.3	0.5	0.1	0.4	0.5	4.7	0.2	1.0	0.4	0.6	0.7	0.3	0.3	3.4	1.2	0.4	5.5	2.9	0.5	0.5	1.6	4.3	0.2	1.4	3.6	0.5	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.1	0.5	0.1
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 1.2;salivary gland: 1.1;testis: 1.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042407	Uncertain									"HPA042407: AB_10806237"																		0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.6	0.3	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.1	0.4	0.0	0.4		0.0	0.0	0.0	0.2	0.0		0.1	0.0		1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892947	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 69.3;kidney: 14.7;liver: 25.6"	"Cell line enriched"	"Detected in some"	6	"CACO-2: 7.0"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014482	Approved									"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favourable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.4	0.2	0.3	3.1	0.2	0.0	0.2	0.2	0.3	0.2	27.5	0.3	0.2	23.7	0.2	1.3	0.2	0.1	9.5	0.2	0.3	0.2	14.7	25.6	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	23.5	0.2	0.2	0.2	0.2	0.1	69.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	7.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 16.1;Karpas-707: 9.5;RPTEC TERT1: 10.7;U-266/70: 8.8"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	2.9	10.7	2.1	0.5	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	8.8	3.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002711-227164453	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.0;Karpas-707: 6.9;RPTEC TERT1: 11.4;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"memory B-cell: 8.0"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favourable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.6	8.8	1.2	7.2	2.4	0.2	1.3	1.0	1.8	1.0	1.1	0.7	16.1	1.2	4.8	12.7	2.4	3.0	13.7	11.5	1.4	1.5	28.7	1.9	15.8	13.0	2.4	0.0	3.2	6.6	0.5	15.3	0.7	7.4	7.2	1.2	8.3	1.4	10.9	7.5	0.9	3.3	12.0	4.6	3.7	1.9	1.9	1.5	0.9	12.1	6.6	6.2	3.9	3.7	8.0	0.0	0.1	0.0	1.1	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.5	0.0	0.5	0.0	1.3	0.0	0.1	2.3	0.8	0.2	0.0	2.6	0.0	25.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	2.1	11.4	4.2	0.6	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.2	5.2	3.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	2.4	1.0	1.8	1.4	1.5	2.4	0.0	7.4	1.5
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		210000	210000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021921, HPA023290"	Approved		Supported	Cytosol		7200000	7200000	Cytosol	Cytosol	"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.3	12.6	3.6	14.5	15.9	8.5	7.8	12.4	11.4	12.8	19.0	10.0	13.6	13.8	15.2	6.7	10.2	9.9	18.6	15.7	4.1	5.6	7.6	38.0	7.6	4.8	11.7	7.3	8.8	18.2	3.3	9.5	17.8	4.9	23.7	5.6	8.7	8.1	9.4	15.8	5.6	11.8	5.0	96.4	7.8	3.5	6.2	1.8	13.2	8.6	11.8	1.6	4.6	2.7	6.8	8.6	11.8	3.5	6.8	6.7	22.3	1.9	7.8	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 52.2;MOLT-4: 49.5;U-266/70: 38.6;U-698: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB055519: , HPA068106: AB_2685955, HPA071459: "	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavourable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favourable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.1	0.2	0.3	20.1	1.4	2.5	0.6	1.8	1.5	0.1	52.2	3.6	0.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.1	1.0	7.0	18.4	1.4	2.7	2.0	0.1	2.2	0.1	21.0	1.7	1.9	49.5	1.3	5.5	2.1	12.2	0.3	24.9	6.6	7.4	18.2	7.2	0.1	7.1	1.1	4.9	0.2	2.9	0.4	5.4	1.7	1.3	38.6	9.6	36.7	5.5	8.3	3.0	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Group enriched"	"Detected in some"	16	"A549: 92.9;Hep G2: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	92.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006308	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		140000	140000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA006308: AB_1847532"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.7	2.3	6.6	1.2	11.1	9.4	0.8	22.1	13.4	7.9	8.4	26.6	5.0	0.0	9.2	25.0	5.4	23.9	4.6	10.1	0.0	9.2	0.0	6.3	9.2	4.0	17.0	1.0	7.8	0.4	6.6	4.2	12.5	0.0	1.9	20.2	1.5	0.9	0.0	7.9	6.9	0.0	15.5	0.2	33.7	14.0	18.7	36.3	2.9	16.8	2.7	9.1	1.3	24.4	6.9	5.6	1.7	15.4	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.2;RPMI-8226: 19.3;SK-MEL-30: 5.3;THP-1: 3.7;WM-115: 3.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	9	"cerebral cortex: 2.3;hippocampal formation: 0.9"	HPA029297	Uncertain									"HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11.0	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7.0	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0.0	1.4	1.5	9.0	0.6	0.4	0.5	3.0	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.2	19.3	0.0	0.8	3.0	0.0	0.0	0.0	5.3	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.5	0.5	4.5	3.2	1.3	7.0	2.5	3.6	6.2
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.0"	"Cell line enhanced"	"Detected in many"		"HSkMC: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	25.0	28.0	7.6	9.3	10.5	11.2	27.3	4.4	9.0	15.5	15.9	5.9	6.6	17.2	12.2	15.0	21.2	10.9	12.6	14.9	7.8	5.2	88.0	80.8	12.1	15.4	8.5	4.6	12.3	21.5	12.5	4.3	7.4	9.6	18.0	9.1	9.5	37.8	10.9	32.8	15.8	16.1	7.7	9.6	8.7	11.0	9.7	7.3	5.7	27.0	17.4	11.4	10.5	19.1	13.6	59.7	49.9	43.2	21.3	24.0	24.0	12.2	13.2	0.1	0.0	12.9	11.0	0.1	5.0	4.1	5.9	4.6	5.3	14.0	0.0	29.9	5.4	0.5	3.4	4.5	3.2	3.0	1.5	16.8	4.7	0.0	19.2	10.1	12.9	46.6	12.2	3.8	13.8	22.4	7.6	6.1	8.2	22.1	1.0	0.4	22.7	18.8	0.0	0.0	5.7	7.1	2.1	5.7	12.7	9.0	19.9	23.2	12.8	15.9	16.4	4.9	0.2	0.6	0.0	4.3	10.3	0.1	8.3	8.2	3.7	20.0	43.2	49.9	24.0	33.4	13.3	13.6	18.1	22.5	59.7	9.8	11.0	16.4	43.2	21.3	22.1	13.6	15.7	24.0	7.6	10.5	4.4	9.0	7.8	5.2	8.5	4.6	9.6	7.3
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682781	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.0;breast: 83.4;kidney: 75.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 29.7;RPTEC TERT1: 16.0;SK-BR-3: 70.9;T-47d: 55.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.1;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	16.1	4.0	32.0	2.3	71.3	1.1	83.4	4.1	39.1	37.2	3.9	85.0	0.8	2.7	22.2	16.5	5.1	16.7	6.0	13.5	42.0	24.5	75.9	24.2	4.0	2.3	85.0	25.2	32.1	39.3	4.8	3.5	55.2	43.2	8.0	3.4	12.9	10.1	13.8	13.5	5.9	3.8	10.3	66.0	20.7	3.7	7.3	80.1	0.0	6.8	3.6	1.8	5.0	9.3	0.8	0.7	6.1	0.7	0.3	1.6	0.3	0.0	0.8	1.3	0.3	0.5	0.0	29.7	6.2	0.4	0.5	0.4	0.2	0.1	0.0	0.4	2.6	0.0	4.4	0.0	0.0	0.1	2.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.1	0.0	1.9	0.0	0.1	1.7	0.1	16.0	0.1	0.0	0.7	2.1	70.9	4.2	55.5	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.7	0.4	0.7	0.3	1.2	0.8	1.0	1.0	0.3	0.3	1.6	1.6	6.1	0.3	0.2	0.7	0.3	0.3	32.0	71.3	4.1	35.5	42.0	24.5	85.0	25.2	43.2	80.1
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CACO-2: 5.6;HEK 293: 12.5;HMC-1: 2.5;RPTEC TERT1: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	Nucleoli				Nucleoli	Nucleoli	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.0	0.0	1.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;RPTEC TERT1: 1.5;U-266/70: 2.4;U-266/84: 3.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	3.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0										
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEK 293: 12.1;MOLT-4: 2.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					37000000	37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.1	0.3	4.5	0.6	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.9	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;kidney: 30.8"	"Group enriched"	"Detected in some"	7	"HDLM-2: 1.8;Karpas-707: 6.3;SH-SY5Y: 7.1;U-266/70: 5.8;U-266/84: 3.1"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042740	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	68000	68000	"Golgi apparatus"	"Golgi apparatus"	"HPA042740: AB_10793984"	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.5	0.6	2.0	1.1	8.0	1.1	1.0	1.7	6.7	0.5	1.3	35.2	0.4	2.0	0.5	6.9	1.3	0.5	0.8	0.5	5.4	3.5	30.8	0.4	0.6	1.1	26.1	3.3	13.7	0.3	0.3	4.1	0.4	19.5	2.7	1.3	7.7	0.9	6.9	0.4	0.5	2.5	0.4	28.2	1.2	1.5	2.7	14.0	0.0	0.5	0.0	3.1	0.9	0.7	0.9	0.8	2.2	0.9	1.5	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.4	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	5.8	3.1	0.1	0.1	0.1	0.0	2.2	0.9	0.6	0.5	0.5	0.6	0.7	0.4	0.3	0.1	0.9	0.4	0.5	1.7	1.5	0.3	0.8	0.5	0.1	2.0	8.0	1.7	6.7	5.4	3.5	26.1	3.3	19.5	14.0
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell line enhanced"	"Detected in all"		"RT4: 33.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced		Approved	Cytosol	"Secreted to blood"	5000000	5000000	Cytosol	Cytosol	"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.3	4.3	4.9	9.1	9.8	9.3	5.7	5.6	4.6	3.7	4.3	3.3	6.4	6.0	2.8	7.6	6.3	4.9	8.1	4.2	5.1	2.3	4.5	3.2	17.8	9.5	2.7	5.3	7.6	8.2	5.3	11.0	7.5	5.0	9.3	5.5	7.6	3.0	3.3	1.5	9.4	3.5	4.7	2.9	6.6	33.8	3.5	3.7	9.5	7.5	5.4	10.9	2.4	6.2	7.6	7.9	4.5	4.1	6.0	9.4	4.9	4.8	5.0	6.8	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977864-55022671	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 31.4;thyroid gland: 14.8"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 54.2;TIME: 101.3"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	32	"NK-cells: 3.7;T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	400000	400000				"unprognostic (4.70e-2)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	1.5	3.5	0.3	0.4	0.6	0.2	0.6	0.2	0.7	1.5	1.1	0.8	4.2	0.3	3.0	1.1	0.3	0.2	0.9	2.4	0.9	3.7	31.4	2.2	12.9	0.9	0.5	0.3	2.3	1.8	1.7	9.0	0.5	1.3	4.8	0.0	1.5	5.6	3.2	0.7	0.3	2.4	0.4	1.1	4.0	0.5	0.6	0.5	0.6	14.8	0.8	0.4	1.4	1.0	0.0	0.0	0.0	0.0	3.7	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	1.7	0.7	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	54.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.8	2.4	7.0	3.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.6	0.0	2.7	1.7	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.6	0.2	0.7	0.9	3.7	0.5	0.3	1.3	0.5
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 14.5;retina: 50.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;K-562: 9.5;U-266/70: 4.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.2	0.1	0.3	0.0	1.0	0.0	0.6	0.3	0.6	0.1	0.0	0.8	0.3	0.0	0.1	0.4	0.1	0.1	0.0	7.8	0.3	0.4	14.5	0.1	0.1	0.9	0.5	0.4	0.0	0.2	0.0	0.3	0.1	1.3	0.2	0.0	50.2	0.1	0.4	9.5	0.0	0.1	0.0	0.5	1.2	5.1	2.0	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.5	1.5	0.5	0.0	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	9.5	0.4	0.0	1.3	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.1	0.5	4.8	1.4	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.3	0.6	0.3	0.4	0.5	0.4	1.3	0.2
FAM24B	"AC073585.2, MGC45962"	ENSG00000213185	"Family with sequence similarity 24 member B"	Q8N5W8	10	122849078-122879641	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 24.5"	"Group enriched"	"Detected in many"	6	"hTERT-HME1: 42.9;LHCN-M2: 54.0;TIME: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA052490	Supported				"Intracellular and membrane"					"HPA052490: AB_2681851"	"unprognostic (4.03e-2)"	"unprognostic (4.27e-2)"	"unprognostic (3.13e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.42e-7)"	"unprognostic (2.99e-1)"	"unprognostic (7.06e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.81e-3)"	2.2	2.4	6.9	13.5	6.4	3.9	4.0	6.7	7.4	2.3	4.1	5.1	2.2	2.8	3.4	3.8	3.1	3.8	3.7	1.5	5.8	5.9	24.5	1.7	3.7	6.5	6.9	3.4	5.0	12.5	2.6	11.4	1.1	6.6	3.2	5.9	1.9	2.7	2.6	1.7	4.5	4.1	3.0	6.8	4.7	4.4	11.4	5.6	9.8	2.9	2.0	6.3	2.4	2.5	5.9	11.3	3.0	2.2	2.7	5.3	1.9	2.2	3.7	0.7	0.0	0.4	1.1	1.0	3.2	3.3	1.5	1.0	3.8	4.1	0.8	1.0	1.7	1.0	0.0	1.6	3.8	4.0	1.4	6.1	3.5	1.9	3.4	0.0	3.6	1.2	0.2	3.0	42.9	3.3	2.6	1.4	54.0	2.0	3.8	3.5	1.3	3.8	0.0	5.5	0.8	2.4	1.7	2.4	1.0	1.4	0.7	4.4	1.1	3.7	17.4	0.3	1.7	1.4	0.3	1.7	2.0	5.1	2.9	6.0	0.0	3.0	2.2	1.4	2.6	1.9	0.9	5.9	5.0	3.4	3.0	3.7	5.3	3.4	1.4	2.7	1.8	11.3	4.9	1.9	6.9	6.4	6.7	7.4	5.8	5.9	6.9	3.4	6.6	5.6
FGF9		ENSG00000102678	"Fibroblast growth factor 9"	P31371	13	21671383-21704498	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.7;kidney: 21.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.4;HEK 293: 2.4;RPMI-8226: 3.6;RPTEC TERT1: 5.5;SCLC-21H: 11.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067007	Enhanced				"Secreted in other tissues"					"HPA067007: AB_2732755"	"unprognostic (6.59e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.42e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.38e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (1.70e-6)"	"unprognostic (5.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.92e-2)"	3.1	7.3	2.1	1.0	4.4	0.8	0.7	17.7	7.3	3.8	2.1	0.3	0.5	1.8	3.7	0.9	0.9	1.0	1.2	5.5	3.7	2.6	21.7	0.5	2.6	0.6	2.6	2.5	2.3	1.8	0.5	12.0	0.7	12.6	1.1	3.1	2.4	1.2	1.6	1.4	0.5	4.0	4.0	2.5	0.6	2.2	1.5	0.3	0.0	0.6	0.0	0.5	3.0	1.4	1.0	0.0	0.0	0.2	0.0	1.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.4	0.0	1.6	0.9	0.0	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	3.6	5.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.7	1.4	1.7	0.0	1.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	2.1	4.4	17.7	7.3	3.7	2.6	2.6	2.5	12.6	0.3
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Group enriched"	"Detected in many"	4	"CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	4300000	4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	11.8	0.2	2.9	0.0	0.0	5.8	0.0	0.0	0.0	0.0	42.0	1.6	1.2	5.5	0.0	0.6	2.3	0.4	0.0	0.7	2.8	0.1	0.6	42.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	3.9	0.1	0.9	9.6	0.0	0.8	7.1	1.0	1.9	67.6	7.1	5.7	0.1	0.4	0.7	0.4	3.0	1.4	2.9	0.6	0.2	0.0	5.7	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4
FIGNL2		ENSG00000261308	"Fidgetin like 2"	A6NMB9	12	51817840-51848766	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"kidney: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 17.6;BEWO: 11.4;CACO-2: 3.4;NTERA-2: 7.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.36e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.78e-6)"	"unprognostic (7.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-2)"	1.1	0.0	0.6	0.6	0.7	0.0	1.0	0.0	2.2	1.4	0.1	0.0	0.4	0.0	2.6	0.9	0.0	0.2	0.3	1.5	0.1		16.7	1.4	2.0	0.7	0.2	1.7	0.0	0.0	4.3	0.1	1.9	1.3	0.9	0.0	1.0	1.8	0.5	2.0	0.2	0.4	0.2	0.2	1.0	0.9	1.3	0.0	0.0	0.2	0.5	0.3	0.2	0.8	0.4	0.8	0.2	0.2	0.0	0.5	0.0	0.0	0.1	17.6	0.0	0.2	0.1	11.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	7.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.3	0.3	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0										
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	240000	240000	"Plasma membrane"	"Plasma membrane"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	15.3	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.4	3.1	0.0	0.5	0.3	4.3	0.0	4.5	0.1	0.0	0.9	0.0	0.2	0.1	1.3	0.0	0.0	2.7	28.9	0.0	5.4	0.0	0.0	0.1	2.9	0.2	1.9	0.0	5.0	0.0	0.0	0.1	0.0	9.7	1.8	0.3	3.1	0.0	0.0	4.8	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7
FMO4	FMO2	ENSG00000076258	"Flavin containing monooxygenase 4"	P31512	1	171314208-171342084	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 33.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favourable (1.09e-4)"	"prognostic favourable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	5.3	3.6	1.4	5.1	4.8	0.9	4.5	0.6	2.7	4.5	6.0	4.8	3.1	4.2	3.0	10.0	4.6	3.8	4.6	6.3	2.3	1.5	33.8	42.2	3.4	2.8	7.5	2.8	4.1	3.2	5.5	5.0	2.3	3.7	3.9	3.7	6.7	2.7	2.0	1.6	2.9	16.1	2.0	7.0	3.8	3.9	2.0	6.2	2.7	4.5	3.3	3.4	2.9	3.7	5.3	2.9	0.9	4.0	3.9	4.9	2.0	0.1	0.0	0.4	0.6	5.4	4.9	0.2	1.1	5.0	1.6	1.7	0.8	7.2	4.4	7.9	0.0	0.3	0.8	1.3	2.2	2.1	1.1	0.0	0.0	0.1	0.8	0.9	1.0	9.3	3.1	0.6	1.3	0.3	0.2	3.3	0.7	1.0	2.1	1.9	0.5	1.6	0.4	0.4	2.5	3.5	0.0	0.2	0.0	1.4	1.5	3.0	3.1	1.3	0.1	1.3	0.4	1.4	1.0	4.0	1.3	2.7	2.4	1.4	1.1	0.6	2.6	0.9	2.5	4.0	1.8	3.1	2.4	3.3	2.2	5.3	3.3	2.5	0.5	3.9	2.7	2.9	4.9	2.0	1.4	4.8	0.6	2.7	2.3	1.5	7.5	2.8	3.7	6.2
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles				"Nucleoli, Vesicles"	"Nucleoli, Vesicles"	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXI2	FLJ46831	ENSG00000186766	"Forkhead box I2"	Q6ZQN5	10	127737235-127741186	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 6.5;pituitary gland: 10.3"	"Cell line enriched"	"Detected in single"	16	"NTERA-2: 3.8"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"			"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.12e-3)"	"unprognostic (4.71e-4)"	"unprognostic (6.78e-3)"	"prognostic favourable (4.23e-7)"	"unprognostic (6.31e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.65e-2)"	0.7	0.0	0.1	3.0	0.1	0.0	0.7	0.1	0.3	5.4	0.4	0.1	3.1	0.1	1.8	2.7	4.7	0.7	0.2	0.5	0.1	0.1	6.5	0.1	0.4	0.9	0.1	0.1	1.2	0.2	0.1	10.3	0.1	0.4	1.2	0.0	0.1	2.3	1.7	0.3	1.4	0.4	0.5	0.1	2.3	0.5	0.3	0.1	0.4	0.1	0.9	0.8	1.6	2.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	0.1
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix protein 2"	Q5SZK8	13	38687129-38887131	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 13.9;lung: 11.2;thyroid gland: 12.2"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.4;MCF7: 7.5;RT4: 7.0;SK-BR-3: 6.3;WM-115: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028831	Uncertain		Approved	Cytosol		170000	170000	Cytosol	Cytosol	"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.6	0.4	1.3	0.1	1.7	0.1	0.5	1.5	6.4	0.7	1.3	1.2	1.1	0.4	1.1	0.5	0.2	0.9	1.5	0.2	2.8	0.4	13.9	3.4	11.2	0.1	0.4	0.8	1.8	5.2	0.1	1.1	2.6	0.8	3.5	0.4	2.9	0.4	1.5	6.3	0.6	0.7	0.7	0.4	0.3	2.2	1.8	1.5	0.1	12.2	4.1	0.1	1.5	0.3	0.3	0.3	0.9	0.2	0.2	0.2	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.3	0.2	0.0	1.5	0.1	2.4	7.0	0.2	0.1	0.0	6.3	0.3	1.1	0.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.8	0.9	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.7	0.2	0.2	0.3	0.1	0.0	1.3	1.7	1.5	6.4	2.8	0.4	0.4	0.8	0.8	1.5
FRG2B		ENSG00000225899	"FSHD region gene 2 family member B"	Q96QU4	10	133623895-133626795	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.0;kidney: 1.9;pancreas: 1.2"	"Cell line enriched"	"Detected in single"	22	"HDLM-2: 13.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"									"HPA039264, HPA047769"	Uncertain									"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.8	0.0	0.0			0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.9	0.1	0.0	0.0	0.0		0.4	1.2	0.0	0.0	0.5		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8			0.0		0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0										
FRG2C		ENSG00000172969	"FSHD region gene 2 family member C"	A6NGY1	3	75664330-75667220	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 3.5;testis: 3.8"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039264, HPA047769"	Uncertain									"HPA039264: AB_2676420, HPA047769: AB_2680149"	"unprognostic (3.47e-2)"				"unprognostic (8.28e-2)"			"unprognostic (9.57e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.33e-1)"		"unprognostic (2.29e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.4	1.4	0.0	0.1	0.1	0.1	0.0	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in some"	29	"MOLT-4: 137.7;RPTEC TERT1: 315.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"midbrain: 2.6"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		26000	26000	Mitochondria	Mitochondria	"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.2	315.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685061-67688338	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 86.7;skeletal muscle: 102.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 59.4;hTERT-HME1: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;T-cells: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA053420			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA053420: AB_2682144"	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favourable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	29.6	6.8	10.7	8.2	20.9	46.2	20.9	1.7	15.8	11.7	10.8	5.8	18.8	10.1	23.3	13.8	12.2	8.8	16.7	12.9	18.1	9.8	86.7	66.9	17.1	4.9	11.4	4.1	13.8	8.3	4.1	5.1	10.8	21.2	16.5	9.0	9.4	9.5	15.6	102.1	14.8	20.4	16.1	15.5	7.4	14.1	9.2	7.5	9.2	26.2	10.1	10.9	23.9	11.1	1.1	2.2	24.9	3.2	3.1	9.3	4.8	21.9	1.4	3.7	1.1	6.7	7.0	35.4	39.1	18.2	13.0	14.2	7.7	3.7	9.5	12.0	6.3	13.2	0.4	33.4	24.6	6.9	3.8	11.8	3.5	7.7	59.4	3.4	1.1	11.8	16.9	16.5	91.6	9.3	25.3	16.9	15.3	0.7	1.0	4.2	4.8	15.5	2.5	29.1	9.7	6.7	16.6	16.2	2.8	8.2	2.3	23.4	0.4	3.7	9.6	13.6	18.3	14.4	27.3	43.3	8.4	17.2	6.0	1.6	13.3	7.2	3.2	24.9	3.7	1.5	3.0	1.1	2.5	3.0	1.4	0.7	0.7	1.2	4.1	3.1	1.0	2.2	9.3	4.8	10.7	20.9	1.7	15.8	18.1	9.8	11.4	4.1	21.2	7.5
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122347	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 82.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain									"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	10.7	9.4	11.1	5.1	18.7	3.8	10.4	20.8	21.8	9.1	7.5	11.4	7.1	5.1	9.6	9.2	9.8	8.3	9.3	9.2	11.4	9.3	82.0	7.1	9.6	4.9	7.0	13.4	10.6	29.7	19.3	10.5	15.9	34.1	12.0	6.5	21.7	7.8	9.8	8.8	8.3	6.9	9.5	6.5	8.5	7.6	7.3	4.4	4.6	12.5	5.6	6.4	9.4	8.1	6.3	8.3	8.2	12.5	15.7	19.3	8.7	10.5	9.4	14.0	15.6	32.5	32.1	14.4	8.4	9.6	7.1	6.7	7.6	11.1	0.0	22.0	13.6	5.0	6.6	11.9	8.8	8.7	9.8	2.1	8.6	6.7	10.7	9.4	11.2	28.2	15.4	5.9	5.0	12.8	10.6	0.1	17.7	9.1	8.1	8.6	11.5	7.6	0.0	6.1	0.3	23.4	16.3	12.5	16.6	14.0	6.8	11.3	10.1	8.2	11.5	9.6	3.4	12.0	9.2	3.1	4.0	0.1	19.9	9.2	32.6	5.8	8.3	8.2	19.3	9.4	19.0	6.3	10.7	17.7	8.3	3.8	9.2	14.0	4.4	15.7	12.5	2.5	7.9	8.7	11.1	18.7	20.8	21.8	11.4	9.3	7.0	13.4	34.1	4.4
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.0"	"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					75000	75000			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	3.6	6.6	3.2	3.4	3.4	0.9	3.4	2.6	4.5	2.0	4.9	3.6	1.7	5.7	4.0	3.4	2.8	2.5	5.5	1.7	2.6	2.2	47.0	10.9	2.4	4.6	3.5	2.1	2.5	9.8	1.8	1.9	2.1	4.4	2.4	3.4	4.1	12.0	14.2	2.7	3.1	6.7	3.4	4.3	6.1	4.4	11.0	3.3	3.7	2.5	5.0	6.4	2.5	2.5	5.2	4.2	1.0	7.5	8.0	8.3	4.2	5.5	0.7	4.5	4.9	3.9	6.0	1.9	3.5	0.9	0.6	1.5	0.0	5.0	0.5	2.0	2.5	0.3	0.7	1.0	0.2	7.7	3.0	2.3	0.4	0.2	5.5	3.3	7.7	7.1	4.0	0.1	0.3	2.3	1.1	0.1	0.9	0.3	0.5	0.4	0.2	1.5	0.3	1.1	0.6	5.6	0.9	54.1	2.0	1.1	2.5	2.5	2.3	11.0	2.1	0.0	0.0	1.2	0.9	2.9	1.6	0.2	0.3	2.5	2.5	0.0	5.1	1.0	7.9	7.2	7.3	5.2	6.4	8.3	4.2	5.0	4.0	5.9	0.0	8.0	7.5	3.0	6.5	4.2	3.2	3.4	2.6	4.5	2.6	2.2	3.5	2.1	4.4	3.3
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63015079-63039171	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.5;liver: 59.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	1400000000	1400000000			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	3.5	3.6	7.4	4.7	8.6	12.3	11.8	15.5	9.9	3.5	17.6	1.5	1.0	3.7	2.6	3.7	11.0	1.6	2.8	5.9	7.9	7.6	42.5	59.5	3.5	5.0	4.7	7.0	1.9	4.2	1.0	1.6	17.7	14.8	1.9	26.4	2.2	6.5	1.8	1.7	11.1	3.6	4.2	7.6	3.7	3.2	14.0	3.8	5.2	1.4	14.5	7.6	3.9	6.6	4.1	18.2	2.1	1.9	2.9	1.4	1.4	20.4	19.7	20.2	3.1	19.9	8.4	14.9	12.6	21.6	20.0	29.1	27.5	36.3	14.0	3.6	15.6	17.1	20.0	21.1	29.8	28.4	15.1	23.0	10.6	18.6	3.8	10.7	13.8	6.1	6.0	20.2	9.7	24.2	12.2	51.3	37.5	11.6	5.2	10.7	9.5	18.6	15.6	19.7	18.8	15.5	7.2	8.1	13.8	18.4	20.1	19.1	22.2	11.9	12.8	21.6	24.2	20.7	22.7	24.0	24.4	16.4	33.4	0.0	38.1	0.0	1.9	2.1	1.1	1.1	0.5	4.1	1.3	1.3	0.6	1.9	1.0	1.3	1.8	2.9	1.2	18.2	1.4	1.4	7.4	8.6	15.5	9.9	7.9	7.6	4.7	7.0	14.8	3.8
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles	"Intracellular and membrane"	4600000	4600000	Vesicles	Vesicles	"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.4	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.3	0.2	4.3	0.0	2.8	1.4	0.2	0.1	35.8	2.9	0.1	8.6	14.1	1.5	0.3	12.0	0.4	0.2	0.6	0.4	0.1	2.0	52.7	0.2	0.4	0.3	14.6	1.4	0.2	0.2	2.2	51.8	48.2	0.6	0.2	0.3	0.1	9.4	0.2	9.4	11.1	2.2	3.5	2.3	10.9	0.3	15.8	6.0	0.2	7.4	15.1	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;HeLa: 4.5;Karpas-707: 2.0;U-2197: 13.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles				Vesicles	Vesicles	"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	13.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3										
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761750-48773648	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.2;kidney: 10.2;liver: 7.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;K-562: 1.9;MCF7: 6.3;SCLC-21H: 1.3;T-47d: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010667	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.2	0.0	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.4	14.7	0.2	0.2	10.3	0.4	5.6	0.3	1.6	3.5	0.2	0.2	0.0	10.2	7.8	1.5	0.2	0.2	0.2	0.4	1.1	0.0	0.6	0.2	0.2	0.4	5.7	1.5	0.6	0.2	0.2	0.1	25.2	0.2	0.2	0.2	1.3	0.7	0.2	0.4	1.9	0.2	0.5	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.3	0.4	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880827-190965552	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 127.9"	"Cell line enhanced"	"Detected in all"		"EFO-21: 138.9;RPTEC TERT1: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	25000	25000	Mitochondria	Mitochondria	"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	16.5	37.3	37.8	20.4	24.7	10.7	34.3	43.8	47.3	11.9	13.1	5.8	8.9	36.9	14.6	11.9	7.6	11.0	17.7	15.7	23.3	22.8	127.9	5.3	22.6	25.4	20.6	36.8	14.1	17.0	26.4	10.1	14.8	35.1	9.4	13.1	10.8	9.0	13.9	7.4	13.0	40.9	15.5	11.7	19.3	8.7	6.9	12.1	15.0	17.7	8.0	22.9	14.1	16.1	5.2	5.0	6.0	2.1	3.9	9.4	1.5	6.2	7.0	4.9	6.4	15.4	10.7	12.7	18.8	14.3	13.7	15.8	8.5	6.2	12.9	138.9	39.7	8.2	8.6	7.4	20.1	31.8	5.6	21.4	10.3	10.5	14.1	12.5	10.1	9.7	7.7	10.8	7.4	17.8	9.9	26.4	30.5	3.3	8.4	12.1	13.1	11.5	10.7	12.7	11.2	63.8	11.6	6.8	7.1	25.7	5.7	23.9	2.2	7.7	12.6	19.9	14.6	9.9	22.8	8.5	19.4	17.8	7.1	10.3	15.7	6.0	1.5	2.5	5.5	2.1	9.4	4.8	6.5	7.0	2.2	5.2	6.8	8.1	3.0	3.9	1.4	5.0	5.6	1.5	37.8	24.7	43.8	47.3	23.3	22.8	20.6	36.8	35.1	12.1
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.5;Hep G2: 15.1;MCF7: 5.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	11.5	0.9	1.2	1.3	0.0	2.2	0.0	0.1	0.0	2.2	1.7	0.1	1.0	15.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	5.3	0.2	0.2	0.2	1.0	0.9	0.6	0.3	0.0	0.9	1.5	1.0	2.2	0.4	0.6	1.3	0.1	2.4	0.8	0.9	0.5	0.4	0.2	0.6	0.1	0.3	0.6	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852877-190892429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.7;kidney: 26.9;liver: 8.5"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043663	Uncertain									"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.1	0.1	3.5	0.1	2.9	0.1	0.1	0.2	0.7	0.8	0.1	5.0	0.0	0.1	2.0	4.4	0.1	12.7	0.1	0.9	4.6	1.4	26.9	8.5	0.1	0.1	0.6	0.9	0.5	1.1	0.1	0.2	0.3	4.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	2.0	0.1	0.1	2.3	3.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.9	0.2	0.7	4.6	1.4	0.6	0.9	4.2	3.0
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 54.5;HMC-1: 20.0;U-87 MG: 23.8;WM-115: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	10.4	10.3	0.0	0.1	0.5	1.3	0.2	0.8	1.5	0.2	0.2	0.7	54.5	0.0	1.1	2.0	2.3	4.9	0.9	0.1	0.7	2.3	0.0	3.2	10.0	1.4	2.9	20.0	0.7	0.0	0.4	1.2	5.1	8.3	8.2	0.2	1.0	0.7	0.7	0.2	4.4	0.1	2.3	3.9	10.3	0.7	0.2	0.0	2.0	2.1	5.7	0.4	0.5	0.2	2.5	4.4	2.4	9.8	0.4	0.7	0.0	23.8	5.9	18.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Group enriched"	"Detected in some"	11	"CACO-2: 30.6;HeLa: 17.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	17.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 417.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	10000000000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	417.4	0.3	0.4	0.1	0.0	0.4	0.1	8.9	0.2	0.0	11.4	0.2	0.1	2.0	22.5	0.3	0.3	0.1	0.0	0.2	9.7	16.0	0.0	0.2	35.3	2.1	0.0	0.0	0.5	0.0	0.0	0.5	1.5	0.0	0.0	0.7	0.0	0.0	0.2	0.0	3.9	0.2	0.6	0.6	0.0	1.6	0.1	2.2	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Group enriched"	"Detected in some"	20	"CACO-2: 20.3;Hep G2: 15.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;U-266/70: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.6	0.0	0.0	0.2	3.0	2.7	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	2.3	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.6	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 2.9;lung: 2.2;skin 1: 2.0"	"Group enriched"	"Detected in some"	8	"HAP1: 5.1;HEK 293: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain									"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.5	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 61.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		89000	89000	"Vesicles, Mitotic spindle"	"Vesicles, Mitotic spindle"	"HPA012381: "	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favourable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148122-123150672	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 5.1;kidney: 5.5"	"Cell line enriched"	"Detected in some"	13	"REH: 28.3"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Group enriched"	"Detected in some"	41	"hypothalamus: 5.1;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.6"	"Group enriched"	"Detected in some"	4	"basal ganglia: 1.1;hypothalamus: 4.0"	"CAB013268, CAB022752"	Approved									"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	3.0	0.0
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"intestine: 24.2;kidney: 17.2;liver: 15.6"	"Group enriched"	"Detected in some"	7	"A549: 6.2;CACO-2: 20.6;Hep G2: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	17.3	0.1	0.1	13.7	0.1	1.5	0.1	0.8	5.1	0.1	0.1	0.0	17.2	15.6	0.1	0.1	0.1	0.1	0.2	6.3	0.0	0.1	0.1	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.0	24.2	0.5	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.5	1.8	0.3	0.3	0.4	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.2	0.2	0.3	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.4	1.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 65.5;kidney: 30.5;liver: 57.3"	"Group enriched"	"Detected in some"	9	"CACO-2: 51.6;Hep G2: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.2	0.2	13.4	0.2	0.0	0.2	0.2	0.3	0.2	54.0	0.2	0.1	33.0	0.2	6.2	0.2	0.4	15.7	0.2	0.2	0.2	30.5	57.3	0.3	0.1	0.2	0.1	0.3	22.7	0.0	0.2	0.1	0.2	0.2	14.4	0.2	0.2	0.1	0.2	0.2	65.5	0.3	0.2	0.2	7.1	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.4	0.4	0.6	1.2	0.8	0.8	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.6	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	0.4	0.4	0.7	0.8	0.8	0.6	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.1
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 39.8;liver: 31.0"	"Group enriched"	"Detected in some"	4	"AN3-CA: 6.0;EFO-21: 7.2;Hep G2: 18.5;RPTEC TERT1: 22.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039466	Approved					15000	15000			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	3.3	5.4	3.3	0.6	3.8	0.8	2.1	7.0	4.3	0.8	0.6	8.2	1.5	0.7	0.9	4.0	1.3	2.0	3.8	10.1	4.2	2.8	39.8	31.0	0.9	0.7	9.3	5.2	0.6	12.0	2.0	2.4	0.6	7.2	1.3	0.6	3.6	1.8	2.2	2.0	1.2	0.6	0.8	8.2	0.7	0.6	0.7	6.9	0.0	1.8	4.1	0.6	0.8	0.6	2.1	1.7	4.4	1.2	1.2	1.3	0.5	0.3	2.7	0.1	6.0	1.2	0.3	0.1	0.1	0.2	0.1	0.0	2.2	0.3	0.2	7.2	0.1	2.0	0.1	0.2	0.1	0.2	3.1	0.1	1.0	18.5	0.8	0.2	0.2	0.3	0.6	0.2	0.1	0.3	0.1	0.4	0.4	1.2	0.1	0.2	0.2	0.0	0.2	0.5	0.4	22.8	0.4	0.5	0.9	0.1	1.1	0.7	2.1	0.1	0.3	0.7	0.2	0.4	0.2	0.4	0.6	0.1	1.5	0.3	0.1	2.4	1.1	1.2	1.2	0.9	1.0	1.1	1.3	0.9	0.5	2.1	1.1	1.2	4.4	1.2	1.2	1.7	0.9	0.5	3.3	3.8	7.0	3.9	4.2	2.8	9.3	5.2	7.2	6.9
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162435-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 42.7;PC-3: 14.9;RPTEC TERT1: 14.7;SCLC-21H: 39.7;U-937: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7"									HPA061982	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061982: AB_2684651"	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	3.2	3.4	0.2	8.8	0.1	2.4	8.7	0.1	0.2	15.5	12.8	0.2	4.1	0.0	10.4	16.8	1.4	12.2	0.3	0.1	0.1	0.0	35.1	0.1	0.8	0.7	0.1	0.1	2.0	0.1	0.0	0.1	1.4	0.4	16.6	4.5	0.2	0.5	5.6	21.0	13.3	8.2	13.1	0.7	1.0	0.0	2.4	0.1	2.6	0.3	0.3	0.3	16.2	11.4	0.5	6.0	5.4	1.0	11.7	1.5	0.5	12.4	0.0	0.0	6.3	2.1	1.6	0.0	5.0	4.0	0.4	0.4	0.8	0.5	0.1	0.5	2.7	11.7	8.1	0.0	0.4	0.0	42.7	0.1	0.3	0.0	0.2	0.0	0.1	2.1	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	0.3	0.0	14.9	2.7	0.0	0.0	14.7	0.2	39.7	0.0	5.3	0.0	0.1	0.0	10.5	0.4	0.0	4.0	4.8	0.0	0.0	0.0	0.0	0.0	14.2	0.0	5.4	1.0	0.0	1.5	0.2	0.2	0.2	0.0	0.1	6.0	0.5	0.3	0.1	0.9	11.7	0.4	1.9	0.2	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.1
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA034625: AB_10612119, HPA034626: AB_2674252"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	6.4	0.0	0.2	9.1	0.0	0.0	0.0	19.3	0.0	13.1	0.0	0.0	0.0	0.0	0.3	8.5	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.1	0.0	4.9	0.2	0.0	28.0	0.0	5.6	13.9	0.7	34.9	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.7;RPMI-8226: 11.5;RT4: 11.6;SCLC-21H: 12.8;SK-BR-3: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.9	0.4	1.2	0.1	1.5	3.1	0.0	0.0	0.1	0.1	5.1	1.1	0.0	2.3	0.1	6.5	4.3	0.4	0.0	0.0	1.5	0.0	0.5	5.4	0.5	0.6	0.0	1.5	2.6	0.2	0.1	0.0	0.3	0.0	0.0	3.1	0.1	0.1	9.7	0.8	0.0	0.1	11.5	0.4	11.6	12.8	0.8	0.7	11.5	0.5	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 22.9;Karpas-707: 26.0;RT4: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved									"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favourable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.3	6.3	1.1	7.5	1.2	0.1	1.2	8.8	0.5	0.5	5.8	0.1	3.9	6.6	0.2	0.0	0.6	0.0	0.6	0.2	0.4	1.7	0.1	0.8	22.9	0.0	10.3	8.8	0.2	0.6	0.2	8.2	0.0	26.0	0.0	0.2	0.5	0.2	0.5	4.3	3.5	0.0	0.7	0.0	18.6	1.7	4.3	0.0	0.9	4.8	0.2	0.2	0.0	0.1	2.4	0.2	0.0	4.5	8.2	0.2	5.6	0.6	0.1	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21239991	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;kidney: 1.2"	"Cell line enriched"	"Detected in single"	10	"HMC-1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846580-53865800	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.0;liver: 26.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.9;Hep G2: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced				"Intracellular and membrane"					"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	1.1	2.1	13.4	2.2	12.2	0.9	9.2	15.1	14.7	17.1	5.8	6.8	0.0	5.1	5.0	1.3	1.9	3.2	2.4	2.5	17.1	7.4	63.0	26.6	3.5	2.3	11.9	6.4	1.8	5.3	1.4	3.9	1.2	11.2	2.5	6.1	1.9	4.1	1.0	1.4	2.3	5.1	1.2	11.3	1.4	3.4	2.5	15.2	0.0	2.9	0.0	1.0	1.7	1.0	0.9	1.1	4.1	0.6	0.5	3.1	0.5	0.9	1.8	2.7	2.0	0.0	0.0	4.3	1.8	0.0	0.0	0.0	11.9	0.8	2.7	0.6	0.6	0.5	7.3	0.0	0.0	0.9	2.1	3.5	3.6	34.5	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	2.4	0.5	1.3	7.3	1.5	1.0	1.1	3.1	0.8	3.1	3.9	2.2	6.0	1.4	1.1	5.6	1.2	1.4	1.8	2.0	1.6	2.2	2.8	3.2	1.7	1.6	1.9	1.0	4.1	0.6	0.2	1.0	0.6	0.6	0.5	2.1	0.6	0.2	0.9	0.8	0.9	0.3	0.5	0.2	1.1	3.1	0.5	13.4	12.2	15.1	14.7	17.1	7.4	11.9	6.4	11.2	15.2
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859018	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.5;brain: 5.9;kidney: 8.3"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 5.4;SH-SY5Y: 18.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA025285	Uncertain									"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.9	5.5	0.0	0.3	5.9	0.1	0.8	1.9	1.4	1.9	0.1	0.0	0.0	0.1	2.7	0.1	0.1	0.6	0.3	1.9	0.5	1.3	8.3	0.1	0.1	0.4	0.8	0.6	0.3	0.9	0.1	1.7	0.4	5.6	2.7	0.1	2.1	0.6	0.5	0.4	0.1	0.2	0.3	0.0	0.2	3.0	4.2	0.4	0.3	0.3	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	1.4	0.5	1.3	0.8	0.6	5.6	0.4
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 36.6;RPTEC TERT1: 73.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.2	0.0	7.5	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	73.2	12.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358284	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.1;pancreas: 4.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 8.5;EFO-21: 6.8;Hep G2: 8.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036021	Approved									"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.3	0.9	0.0	0.1	0.4	0.0	0.0	0.0	9.1	1.3	0.0	0.0	0.0		0.1	4.3	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 8.5;SH-SY5Y: 3.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 4.7"	HPA061704	Approved									"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.2	0.3	0.7	1.1	0.3	0.0	0.1	1.2	0.0	4.2	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.1	0.6	0.3	2.8	15.4	0.0	0.9	0.1	1.1	0.5	0.1	2.4	0.1	7.6	0.6	1.0	6.2	0.4	7.6	0.1	0.0	0.2	0.3	8.7	0.0	0.7	0.1	1.7	1.4	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.8	0.4	1.7	0.5	0.7	0.5	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.7	0.2	0.1	0.1	0.0	0.0	0.3	8.5	3.3	0.0	0.2	0.1	0.3	0.2	0.0	0.3	1.0	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	1.2	0.5	0.4	0.4	0.3	0.1	0.6	0.2	0.2	0.2	0.8	0.5	0.4	1.7	0.7	0.3	0.4	0.2	0.4	0.3	1.1	0.1	1.2	0.3	2.8	1.1	0.5	1.0	0.3
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favourable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.5	28.0	0.2	0.4	1.9	0.0	0.0	0.0	0.2	0.1	0.0	2.9	9.4	0.0	26.9	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	8.2	2.7	7.0	1.5	1.3	0.1	0.2	12.3	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	26.8	31.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.1	1.4	0.0	0.7	0.1	0.0	2.2	1.6	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 78.9"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	78.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 17.9;T-47d: 14.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favourable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	17.9	0.0	0.0	6.0	8.7	4.3	7.9	0.0	0.0	0.8	7.2	3.0	2.9	1.0	0.8	3.1	4.0	0.0	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.1;kidney: 51.5;pancreas: 42.1"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020192, HPA024127"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.4	0.0	0.8	0.8	1.2	0.0	9.1	0.8	0.6	3.3	5.8	0.4	3.3	11.8	4.7	18.0	0.5	3.8	33.1	0.4	0.4	0.2	51.5	9.8	1.0	0.4	0.4	0.5	1.1	42.1	0.0	0.6	1.3	0.4	2.4	1.7	0.8	1.8	4.2	0.4	0.4	7.3	0.4	0.4	0.4	5.5	1.5	0.4	1.0	11.6	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	3.6	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.4	0.0	0.0	0.0	30.9	0.1	4.5	0.1	0.0	0.6	0.0	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.8	0.6	0.4	0.2	0.4	0.5	0.4	0.4
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50548033-50551022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.4;parathyroid gland: 12.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 42.3;urothelial cancer: 40.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA000518: AB_1079213, HPA076540: "	"prognostic favourable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.4	0.4	0.3	3.9	1.2	1.2	0.7	0.3	1.5	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.2	0.3	0.3	0.3	0.1	8.4	1.1	1.1	4.0	0.3	0.3	0.8	0.3	12.5	2.2	0.3	0.9	0.7	0.0	0.8	3.0	0.3	0.3	0.3	2.0	0.3	0.3	5.4	0.5	0.3	0.3	6.5	2.9	0.3	1.7	3.0	0.3	3.8	2.0	2.4	4.0	1.4	5.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	46.4	0.0	0.5	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.4	2.2	0.2	4.5	4.0	3.3	3.8	4.7	5.7	2.0	3.1	5.2	4.3	0.4	1.4	2.8	0.7	4.1	2.5	0.3	1.2	0.3	1.5	0.3	0.1	0.3	0.3	0.9	0.3
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669174	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.1;liver: 58.8"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		24000	24000	Cytosol	Cytosol	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	9.3	31.4	6.8	6.7	10.0	1.2	8.9	2.0	7.1	5.5	13.5	9.0	5.3	17.8	5.7	8.3	7.6	5.2	14.6	19.3	7.2	7.2	70.1	58.8	9.7	8.9	11.5	7.5	5.5	10.6	6.2	12.6	6.3	10.1	7.5	10.0	6.2	7.8	8.6	12.0	6.1	19.1	7.2	11.6	8.0	7.7	45.7	11.7	6.0	9.8	10.9	5.9	8.2	7.4	14.0	18.2	13.4	17.3	11.0	13.8	6.4	14.0	14.7	4.6	1.9	8.1	12.5	2.8	7.9	4.6	8.6	6.4	7.0	15.9	0.0	3.2	3.8	10.1	5.6	8.3	6.8	8.5	6.2	6.6	1.9	3.8	17.1	6.4	5.7	15.0	10.2	4.2	6.4	2.2	11.3	13.4	11.2	4.2	3.6	1.2	5.0	13.9	3.2	2.7	2.9	32.6	7.5	6.7	2.3	17.6	97.4	8.8	16.3	8.6	3.5	0.6	4.7	15.1	6.4	10.9	8.2	0.0	4.8	11.0	6.3	11.1	15.2	13.4	9.9	17.3	12.5	14.0	10.4	9.7	18.2	13.2	10.1	10.6	6.4	11.0	16.4	12.8	13.8	6.4	6.8	10.0	2.0	7.1	7.2	7.2	11.5	7.5	10.1	11.7
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		780000000	780000000	Cytosol	Cytosol	"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.7	88.0	77.4	50.9	55.5	61.8	90.0	45.8	45.8	64.1	63.5	139.3	0.1	116.1	30.1	30.8	16.5	106.4	84.9	81.7	29.7	74.1	119.5	84.1	0.1	53.1	111.5	51.7	70.6	30.4	56.1	76.4	73.1	65.3	17.5	70.5	0.1	94.7	135.0	223.2	38.2	85.6	108.0	93.6	318.2	146.3	24.9	57.7	21.0	32.6	79.0	0.2	87.5	28.4	43.2	56.7	30.7	86.3	15.5	20.9	152.5	47.9	53.4	51.2	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.4;BEWO: 5.5;CACO-2: 3.3;HeLa: 3.8;Karpas-707: 2.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.4	0.1	0.1	0.0	0.0	5.5	0.1	0.1	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.8	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Group enriched"	"Detected in some"	12	"AF22: 21.4;CACO-2: 35.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MACC1, MET transcriptional regulator"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.5;kidney: 23.9"	"Cell line enhanced"	"Detected in some"		"A-431: 40.5;CAPAN-2: 9.5;HaCaT: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB068194: , HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	4.8	2.6	0.5	5.6	0.4	0.7	4.5	0.4	0.5	8.3	13.7	0.0	4.4	10.1	0.7	6.1	14.1	0.9	9.6	0.5	0.5	0.5	23.9	1.0	13.3	1.1	0.4	0.0	1.3	11.3	0.1	4.0	1.6	0.1	3.9	3.3	0.1	11.4	6.0	0.5	4.5	29.5	0.1	0.8	6.0	5.0	0.8	0.0	1.7	1.5	16.0	13.6	4.0	5.1	2.3	1.0	1.4	1.0	0.8	0.6	0.5	40.5	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	9.0	9.5	5.7	0.4	0.0	28.5	0.1	0.3	0.0	0.0	0.1	5.4	0.1	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	0.0	5.8	2.8	0.0	3.4	0.0	0.5	0.4	0.0	0.0	0.3	4.4	7.2	2.8	0.1	0.2	0.0	3.2	0.0	1.7	0.1	0.1	0.1	0.0	0.0	0.1	8.7	0.4	2.1	0.0	0.3	0.0	1.0	0.6	0.3	0.3	0.7	0.6	2.3	0.2	0.5	0.3	2.0	0.3	0.3	1.4	0.8	1.0	1.0	0.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.4	0.0	0.1	0.0
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77690658-77926974	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;TIME: 3.0;U-266/70: 1.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.0	1.3	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.3	1.0	0.2	0.9	8.5	1.7	0.0	0.0	0.8		0.0	4.1	0.0	2.6	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	4.7			4.6		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.5	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;kidney: 37.6;stomach 1: 60.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;HAP1: 2.7;HMC-1: 4.5;SCLC-21H: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0"												"unprognostic (7.15e-4)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favourable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	1.7	0.6	17.3	0.8	10.6	0.3	2.1	18.8	24.9	4.9	7.3	1.3	0.0	1.2	0.8	5.2	1.0	1.6	11.1	0.8	11.9	4.3	37.6	0.5	3.8	0.5	3.6	13.3	0.6	1.0	0.4	3.2	3.5	8.4	1.1	9.5	2.4	8.6	0.6	0.6	3.3	1.1	0.7	2.8	0.6	60.0	0.5	0.2	0.0	0.7	0.8	2.8	0.9	0.8	1.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.8	0.0	2.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	4.5	0.2	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2	0.5	4.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.3	0.1	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	17.3	10.6	18.8	24.9	11.9	4.3	3.6	13.3	8.4	0.2
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 95.0;BJ hTERT+: 142.9;HSkMC: 92.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced					99000	99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.6	95.0	0.2	21.2	142.9	10.8	28.1	0.0	0.0	23.4	0.0	18.8	0.0	0.7	0.8	26.1	0.0	0.1	0.0	0.0	0.0	30.9	0.0	0.0	92.1	0.1	5.8	41.6	8.2	0.0	0.0	17.3	0.1	0.0	0.1	0.9	0.1	38.8	18.2	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.1	0.0	0.0	23.3	46.7	0.1	15.9	3.7	0.0	0.0	30.8	5.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavourable (2.53e-4)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	126.5	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2
MRO	"B29, C18orf3, FLJ30140"	ENSG00000134042	Maestro	Q9BYG7	18	50795120-50825402	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;kidney: 24.3;testis: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 4.5;ASC TERT1: 13.7"	"Cancer enriched"	"Detected in some"	7	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022011	Approved									"HPA022011: AB_2670880"	"unprognostic (9.21e-5)"	"unprognostic (5.22e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.99e-3)"	"unprognostic (6.06e-4)"	2.7	3.2	12.2	0.9	13.9	0.6	1.0	4.5	17.5	0.7	0.7	13.9	1.0	8.3	0.5	4.1	0.9	0.7	1.7	4.4	15.4	5.9	24.3	7.7	0.7	0.7	9.1	10.3	3.8	2.2	3.8	1.3	1.2	11.1	0.7	0.6	1.6	0.7	2.7	2.4	0.5	5.3	0.7	10.7	2.5	1.8	30.9	12.4	0.0	6.6	0.0	0.5	0.8	0.6	0.8	0.9	2.1	1.2	0.5	0.4	0.0	0.0	0.0	0.1	0.3	4.5	13.7	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.4	2.1	0.1	0.0	0.3	0.0	0.0	0.4	0.6	0.1	0.4	0.2	0.4	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.2	1.0	0.5	0.2	0.3	0.9	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.1	0.5	1.2	0.9	0.2	0.0	12.2	13.9	4.5	11.2	15.4	5.9	9.1	10.3	11.1	12.4
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657694-56660698	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 84.1;liver: 98.0;thyroid gland: 152.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.0;NB-4: 29.2;NTERA-2: 18.7;RPTEC TERT1: 80.9;THP-1: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 14.7;classical monocyte: 10.2;gdTCR: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9"	"Low lineage specificity"	"Detected in all"																						"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	6.4	12.1	14.8	5.8	22.9	2.4	3.1	5.9	18.6	2.2	24.6	9.7	4.9	15.9	2.3	13.5	2.2	3.7	10.6	1.9	16.0	13.7	84.1	98.0	2.5	6.5	27.5	15.7	1.3	55.7	1.4	4.5	1.5	37.0	11.6	17.6	8.3	3.9	4.3	1.1	2.0	37.9	3.3	23.8	3.9	15.1	1.6	9.2	0.0	152.5	0.0	2.8	3.3	1.1	7.4	2.5	14.7	10.2	2.3	25.4	14.4	1.2	0.8	0.0	0.0	0.0	0.0	1.6	0.9	1.8	0.6	1.0	0.3	4.8	0.0	3.2	0.1	4.5	5.7	0.9	0.7	18.0	0.8	1.3	0.2	0.5	0.4	0.0	14.9	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	29.2	18.7	1.8	0.0	0.0	0.7	80.9	0.8	9.4	1.1	1.1	0.3	0.5	0.6	17.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	13.6	15.7	0.1	14.7	10.2	2.8	14.0	0.9	12.7	7.4	15.3	23.9	2.5	3.0	15.2	25.4	1.5	2.3	0.4	0.8	23.9	14.4	14.8	22.9	5.9	18.6	16.0	13.7	27.5	15.7	37.0	9.2
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;EFO-21: 8.3;NB-4: 2.9;SCLC-21H: 2.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	2.9	0.4	0.0	0.3	0.0	1.6	0.6	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;EFO-21: 2.0;HEK 293: 2.0;NTERA-2: 1.8;SCLC-21H: 1.5;SH-SY5Y: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"																"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.1	1.2	0.1	0.0	0.0	3.8	0.2	0.0	3.1			0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	5.7	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.0	2.4		0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5			0.0		0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.5	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Group enriched"	"Detected in many"	7	"CAPAN-2: 139.8;RPTEC TERT1: 107.3;T-47d: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	4900000	4900000	"Plasma membrane"	"Plasma membrane"	"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.5	0.7	1.9	0.0	139.8	0.0	10.2	1.1	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	0.2	0.2	0.0	3.4	107.3	0.1	0.6	0.2	3.4	5.9	0.1	47.1	0.6	0.2	0.4	0.8	1.3	0.1	2.2	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	11000	11000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.5	0.0	1.3	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	24.8	0.1	0.1	0.0	0.0	0.2	0.7	0.8	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575681	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;kidney: 24.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.9;RH-30: 1.5;SH-SY5Y: 4.1;U-2 OS: 2.3;WM-115: 2.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	120000	120000			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.6	0.6	5.5	0.6	10.3	0.4	0.5	1.8	19.6	0.9	0.8	0.5	0.1	0.5	0.9	2.8	1.3	0.6	1.0	0.4	8.8	6.9	24.2	0.4	1.1	0.4	2.0	13.3	0.6	0.4	0.5	4.5	0.4	4.1	7.9	1.0	0.0	1.1	4.2	0.4	0.9	0.6	0.7	0.9	0.6	1.3	1.8	0.5	0.0	0.4	0.0	1.3	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	1.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	1.8	18.7	8.8	6.9	2.0	13.3	4.1	0.5
NPR3	"ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC"	ENSG00000113389	"Natriuretic peptide receptor 3"	P17342	5	32689070-32791724	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.0;fHDF/TERT166: 10.3;HeLa: 36.7;HSkMC: 23.8;U-138 MG: 10.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 19.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA052702	Supported		Approved	Cytosol				Cytosol	Cytosol	"HPA052702: AB_2681922"	"unprognostic (8.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.46e-3)"	"prognostic favourable (5.43e-6)"	"unprognostic (6.00e-4)"	"unprognostic (5.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.38e-2)"	26.9	3.5	0.4	0.4	1.5	1.9	2.7	0.2	0.8	4.5	5.3	0.3	1.4	0.3	4.2	3.3	6.8	2.5	3.9	16.4	0.4	0.5	54.2	7.6	24.2	0.5	0.2	0.8	1.9	0.7	0.3	0.7	5.3	3.1	8.8	0.5	7.3	1.2	18.1	9.5	3.7	1.4	1.8	0.3	4.5	1.0	1.5	0.0	1.1	11.0	13.4	1.4	5.5	4.5	1.4	0.9	7.3	0.6	1.1	1.1	0.2	0.1	1.9	0.1	0.1	1.1	17.0	0.0	4.5	0.8	0.2	0.2	0.0	0.1	0.0	0.1	10.3	0.0	2.2	0.0	0.5	0.0	0.0	0.2	36.7	0.0	3.4	0.0	0.1	23.8	0.2	1.2	3.2	0.1	0.0	0.3	1.5	0.3	0.0	0.2	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	6.1	0.0	0.1	0.0	0.1	10.1	0.1	0.8	0.1	0.1	0.0	0.0	1.6	0.0	0.1	0.3	0.6	0.4	0.8	0.3	0.5	0.9	0.7	0.5	0.0	1.4	0.9	1.1	7.3	1.1	0.1	0.9	0.4	0.2	0.4	1.5	0.2	0.8	0.4	0.5	0.2	0.8	3.1	0.0
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase like"	Q9ULD0	10	49734643-49762379	"Citric acid cycle related proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.9;liver: 48.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.4;RPTEC TERT1: 27.6;SH-SY5Y: 10.4;SK-BR-3: 10.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favourable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.9	8.1	8.3	1.0	15.3	0.8	0.8	16.2	23.6	1.3	1.3	4.9	2.7	1.4	2.2	1.7	0.9	1.5	1.1	4.1	8.7	13.7	74.9	48.8	0.8	0.9	12.1	11.0	1.9	3.4	23.1	11.7	0.9	23.6	1.8	1.0	8.2	10.3	5.0	0.9	0.8	1.4	1.2	2.9	1.0	1.4	1.9	3.2	0.0	13.0	0.0	1.1	1.4	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.9	13.4	0.0	0.0	1.7	0.0	0.0	0.7	0.1	6.4	1.4	0.0	7.2	0.0	0.2	4.6	0.1	0.2	0.0	0.3	0.0	0.1	3.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	4.9	4.4	1.2	0.6	0.0	0.0	0.0	27.6	0.4	7.6	10.4	0.1	10.2	0.7	2.8	1.8	0.0	0.0	7.0	0.0	0.4	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.3	16.2	23.6	8.7	13.7	12.1	11.0	23.6	3.2
OR2T29		ENSG00000182783	"Olfactory receptor family 2 subfamily T member 29"	Q8NH02	1	248556912-248562772	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;kidney: 2.7;prostate: 1.6"	"Cell line enriched"	"Detected in single"	32	"Karpas-707: 3.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"																																					0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	0.0		0.0	0.1	0.0	0.0	0.0		1.6	0.0		0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2			0.3		0.1	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.8;U-2 OS: 2.5;U-87 MG: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA040364: , HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 7.0"	"Cell line enhanced"	"Detected in some"		"RT4: 7.6;SK-BR-3: 3.5;T-47d: 1.7;U-2 OS: 4.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"myeloid DC: 2.9;plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA067673			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	2.1	0.0	0.7	1.7	0.2	0.0	6.7	0.0	2.0	1.6	3.0			0.1	0.6	4.0	3.2	2.5	0.0	0.0	0.8	0.8	7.0	0.0	0.5	0.0	0.7		0.0	0.6	0.0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0.0			0.8		0.9	1.8	0.9	0.0	5.2	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.2	0.0	3.5	0.0	1.7	0.0	0.0	0.0	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.8	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.1										
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 36.0;RPTEC TERT1: 36.7;RT4: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	"Golgi apparatus"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.9	5.9	11.7	0.0	0.2	0.4	14.0	15.9	6.3	2.6	4.2	4.8	5.9	0.0	9.1	2.8	36.0	0.0	21.3	5.5	0.1	2.0	0.0	4.0	0.0	12.1	0.0	0.1	5.7	7.2	5.0	1.8	0.4	0.0	0.1	4.0	0.3	0.0	0.1	3.6	1.2	0.0	2.3	0.8	36.7	25.1	0.8	0.1	21.6	1.2	9.5	0.0	0.2	7.9	15.5	5.8	0.1	2.8	1.1	0.0	0.1	3.6	0.0	19.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3
PANK1	"MGC24596, PANK, PANK1a, PANK1b"	ENSG00000152782	"Pantothenate kinase 1"	Q8TE04	10	89579497-89645572	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.1;liver: 63.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.00e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.55e-4)"	"unprognostic (4.61e-2)"	"prognostic favourable (1.55e-10)"	"unprognostic (3.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	"unprognostic (6.64e-2)"	1.1	2.5	2.3	1.2	1.9	0.0	1.0	13.4	4.1	2.4	6.1	1.3	0.5	9.0	0.9	1.9	2.9	1.2	1.5	3.9	1.9	2.6	20.1	63.8	2.1	0.6	2.1	2.7	1.1	1.2	2.6	2.2	1.0	3.1	1.5	7.8	1.8	1.4	1.0	5.7	5.5	9.2	1.0	1.7	0.9	2.0	1.5	1.0	2.6	4.7	2.4	1.0	1.1	5.5	1.0	2.3	0.9	0.6	0.1	1.6	0.7	5.6	3.7	20.8	14.2	11.3	8.2	10.5	3.3	3.6	3.2	4.3	5.8	5.9	4.1	2.2	2.5	5.7	9.4	2.1	3.5	1.4	4.2	2.7	4.1	11.5	3.3	8.6	1.6	5.0	9.4	4.8	3.8	3.7	4.7	0.5	4.6	4.4	9.5	8.8	16.3	2.3	8.4	4.1	2.7	9.9	2.7	6.5	7.8	4.2	5.1	3.3	5.5	6.3	1.6	1.9	1.8	3.8	4.0	4.8	8.8	5.1	2.6	6.9	1.3	0.9	0.3	0.1	0.7	0.1	1.4	1.0	0.8	1.6	1.0	0.1	1.0	0.2	0.7	0.1	0.6	2.3	1.1	0.7	2.3	1.9	13.4	4.1	1.9	2.6	2.1	2.7	3.1	1.0
PAQR5	"FLJ20190, MPRG"	ENSG00000137819	"Progestin and adipoQ receptor family member 5"	Q9NXK6	15	69298947-69407780	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.4"	"Cell line enhanced"	"Detected in many"		"A549: 17.1;CAPAN-2: 20.6;fHDF/TERT166: 14.6;HMC-1: 36.2;U-87 MG: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA076729			Approved	Vesicles				Vesicles	Vesicles	"HPA076729: AB_2686813"	"unprognostic (4.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.05e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.47e-14)"	"unprognostic (5.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.16e-4)"	"unprognostic (4.94e-2)"	1.8	15.4	1.9	4.1	2.6	0.7	1.2	1.5	3.1	1.6	12.3	3.0	1.7	1.5	1.1	1.6	9.0	1.0	1.7	1.9	1.8	1.5	41.4	1.0	10.4	0.3	2.0	1.0	0.5	4.8	5.8	0.9	1.0	3.5	1.1	10.8	3.6	1.8	4.2	0.4	3.2	5.2	3.2	3.8	0.2	4.5	1.5	2.2	0.0	0.6	5.7	4.9	2.3	2.6	0.2	0.2	3.5	0.3	0.4	0.7	0.0	5.0	17.1	0.3	0.3	0.7	1.9	0.1	1.6	9.9	1.9	4.2	0.9	20.6	0.0	2.7	14.6	0.3	4.9	0.2	3.4	0.0	0.7	3.0	2.6	0.3	1.3	0.1	36.2	1.0	0.7	8.8	9.5	0.0	0.0	0.2	8.2	0.6	0.0	0.1	1.1	1.5	0.0	0.2	0.9	7.6	0.4	1.5	0.3	2.7	1.0	1.4	0.4	1.2	0.2	5.9	1.9	0.4	0.2	0.1	0.1	0.0	15.1	0.0	1.6	3.5	0.3	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.7	1.3	0.4	0.2	0.2	0.1	0.0	1.9	2.6	1.5	3.1	1.8	1.5	2.0	1.0	3.5	2.2
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731544-50756795	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 40.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.4;MCF7: 27.2;T-47d: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	3.7	2.3	1.6	3.1	2.3	2.6	7.9	3.5	2.0	2.7	13.9	1.4	11.3	4.5	2.2	12.1	5.8	5.7	6.6	2.1	2.0	1.9	40.0	8.0	15.4	1.9	1.5	1.3	3.4	9.9	7.3	3.7	24.1	2.7	4.0	3.0	12.2	3.6	17.2	4.3	3.8	17.5	1.0	1.6	2.4	8.3	6.4	0.5	2.9	14.4	1.0	5.8	3.5	5.5	3.6	3.1	3.4	1.5	3.8	6.1	1.1	2.8	3.3	0.9	2.0	0.6	0.2	4.4	0.2	0.3	0.5	0.4	15.4	6.8	1.3	3.0	0.0	2.3	1.4	2.1	0.8	0.6	0.8	0.7	1.0	6.1	0.6	0.4	0.7	0.0	1.0	0.3	0.9	0.0	1.6	0.9	0.0	27.2	1.3	1.2	1.6	1.3	0.7	0.9	1.1	7.0	3.2	0.6	0.9	2.2	5.2	1.5	26.6	0.7	0.1	0.3	1.8	0.3	0.5	1.1	0.7	1.0	0.7	0.5	0.6	2.9	0.7	3.4	3.6	0.9	4.0	2.9	3.7	3.6	0.8	3.6	6.1	3.8	2.8	3.8	1.5	3.1	2.3	1.1	1.6	2.3	3.5	2.0	2.0	1.9	1.5	1.3	2.7	0.5
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	9	"AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 7.9;pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"			Nucleoli	Nucleoli	"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: "	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	14.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.3;kidney: 74.5;liver: 91.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		420000	420000	Vesicles	Vesicles	"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	5.0	5.9	3.6	2.4	6.4	2.5	2.9	2.3	8.0	4.1	9.4	11.8	6.8	47.3	4.5	5.1	1.5	2.3	2.9	3.3	3.9	3.1	74.5	91.4	2.3	2.8	6.7	5.6	2.3	17.9	2.4	2.4	7.0	8.4	2.6	8.0	9.4	2.2	6.2	2.3	1.8	39.3	6.5	4.9	1.6	15.0	2.1	6.2	2.5	1.9	4.3	1.6	4.1	1.6	1.7	5.6	6.4	5.8	3.3	2.3	2.5	3.4	6.9	6.7	4.6	6.1	3.5	3.1	13.9	8.8	5.3	5.5	6.2	8.8	3.9	5.4	9.6	5.3	3.1	3.6	4.6	1.8	5.0	3.1	7.5	5.6	3.0	4.5	3.1	6.2	4.3	3.2	4.0	3.2	2.7	8.6	8.3	5.3	4.1	7.9	1.9	3.0	7.2	8.8	6.3	10.6	5.0	3.9	5.2	9.3	5.4	6.3	18.7	5.4	10.0	5.3	3.8	2.5	2.2	5.2	3.7	5.7	6.3	2.5	1.3	4.2	5.8	2.9	0.9	2.9	1.8	1.7	1.4	0.9	5.6	1.6	2.3	1.6	6.4	3.3	1.7	2.4	2.3	2.5	3.6	6.4	2.3	8.0	3.9	3.1	6.7	5.6	8.4	6.2
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	5300000	5300000	Vesicles	Vesicles	"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.2	0.0	0.3	0.0	0.0	19.6	0.0	0.0	2.9	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.7	49.6	0.0	0.0	0.1	0.4	0.0	19.7	18.2	17.2	0.0	1.4	0.0	0.0	0.0	0.0	7.6	0.0	1.6	4.5	22.9	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 22.3;HHSteC: 13.2;HSkMC: 28.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in many"			HPA022151	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	22.3	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	3.1	0.0	13.2	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	4.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.8;intestine: 44.2;kidney: 12.5"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 4.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077887	Enhanced									"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.9	0.0	0.1	5.8	0.1	0.0	0.1	0.1	0.1	0.1	24.9	0.0	0.0	15.1	0.0	2.6	0.1	0.8	12.8	0.3	0.0	0.0	12.5	0.5	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.0	0.1	0.1	44.2	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 42.1;T-47d: 109.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favourable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.2	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.5	0.1	0.1	0.2	1.1	0.5	0.0	0.0	0.1	1.7	0.3	0.1	0.4	7.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.2	0.2	0.5	0.0	1.2	0.2	42.1	0.0	0.1	1.2	0.2	0.3	0.0	109.4	0.1	0.1	0.2	0.2	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		1000000000	1000000000	Nucleoplasm	Nucleoplasm	"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.2	35.9	10.6	17.0	45.2	17.4	24.5	11.7	24.1	15.0	17.1	31.2	11.6	5.4	17.6	29.5	3.4	15.2	9.6	12.4	15.2	15.0	34.3	7.3	31.7	30.9	9.9	41.6	21.4	9.1	13.7	8.5	20.0	6.5	15.6	16.3	16.1	7.6	3.3	14.6	14.6	15.0	14.4	14.9	13.0	34.9	13.0	33.4	21.9	10.8	17.7	7.5	10.8	16.7	14.5	15.7	18.8	13.6	14.3	21.2	4.7	15.5	14.4	20.6	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		2900000	2900000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell line enhanced"	"Detected in some"		"BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	1.1	2.3	1.4	0.1	1.3	0.0	0.0	10.7	0.1	0.9	0.2	1.2	1.4	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.0	8.7	0.9	2.1	0.9	0.0	0.0	0.0	0.9	2.7	0.0	0.0	0.0	4.4	0.0	0.8	0.2	0.7	0.0	0.7	1.9	0.0	12.0	9.6	5.3	0.5	46.4	0.0	0.0	0.0	8.9	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.5;liver: 49.7;skeletal muscle: 55.6"	"Cell line enriched"	"Detected in some"	7	"A-431: 42.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.07e-3)"	5.7	2.4	3.1	2.4	4.2	0.3	1.3	4.7	5.5	2.6	9.4	4.2	1.8	5.7	0.9	4.8	3.0	1.2	2.2	24.6	3.3	3.1	49.5	49.7	2.5	0.4	3.1	1.8	1.3	2.8	14.6	7.6	0.3	7.8	2.6	6.6	14.0	30.4	3.0	55.6	5.5	14.2	1.6	3.2	0.8	3.1	3.4	3.4	0.3	17.4	18.2	1.5	1.7	1.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	42.9	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.1	4.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	6.2	0.0	2.0	0.1	1.4	0.0	1.7	0.2	0.7	0.0	0.4	0.3	0.0	0.8	3.8	0.0	0.0	0.8	0.7	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	4.2	4.7	5.5	3.3	3.1	3.1	1.8	7.8	3.4
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		1700000	1700000	Cytosol	Cytosol	"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 13.6;lymphoid tissue: 14.2"	"Cell line enhanced"	"Detected in some"		"HEL: 5.2;NB-4: 2.8;PC-3: 7.1;SH-SY5Y: 4.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.5;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.7	1.4	1.1	2.7	1.3	0.2	1.5	0.6	1.2	1.3	1.5	0.1	0.0	1.2	0.4	0.3	1.7	1.0	0.4	3.1	0.4	0.4	13.6	0.5	4.9	6.7	1.8	0.0	1.6	1.8	0.2	1.4	0.3	1.0	0.5	0.3	0.3	0.3	0.4	0.7	0.2	1.9	1.4	0.1	14.2	3.2	0.4	0.6	0.0	0.7	0.0	0.3	0.6	1.3	0.0	0.4	0.0	1.5	2.6	1.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	5.2	0.0	0.3	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.3	7.1	0.8	0.0	0.2	0.0	0.1	0.5	4.1	0.1	0.1	0.1	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.2	1.1	1.3	0.6	1.2	0.4	0.4	1.8	0.0	1.0	0.6
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase, receptor type O"	Q16827	12	15322397-15597399	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;intestine: 28.5;kidney: 21.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.3;SCLC-21H: 5.7;SH-SY5Y: 11.2;THP-1: 4.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 215.3"	"Low region specificity"	"Detected in many"			HPA034525	Enhanced				"Intracellular and membrane"					"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	3.3	1.2	16.2	3.1	26.1	0.6	1.1	1.0	15.3	1.7	10.4	1.5	0.0	2.0	4.5	2.1	0.8	1.2	1.6	0.7	11.3	10.6	21.6	1.6	6.7	3.2	4.8	8.8	0.7	0.6	0.6	3.8	4.4	4.0	0.7	28.5	1.1	0.8	1.1	0.5	0.7	1.9	7.1	2.6	3.6	1.0	0.9	3.5	0.0	0.5	0.0	3.5	1.7	0.5	8.3	9.5	0.0	10.5	0.1	2.9	2.7	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.9	2.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.3	0.1	0.2	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	9.3	0.1	0.0	0.0	0.1	0.2	0.3	5.7	11.2	1.3	0.0	0.1	0.1	4.6	0.0	0.1	0.4	0.0	0.4	1.4	0.1	0.4	0.1	0.3	1.7	0.0	5.2	0.0	0.0	10.5	0.0	8.3	1.7	0.4	7.4	7.0	2.9	1.3	0.0	0.1	10.5	9.5	1.3	2.7	16.2	26.1	1.0	15.3	11.3	10.6	4.8	8.8	4.0	3.5
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Approved		Supported	"Vesicles,Cytokinetic bridge,Centriolar satellite"				"Vesicles, Cytokinetic bridge, Centriolar satellite"	"Vesicles, Cytokinetic bridge, Centriolar satellite"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favourable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favourable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.1	9.7	8.5	14.3	9.4	8.4	8.4	7.9	7.7	5.6	7.4	2.1	12.2	9.9	12.3	4.6	6.0	8.9	2.7	9.0	8.6	5.5	9.4	21.5	15.3	5.4	6.8	9.0	6.1	7.9	6.9	11.7	2.8	4.8	9.7	13.6	8.8	10.8	8.1	4.1	18.3	7.8	3.2	7.8	2.7	10.1	9.4	8.6	10.5	5.3	5.9	10.1	19.0	11.3	7.5	10.5	5.5	6.7	5.3	14.4	4.3	3.9	8.3	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36248434-36302114	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.3;kidney: 33.8"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 16.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	4.6	2.8	25.7	1.0	27.5	0.8	10.7	8.5	24.5	2.4	1.1	5.6	0.6	1.0	1.4	3.1	1.4	2.3	3.0	2.5	30.3	5.6	33.8	12.2	3.2	1.1	8.2	16.5	3.4	1.2	1.1	5.3	7.0	12.2	18.6	1.3	1.0	1.5	4.7	0.9	0.9	1.0	6.6	21.4	1.0	2.7	6.4	18.4	0.0	3.6	0.0	1.5	8.2	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	16.6	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	27.5	8.5	21.2	30.3	5.6	8.2	16.5	12.2	18.4
RARRES3	"HRASLS4, TIG3"	ENSG00000133321	"Retinoic acid receptor responder 3"	Q9UL19	11	63536809-63546462	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.1;HHSteC: 21.6;HSkMC: 21.6;RPTEC TERT1: 29.9;SK-BR-3: 45.2;U-266/70: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"prognostic favourable (1.35e-5)"	"prognostic favourable (4.00e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (6.26e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.64e-1)"	13.3	5.9	15.0	16.4	14.6	4.6	30.9	3.1	10.6	13.7	32.7	12.9	12.5	25.1	16.0	18.6	12.1	29.7	21.0	7.3	11.7	10.2	86.6	31.8	36.5	23.5	12.1	10.8	23.1	8.2	0.2	7.9	5.8	8.7	25.0	16.8	9.8	25.4	23.5	7.1	2.6	50.0	12.6	15.0	21.6	18.0	5.4	11.4	24.0	66.4	8.5	17.0	14.3	7.5	10.9	6.6	30.8	15.4	33.3	66.1	63.1	5.7	3.5	0.0	0.1	5.4	18.7	1.3	0.5	9.9	7.6	6.9	0.1	59.1	0.8	5.0	1.0	1.5	1.3	1.0	1.5	9.7	0.0	0.3	0.4	0.0	21.6	0.1	0.2	21.6	0.1	2.9	0.0	0.8	0.0	7.5	1.0	0.0	13.8	1.1	0.0	0.5	6.3	0.0	0.4	29.9	1.2	0.0	0.0	1.2	45.2	2.3	5.3	0.4	1.6	0.5	0.0	1.1	0.2	22.6	0.3	0.2	2.3	3.5	0.3	30.8	11.3	7.1	63.6	15.4	47.3	10.9	47.6	66.1	6.6	7.2	41.5	53.7	8.4	33.3	12.5	0.8	35.7	63.1	15.0	14.6	3.1	10.6	11.7	10.2	12.1	10.8	8.7	11.4
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.9;HMC-1: 43.9;SK-MEL-30: 29.0;U-266/84: 25.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced					42000	42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.0	0.0	2.5	0.0	0.0	0.0	0.5	9.8	0.0	0.8	7.6	0.0	43.9	0.3	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.2	2.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.0	0.0	3.4	0.4	0.0	0.3	0.0	0.0	4.4	25.2	1.7	0.9	4.6	3.4	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903335	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.4;liver: 11.5"	"Cell line enriched"	"Detected in some"	8	"RH-30: 12.0"	"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA052284	Uncertain				"Intracellular and membrane"					"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.2	0.9	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.0	6.4	11.5	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.0	2.4	0.2	1.8	0.4	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
RNF152	FLJ39176	ENSG00000176641	"Ring finger protein 152"	Q8N8N0	18	61808063-61894247	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"kidney: 53.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.0;SH-SY5Y: 9.9;TIME: 9.9;U-138 MG: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (1.13e-8)"	"prognostic unfavourable (2.85e-5)"	"unprognostic (3.26e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.83e-2)"	8.3	3.9	2.4	2.3	6.8	1.5	8.8	19.1	3.8	8.5	7.4	4.0	6.2	2.2	8.6	10.4	4.5	3.9	8.0	6.5	2.5	3.1	53.7	28.3	7.8	1.2	4.1	1.4	3.8	3.1	4.7	2.6	6.6	7.7	4.7	6.7	3.4	11.8	6.8	4.6	9.6	9.8	4.6	4.2	1.3	5.7	3.9	4.5	0.0	5.1	4.9	2.0	5.0	11.6	0.5	0.4	1.7	0.4	0.6	0.4	0.2	0.0	0.0	3.5	0.8	3.3	0.4	0.0	2.2	7.0	0.5	0.4	0.0	0.1	0.1	0.7	3.5	16.0	4.3	8.5	0.9	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	0.5	5.9	2.7	1.7	6.4	0.0	0.0	1.0	0.6	0.6	0.0	0.2	0.0	0.2	2.3	0.0	0.3	2.6	2.9	9.9	0.0	6.3	1.1	3.8	0.0	9.9	16.2	1.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	5.3	1.7	0.3	0.4	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.4	1.5	0.6	0.4	0.4	0.3	0.2	2.4	6.8	19.1	3.8	2.5	3.1	4.1	1.4	7.7	4.5
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 19.0;kidney: 9.5"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 20.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057675	Uncertain									"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.2			0.2	1.2	19.0	5.1	1.2	6.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.9	0.0		0.8	0.3		6.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	3.7	4.3			0.1		0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 37.7;SK-BR-3: 40.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.1	8.3	0.2	0.2	0.1	0.6	0.1	1.3	0.1	0.2	0.0	37.7	1.4	1.7	0.0	0.4	40.9	0.0	4.3	0.3	0.0	0.1	0.3	0.8	0.0	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 alpha subunit"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 70.2;HBEC3-KT: 47.1;hTCEpi: 20.2;RPTEC TERT1: 24.6;RT4: 26.4;SK-BR-3: 22.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced									"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (8.86e-4)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favourable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	0.9	3.7	0.4	7.5	0.4	0.0	10.1	0.4	0.9	22.0	20.6	2.2	60.9	5.6	8.1	15.7	47.3	19.3	7.0	0.4	1.1	0.1	100.4	2.2	53.6	0.4	0.5	0.4	5.9	14.2	0.0	10.2	1.6	9.4	15.0	21.5	6.2	53.1	55.5	0.6	14.4	11.8	1.0	0.4	0.4	20.3	2.8	0.4	0.9	74.7	21.1	41.3	10.3	13.8	0.0	3.0	4.4	0.5	0.0	1.7	0.3	4.9	0.9	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.0	0.0	1.4	70.2	0.0	0.1	0.0	3.2	0.0	47.1	0.0	0.0	0.0	0.0	3.9	0.7	5.1	0.0	0.0	1.2	20.2	0.0	14.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.1	24.6	26.4	0.2	0.0	0.5	22.8	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.0	0.0	0.2	0.6	0.5	0.0	1.7	0.3	4.4	0.0	0.1	3.0	1.3	0.3	0.4	0.4	0.4	0.9	1.1	0.1	0.5	0.4	9.4	0.4
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 30.7;RT4: 13.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	13.8	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0
SGK2		ENSG00000101049	"SGK2, serine/threonine kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.1;kidney: 39.1;liver: 32.9"	"Group enriched"	"Detected in some"	5	"A549: 13.5;CAPAN-2: 10.6;EFO-21: 5.4;Hep G2: 13.7;RPTEC TERT1: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (5.65e-4)"	11.4	0.7	2.8	4.3	9.9	0.2	3.1	1.0	10.2	1.4	21.3	33.1	0.9	17.8	1.0	19.7	0.7	1.6	7.9	0.7	4.3	2.5	39.1	32.9	0.6	0.5	6.9	5.1	3.2	14.1	0.5	1.7	0.5	13.7	1.4	23.4	0.0	0.9	1.8	0.4	3.2	20.7	1.0	14.2	0.7	11.9	1.0	6.0	0.0	1.0	0.2	0.2	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	10.6	0.0	5.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	13.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	19.4	2.2	0.1	0.5	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	9.9	1.0	10.2	4.3	2.5	6.9	5.1	13.7	6.0
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	7	"AN3-CA: 69.1;PC-3: 40.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"				Cytosol	Cytosol	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	7.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	3.1	40.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023314	Enhanced		Supported	Nucleoplasm,Cytosol		240000	240000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023314: AB_1856830"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favourable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	23.7	24.1	7.6	12.0	19.5	12.2	28.3	5.0	6.2	16.9	18.7	23.9	10.6	18.5	15.0	4.3	23.5	16.0	20.2	9.6	11.0	23.3	8.3	18.9	18.0	4.9	5.5	9.0	10.1	8.0	13.1	5.9	11.6	7.0	4.2	6.0	17.5	27.4	7.6	9.6	7.9	22.5	30.3	15.7	26.9	16.2	10.5	5.5	34.2	6.5	8.6	26.6	7.8	2.7	3.3	9.8	29.9	15.8	8.6	8.2	7.4	6.4	13.0	7.8	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA024385: "	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favourable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	7.8	0.0	12.5	18.3	5.6	5.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	5.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683686	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;kidney: 5.7"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"basal ganglia: 17.9"	"Low region specificity"	"Detected in many"														"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.8	1.0	0.0	0.1	0.4	0.6	0.9	0.0	0.7	0.1	0.0			0.3	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	5.7	0.0	0.2	0.1	0.0		0.1	0.0	0.3	0.1	0.0		0.2	0.0		0.2	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.1	1.3			1.0		0.0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.3	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.4	0.3	0.7	0.2	0.1	0.3	0.0	0.0	0.1	0.4	0.2	0.4	0.6	0.0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.2	0.3	0.6	0.0	0.3	0.4	0.5	0.3	0.4	0.3	0.1	0.7	0.1	0.4	0.5	0.1	0.2	0.1	0.1	0.1	0.3	0.3	0.4	0.3	1.0	0.4	7.0	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1										
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.3;HSkMC: 7.9"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	2.9	22.3	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.1	3.6	0.0	0.0	7.9	0.2	1.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.6;BJ hTERT+: 12.7;CAPAN-2: 18.8;HHSteC: 12.6;SK-MEL-30: 19.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	6.0	1.3	1.9	4.3	8.5	12.6	3.3	12.7	1.1	3.2	1.8	18.8	0.3	3.5	10.3	0.3	0.1	1.2	1.2	0.3	1.5	0.3	1.3	1.9	12.6	0.4	0.3	6.3	0.2	1.9	0.1	2.6	0.3	0.6	2.1	0.6	0.2	0.3	0.4	0.2	0.1	0.9	0.1	2.2	0.3	0.7	0.4	0.3	6.1	19.3	0.3	0.0	0.3	0.7	0.5	0.2	0.9	0.3	0.1	0.9	0.6	0.3	3.5	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.6;HDLM-2: 30.9;HUVEC TERT2: 14.6;RPTEC TERT1: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015466, HPA020086"	Approved									"CAB015466: AB_1278942, HPA020086: AB_1849766"	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.3	11.3	13.6	3.8	4.6	9.6	1.4	1.4	7.6	0.2	6.0	0.3	2.4	0.0	1.6	2.5	1.3	30.9	2.0	0.0	6.4	0.0	0.3	0.4	0.0	0.9	0.1	5.5	0.0	14.6	0.0	0.0	1.0	0.1	0.0	0.1	1.9	0.8	0.0	0.0	0.0	30.4	2.7	1.0	0.9	0.3	1.7	0.0	0.6	0.2	7.8	2.2	0.1	4.3	1.3	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;CAPAN-2: 6.9;MCF7: 13.0;SK-MEL-30: 24.1;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"									HPA068288	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.0	0.1	0.3	0.0	0.0	0.6	0.4	0.3	0.0	0.2	1.6	6.9	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.0	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	13.0	0.0	0.3	0.1	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.1	0.0	0.6	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	10.8	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.8;SiHa: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA063062			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favourable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favourable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.5	8.5	0.5	6.9	2.7	1.3	11.8	1.6	1.7	2.7	3.8	6.3	7.3	1.7	3.7	1.5	8.6	5.6	4.2	3.2	2.1	6.9	0.9	21.8	2.8	4.6	1.4	1.5	1.3	7.9	1.8	9.7	0.7	3.9	1.1	2.6	6.0	2.0	1.4	0.6	3.7	0.8	0.0	9.2	8.2	8.9	3.0	2.0	22.5	17.6	4.4	8.2	1.8	0.4	0.4	2.4	5.7	2.0	3.7	7.2	0.1	1.8	3.5	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.4;kidney: 11.7;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.9;HEK 293: 4.1;HEL: 4.0;RPMI-8226: 3.6;SCLC-21H: 3.8;U-2 OS: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	1.0	0.8	10.8	1.0	13.0	0.9	1.6	1.3	18.8	0.9	2.0	10.3	0.0	2.0	1.0	0.7	1.3	0.7	0.9	0.9	11.9	8.1	11.7	1.3	0.7	1.0	22.4	4.1	0.7	3.3	0.8	0.4	1.1	5.6	1.3	1.8	0.0	3.5	0.6	12.8	3.2	4.1	0.7	5.4	0.9	0.8	1.2	15.2	0.0	1.0	0.5	0.7	0.8	0.3	0.6	1.0	2.1	1.0	0.8	0.7	0.2	0.3	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.4	0.7	0.1	0.4	0.0	0.5	4.9	0.0	0.0	0.7	4.1	4.0	0.6	0.8	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	1.7	0.8	0.1	0.1	0.0	3.6	0.3	0.6	3.8	0.4	0.6	0.5	1.0	1.8	0.6	0.5	0.4	5.0	0.3	0.2	1.7	0.5	0.2	0.4	0.4	0.3	2.1	0.3	0.7	0.5	0.5	0.6	0.5	0.5	0.4	0.3	0.6	0.6	0.7	1.5	0.8	1.0	1.0	0.5	0.2	10.8	13.0	1.3	9.9	11.9	8.1	22.4	4.1	5.6	15.2
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.0;HMC-1: 8.9;T-47d: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041654	Uncertain		Approved	Microtubules				Microtubules	Microtubules	"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.2	0.0	1.7	0.2	0.4	4.1	1.9	0.1	0.0	0.0	4.4	2.5	0.7	2.2	0.0	1.3	0.1	0.0	0.0	2.5	0.9	3.3	3.0	13.0	0.2	2.1	8.9	0.6	0.2	0.1	0.0	0.3	3.4	0.0	0.3	2.8	1.3	3.5	1.0	7.0	7.1	0.0	0.3	0.7	5.0	0.2	1.3	0.5	0.2	1.2	9.0	1.4	2.1	4.7	0.9	4.7	1.3	6.8	3.1	1.2	1.6	4.3	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 43.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 29.0;Hep G2: 13.8;hTCEpi: 12.2;THP-1: 12.2;U-937: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 20.6;myeloid DC: 16.7"	"Group enriched"	"Detected in many"	31	"dendritic cells: 16.7;monocytes: 20.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA066229	Enhanced									"HPA066229: AB_2685639"	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	5.6	2.8	1.0	1.3	2.0	1.2	3.2	0.6	1.2	2.6	10.4	2.3	5.7	7.8	1.7	12.0	5.8	2.6	1.7	2.7	1.0	0.9	43.4	17.7	4.7	2.8	1.9	0.7	1.5	1.3	1.5	1.8	8.8	2.1	4.6	1.1	4.1	10.8	15.6	1.1	2.4	12.0	1.4	4.1	3.0	1.2	1.3	2.3	3.0	2.9	3.4	3.9	7.1	3.9	0.2	16.7	0.6	20.6	0.1	0.2	4.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	1.4	0.0	2.2	0.4	4.4	0.0	29.0	0.0	4.7	0.1	0.0	0.0	13.8	1.0	0.1	3.9	2.1	12.2	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	20.6	0.4	0.1	4.1	0.2	0.2	0.2	0.0	16.7	0.1	0.1	0.0	0.6	0.1	0.4	6.6	0.1	4.9	1.0	2.0	0.6	1.2	1.0	0.9	1.9	0.7	2.1	2.3
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;HDLM-2: 3.6;HeLa: 3.9;MCF7: 9.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced									"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	5.9	0.4	0.2	0.0	2.9	0.0	0.0	0.0	3.6	0.2	0.0	3.9	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	9.5	0.1	0.1	0.6	1.1	1.3	0.5	0.0	0.0	0.5	0.0	1.4	0.6	1.4	0.3	3.3	0.1	0.3	0.5	0.4	1.9	0.1	1.1	0.4	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 48.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"				Mitochondria	Mitochondria	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.2	48.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.6;kidney: 51.1;liver: 44.9"	"Cell line enhanced"	"Detected in many"		"A549: 13.0;AN3-CA: 10.3;Hep G2: 24.9;U-266/70: 19.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 11.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 12.2;plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.9;granulocytes: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced									"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	2.2	45.6	0.8	0.4	2.2	1.1	0.6	1.0	3.1	13.2	1.2	3.7	1.3	0.7	7.6	12.2	0.9	2.4	1.7	3.5	4.7	0.5	51.1	44.9	3.0	3.5	0.9	2.5	5.0	0.2	0.2	7.2	0.3	11.4	2.6	0.5	4.3	1.1	5.5	12.1	10.4	0.6	3.5	2.3	1.9	0.5	15.5	0.6	0.9	4.7	5.7	1.2	0.6	4.5	0.1	6.9	12.2	1.3	0.0	0.7	0.4	0.0	13.0	0.3	10.3	0.3	0.0	0.0	0.3	0.3	1.6	1.4	0.0	0.4	0.1	2.5	1.8	0.0	4.6	0.3	0.4	0.0	6.1	0.1	6.9	24.9	0.1	0.1	0.3	0.2	2.3	1.2	0.2	3.6	0.0	0.0	0.0	1.8	0.0	0.2	1.4	0.5	0.1	0.1	0.1	0.0	0.8	2.5	2.1	4.3	0.0	1.1	4.4	1.1	0.0	0.1	0.5	0.2	1.2	19.4	7.6	0.0	0.5	0.1	2.2	0.2	1.3	12.2	0.3	1.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.7	0.3	0.0	0.2	6.9	0.0	0.4	0.8	2.2	1.0	3.1	4.7	0.5	0.9	2.5	11.4	0.6
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.7;fHDF/TERT166: 6.2;HBF TERT88: 5.7;RPTEC TERT1: 14.7;U-138 MG: 7.8;U-2197: 5.6"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629"	Enhanced									"CAB022493: , HPA035628: AB_2674708, HPA035629: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.7	1.8	2.3	1.8	0.0	0.1	0.0	0.1	6.2	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.9	14.7	4.1	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	7.8	0.7	5.6	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA029791: "	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.2	5.6	11.8	8.3	9.9	8.1	5.7	7.2	21.8	4.5	6.8	9.3	13.8	10.1	5.8	14.5	3.2	14.3	4.1	7.6	10.5	3.7	10.4	5.2	3.1	2.6	4.4	4.4	3.9	10.6	12.2	4.9	2.6	10.3	2.4	11.5	4.2	4.7	3.6	5.9	5.5	4.8	2.1	4.6	17.6	8.8	6.2	2.8	14.9	4.0	3.4	2.4	4.8	2.5	8.8	6.8	16.8	2.8	12.5	10.8	7.6	17.7	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.1;liver: 59.3"	"Group enriched"	"Detected in some"	12	"Hep G2: 8.3;RPTEC TERT1: 16.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	51	"dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favourable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.6	0.8	6.3	1.3	12.9	0.6	0.8	6.6	14.7	0.9	1.0	4.3	0.0	3.7	1.3	5.6	0.5	3.0	1.2	0.7	7.2	4.6	22.1	59.3	2.2	0.8	8.1	4.9	0.7	1.3	0.6	0.3	0.9	9.4	0.6	1.8	0.2	0.6	0.5	0.5	0.7	1.1	1.2	3.1	0.8	2.3	1.6	8.8	0.0	4.5	0.0	0.7	0.9	0.2	0.0	2.9	3.7	8.6	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.7	0.1	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.7	0.0	8.6	0.0	0.0	1.9	6.3	12.9	6.6	14.7	7.2	4.6	8.1	4.9	9.4	8.8
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 63.8;intestine: 93.5;kidney: 67.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 48.1;CACO-2: 78.0;EFO-21: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 59.5;non-classical monocyte: 63.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 63.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced									"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	10.4	2.8	1.9	8.3	3.1	3.6	3.2	0.7	2.7	2.6	48.0	4.1	0.2	24.1	2.7	2.3	2.1	4.6	7.6	3.0	2.2	1.6	67.3	6.5	15.3	20.5	3.7	1.0	2.6	2.7	26.3	1.0	6.5	3.2	2.7	3.4	2.1	3.3	0.9	1.6	1.8	93.5	3.5	4.5	32.4	3.0	13.4	2.7	2.1	2.8	0.8	5.7	4.1	3.6	3.0	14.6	5.4	63.8	0.0	0.1	17.8	0.0	2.6	0.2	0.1	0.4	0.9	48.1	0.5	3.9	0.1	0.3	78.0	7.9	3.8	16.9	0.3	2.9	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.8	2.3	0.4	0.4	1.7	0.2	0.2	0.1	6.0	0.0	3.0	0.6	0.1	0.0	0.3	0.8	0.0	0.6	8.4	2.2	0.2	0.2	0.0	0.2	0.1	0.1	0.5	0.1	1.8	0.3	0.2	0.4	0.1	0.1	0.6	0.2	2.0	0.2	0.2	0.0	0.0	41.2	0.1	0.0	59.5	0.0	3.0	0.0	0.0	14.6	2.3	0.1	0.0	5.4	0.0	63.8	0.5	0.1	17.8	1.9	3.1	0.7	2.7	2.2	1.6	3.7	1.0	3.2	2.7
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	6.9	7.3	1.6	1.9	5.5	4.2	2.4	5.1	3.2	9.2	4.8	10.1	5.5	1.8	6.9	3.8	2.5	2.5	27.9	7.2	4.6	16.3	3.3	2.6	3.4	5.9	2.7	5.2	2.2	3.5	1.5	6.0	5.3	1.8	6.5	3.7	16.5	2.6	6.2	5.5	6.5	5.3	1.7	3.6	7.8	3.3	12.5	3.5	2.6	7.9	2.6	1.9	5.9	5.3	4.0	2.6	8.9	3.6	5.7	3.7	15.1	3.7	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	45.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.2	34.2	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.6	4.6	0.0	0.0	17.9	0.0	1.2	0.4	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	25.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3
SMIM34A		ENSG00000243627	"Small integral membrane protein 34A"	A8MWV9	21	34418715-34423966	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;SK-MEL-30: 1.2;U-87 MG: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029085	Uncertain									"HPA029085: AB_10669867"																		0.3	0.1	0.3	0.3	0.5	0.2	2.9	1.6	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.1	0.3	0.6	0.3	0.2	9.6	0.5	0.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.3	0.7	1.0	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.7	0.0	0.6	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	1.6	0.3	0.3	0.2	0.3	0.3	0.3	0.3
SMIM34B		ENSG00000278961	"Small integral membrane protein 34B"	A8MWV9	21	7784482-7793954	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 4.5;kidney: 16.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;SK-MEL-30: 2.6;U-87 MG: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 3.1;myeloid DC: 1.7"	"Low lineage specificity"	"Detected in many"											HPA029085	Uncertain									"HPA029085: AB_10669867"																		0.0	0.0		0.0		0.0	4.5		0.0	0.0	0.0			0.0	0.0	0.1	0.0	3.7	0.0	0.4			16.1	0.1	0.4	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.5	0.7	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	1.7	3.1	0.6	0.0	0.0	0.4	1.1	0.2	0.2	0.0	0.0	0.0	0.3	0.2	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	2.6	1.2	0.3	0.0	0.0	0.5	0.4	0.0	1.1	0.1	0.0	2.5	0.3	0.1	0.0	0.5	3.1	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4										
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell line enriched"	"Detected in single"	42	"HaCaT: 10.7"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	CAB025660	Approved				"Secreted to extracellular matrix"					"CAB025660: "	"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0
SOX6		ENSG00000110693	"SRY-box 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.1;kidney: 28.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.8;HAP1: 4.8;hTCEpi: 5.5;SK-MEL-30: 4.9;WM-115: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favourable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.4	0.9	3.9	0.8	3.5	17.7	0.8	0.8	5.7	1.4	30.5	0.8	2.3	5.0	0.8	4.9	1.6	3.3	6.3	2.5	2.6	2.5	28.4	3.8	2.0	0.8	3.0	0.8	1.7	14.5	0.0	2.9	1.9	0.9	0.8	0.8	1.1	0.8	0.8	8.1	4.5	70.1	0.8	1.4	1.1	0.6	10.3	1.0	0.8	2.8	1.4	0.8	0.8	0.8	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.6	4.3	4.1	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.8	0.0	0.0	3.7	0.0	0.1	4.8	1.3	0.0	0.0	0.5	0.0	0.0	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	2.1	0.0	0.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	3.9	3.5	0.8	2.5	2.6	2.5	3.0	0.8	0.9	1.0
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 213.7;Hep G2: 105.2;RPTEC TERT1: 466.7"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"CAB002212, HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	54000000	54000000	"Golgi apparatus"	"Golgi apparatus"	"CAB002212: AB_564074, HPA027540: , HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	213.7	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	105.2	0.0	0.2	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	9.9	0.0	0.1	0.0	50.1	466.7	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	19.5	0.0	19.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058536			Approved	Vesicles,Microtubules				Microtubules	Microtubules	"HPA058536: AB_2683746"	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.7	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.8	8.1	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	11.5	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	10.1	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.9	0.0	1.1	18.5	0.0	0.4	0.0	0.0	0.0	0.0	47.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9
STRA8		ENSG00000146857	"Stimulated by retinoic acid 8"	Q7Z7C7	7	135231979-135258492	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.0;skin 1: 2.5;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;K-562: 1.1;SK-BR-3: 2.3;THP-1: 6.7;U-266/84: 2.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (2.84e-1)"		"unprognostic (4.86e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.67e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.55e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.69e-1)"			0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0			0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	1.2		0.0	0.0		0.1	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Supported	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	330000	330000	Mitochondria	Mitochondria	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	23.5	25.9	20.5	25.0	38.6	26.0	35.5	26.9	23.0	34.6	25.3	59.3	19.5	32.4	18.6	32.1	34.4	42.1	31.6	41.2	31.3	38.3	28.1	22.4	33.7	32.6	28.6	23.0	30.9	26.0	29.1	39.8	30.8	28.5	26.7	31.5	36.0	40.6	26.2	10.7	46.4	25.8	47.5	35.5	46.4	28.6	24.9	13.9	21.4	44.5	42.7	27.1	22.6	24.8	27.2	26.3	33.3	32.9	23.5	33.3	28.0	31.7	39.7	23.9	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.1;lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	5	"HEL: 27.4;NB-4: 15.8;U-937: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022745	Uncertain									"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	13.7	1.6	0.6	0.7	0.9	4.7	1.6	0.2	1.2	0.3	0.5	0.7	0.0	0.7	0.4	0.6	0.5	0.3	0.2	2.8	0.4	0.4	63.1	3.6	2.2	3.3	0.6	0.1	0.7	0.4	4.2	0.3	0.2	0.8	0.5	0.5	0.1	1.3	0.0	0.3	0.7	0.5	0.3	0.5	23.3	6.7	0.4	0.0	1.3	14.6	0.8	0.3	0.7	0.3	0.0	2.2	2.0	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	4.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.1	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.7	2.2	0.0	0.2	0.6	0.9	0.2	1.2	0.4	0.4	0.6	0.1	0.8	0.0
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40134977-40860763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.1;liver: 27.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.5;LHCN-M2: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced									"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavourable (2.53e-4)"	2.7	13.5	3.2	5.1	4.6	0.7	4.0	1.1	3.1	4.4	5.0	1.1	0.7	1.4	9.6	2.9	3.2	2.7	4.5	6.9	4.3	2.4	42.1	27.6	1.2	3.9	2.8	2.4	5.7	3.8	3.8	3.5	1.2	4.8	3.4	2.9	5.4	2.4	4.3	11.3	1.6	5.6	13.9	5.0	1.3	1.8	4.1	4.1	0.0	2.4	6.3	1.5	2.9	3.5	1.4	0.2	1.1	0.2	0.0	4.6	0.7	0.5	0.0	3.0	2.3	3.3	7.6	1.2	1.5	2.9	2.2	2.5	1.2	0.6	2.0	0.7	2.2	0.1	1.0	27.5	3.4	0.0	1.3	1.7	0.2	4.4	4.1	0.2	0.2	9.6	6.2	2.3	1.4	0.6	2.3	0.3	16.5	0.0	0.1	0.3	5.2	2.3	1.9	0.3	0.0	4.7	0.0	0.2	1.7	2.5	1.1	3.5	0.1	0.4	2.3	9.4	2.7	0.1	0.6	0.2	0.0	0.1	1.8	0.8	2.1	0.0	0.1	0.3	0.7	0.0	1.2	1.4	2.0	1.0	0.1	1.2	4.6	2.7	1.1	0.0	0.2	0.2	0.0	0.7	3.2	4.6	1.1	3.1	4.3	2.4	2.8	2.4	4.8	4.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.2;kidney: 58.4;stomach 1: 59.2"	"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 23.5;RT4: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved									"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.5	0.1	0.2	2.2	0.2	0.0	0.4	0.1	0.2	0.8	1.5	1.0	0.5	10.6	0.8	13.3	0.4	1.0	69.2	0.5	0.2	0.2	58.4	1.5	2.5	0.6	0.4	0.3	0.3	3.2	0.2	4.6	0.6	2.2	0.3	1.9	18.6	3.5	4.9	0.1	0.2	1.8	0.6	0.6	0.4	59.2	0.4	0.0	0.4	10.3	0.4	0.3	0.6	0.4	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.2	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	23.5	6.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.4	0.3	2.2	0.0
TAAR6	"TA4, TRAR4"	ENSG00000146383	"Trace amine associated receptor 6"	Q96RI8	6	132570322-132571359	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"kidney: 1.6"	"Cell line enriched"	"Detected in single"	10	"REH: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																														"unprognostic (1.70e-1)"					0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.1	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0			0.0		0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCF24	bHLHa25	ENSG00000261787	"Transcription factor 24"	Q7RTU0	8	66946501-66962590	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.0;kidney: 4.1;testis: 7.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HEK 293: 9.3;HMC-1: 8.1;K-562: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (1.07e-1)"	"unprognostic (9.14e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.74e-1)"		"unprognostic (2.25e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.14e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.5	0.1	0.9	0.3	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.0	0.2	0.3	0.1	1.6	0.1	8.0	0.6	0.8	4.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.5	0.1	0.6	7.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.0	3.7	0.0	0.1	0.0	9.3	0.4	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.7	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.9	0.1	0.9	0.6	0.8	0.1	0.1	1.0	0.1
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30606838-30627278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34.6;HUVEC TERT2: 40.5;Karpas-707: 52.7;RPTEC TERT1: 20.5;TIME: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8"	"Lineage enriched"	"Detected in many"	8	"monocytes: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	13000000	13000000	Cytosol	Cytosol	"HPA000837: "	"unprognostic (6.43e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	39.8	15.2	6.5	7.2	8.1	2.2	30.0	3.4	10.9	13.1	14.8	9.2	9.6	10.9	15.0	23.9	7.0	11.2	31.7	15.8	6.6	7.3	73.2	8.7	21.7	43.3	8.6	8.5	7.8	6.3	5.7	7.9	8.7	10.7	9.6	13.5	13.5	6.8	23.0	5.4	4.5	30.4	17.6	9.0	24.8	8.4	9.7	5.1	1.9	12.8	4.8	4.6	11.6	10.9	0.0	3.4	0.6	29.0	0.0	0.3	6.5	0.0	2.5	11.8	0.0	7.0	34.6	0.4	0.8	8.7	2.2	3.7	1.2	6.0	0.1	13.1	1.6	0.4	1.0	0.6	0.7	0.0	0.6	0.0	0.3	0.5	17.0	0.1	9.7	5.6	0.6	1.7	1.5	40.5	0.2	52.7	3.5	0.0	0.0	0.9	4.6	0.2	1.3	1.7	17.7	20.5	0.3	4.1	0.5	0.0	0.1	3.4	0.1	0.5	23.7	7.6	1.0	0.9	0.3	1.4	0.3	0.0	2.7	0.4	0.1	0.0	19.2	0.0	0.0	29.0	0.3	0.0	0.3	0.2	3.4	0.0	0.1	0.2	0.6	0.0	9.8	0.6	0.1	6.5	6.5	8.1	3.4	10.9	6.6	7.3	8.6	8.5	10.7	5.1
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 45.5"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Vesicles	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	10.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.6"	"Cell line enhanced"	"Detected in some"		"HEL: 12.0;HUVEC TERT2: 8.4;THP-1: 15.9;TIME: 9.3;U-937: 18.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.7;myeloid DC: 7.7"	"Group enriched"	"Detected in many"	32	"B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	11.2	3.5	5.8	15.4	9.2	12.3	7.6	0.8	4.6	1.8	3.7	1.4	0.6	3.4	1.6	6.1	2.4	2.6	4.2	2.5	6.0	2.1	22.6	2.8	15.7	17.0	13.0	2.2	1.6	1.8	0.4	1.8	3.9	8.8	1.9	3.6	0.8	3.1	0.7	1.2	1.3	11.6	2.6	15.2	16.4	2.3	1.7	9.4	1.6	2.1	1.1	10.0	3.8	1.7	4.9	7.7	0.2	8.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	9.3	1.6	0.1	0.9	0.0	4.2	0.0	0.0	0.0	18.1	0.8	0.0	8.7	0.0	0.0	3.7	0.0	4.9	0.0	0.0	7.7	2.1	0.0	0.0	0.2	0.0	0.5	3.9	0.0	1.7	5.8	9.2	0.8	4.6	6.0	2.1	13.0	2.2	8.8	9.4
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4;hTERT-HME1: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		81000000	81000000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"CAB017194: , HPA051828: AB_2732570, HPA054787: "	"prognostic favourable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.81e-6)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	12.5	3.1	7.0	12.1	7.0	2.3	5.3	5.4	18.9	5.6	24.3	4.0	1.7	3.3	6.5	4.2	3.4	3.2	6.3	8.5	6.8	6.0	36.9	1.8	1.9	1.3	6.2	4.2	7.0	3.3	2.3	3.0	2.4	4.5	3.1	5.4	5.5	5.4	1.6	16.9	1.6	16.6	6.9	9.6	0.8	4.1	3.5	1.3	0.9	29.0	4.5	1.3	4.3	7.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.8	2.6	3.9	4.5	29.4	2.8	4.3	6.5	5.1	6.0	6.0	7.1	0.9	2.2	3.0	11.3	1.1	4.9	1.0	5.3	7.0	0.5	0.2	10.7	4.7	1.0	0.7	0.2	5.1	2.7	8.0	23.9	0.2	0.2	0.1	10.0	3.4	0.3	0.3	6.8	1.9	2.7	9.8	2.7	3.1	5.4	0.9	4.5	5.0	0.5	1.7	1.4	1.7	1.8	10.9	14.8	17.5	16.5	0.1	0.4	1.4	4.9	1.6	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	7.0	7.0	5.4	12.9	6.8	6.0	6.2	4.2	4.5	1.3
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;kidney: 8.8"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 30.9"	"Group enriched"	"Detected in some"	8	"glioma: 7.6;renal cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 1.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		140000	140000	"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0.0	0.9	5.3	0.4	0.5	0.0	0.8	0.8	0.3	0.8	2.8	0.6	20.0	0.7	0.6	2.4	2.2	0.0	0.4	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.0	1.4	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	3.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.4	0.5	0.0	0.0	2.6	1.8	0.0	1.4	0.0	0.0	0.0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.5	0.7	0.1	0.0	0.0	0.0	6.4	0.1	0.0	0.0	0.0	2.2	17.9	0.1	12.6	0.0	8.1	0.0	4.1	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.4	0.0	0.7	0.1	0.1	0.0	31.5	2.4	0.1	0.0	0.4	11.1	0.0	30.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120292-73131817	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.5;RPTEC TERT1: 15.6;WM-115: 57.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 18.2;memory CD8 T-cell: 6.3"	"Lineage enriched"	"Detected in single"	86	"T-cells: 18.2"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.6"	HPA042308	Approved									"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.2	0.2	0.8	5.6	2.1	0.0	0.7	0.7	3.3	0.4	20.1	3.2	2.2	16.2	0.2	1.4	3.9	0.2	1.5	0.2	1.2	0.7	25.4	3.9	0.4	0.1	0.9	1.6	0.2	0.6	0.0	0.3	0.1	1.1	0.5	18.9	0.6	1.4	2.8	0.6	0.7	18.8	0.6	1.4	14.6	16.7	0.6	0.6	0.0	25.9	3.2	6.3	0.4	0.3	0.0	0.0	0.2	0.0	0.0	18.2	0.5	7.3	0.3	0.0	0.0	2.4	3.2	0.0	2.3	10.9	4.4	7.5	0.2	3.5	0.0	5.0	2.9	5.5	0.1	0.3	3.5	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.3	0.7	0.2	6.0	0.5	2.7	0.0	0.1	20.5	0.7	0.0	0.0	0.6	0.4	0.0	0.0	3.7	15.6	0.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.5	0.1	0.0	0.0	0.0	6.0	0.0	57.2	0.0	0.0	0.0	1.3	0.0	18.2	0.0	0.7	6.3	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.5	0.8	2.1	0.7	3.3	1.2	0.7	0.9	1.6	1.1	0.6
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 124.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438520	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 110.5;kidney: 82.5"	"Group enriched"	"Detected in some"	5	"EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	31	"monocytes: 2.8;T-cells: 3.3"	"Low region specificity"	"Detected in many"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	18.5	5.2	0.6	5.9	1.0	0.0	10.0	0.5	1.2	6.7	60.3	1.8	3.8	16.2	3.1	3.8	2.8	1.4	18.5	5.7	1.0	0.4	82.5	40.8	9.5	8.7	0.9	0.7	5.9	5.8	20.1	0.7	13.4	1.3	4.5	5.6	6.3	2.8	6.5	1.6	4.4	110.5	1.9	1.4	11.5	6.6	6.4	0.7	1.2	21.0	1.6	2.2	3.4	2.4	0.0	0.0	0.0	2.8	0.0	3.3	0.6	0.0	3.4	0.3	0.1	2.1	0.2	0.5	0.1	0.0	0.0	0.0	5.3	3.0	0.0	13.1	1.6	0.8	1.4	0.0	0.0	0.0	1.3	0.4	2.0	34.4	2.9	0.0	0.0	4.8	0.0	0.0	0.0	2.8	0.1	5.2	0.0	0.3	0.0	0.3	2.5	0.1	0.0	0.0	4.5	28.8	2.3	0.4	0.2	0.1	1.4	0.0	0.6	0.8	1.8	0.0	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.6	1.0	0.5	1.2	1.0	0.4	0.9	0.7	1.3	0.7
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA030614	Uncertain									"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favourable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	22.1	2.3	0.0	1.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118952200	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 18.6;thyroid gland: 52.8"	"Group enriched"	"Detected in some"	4	"BJ: 49.7;BJ hTERT+: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034939	Approved				"Secreted in other tissues"					"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavourable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (3.88e-4)"	3.0	3.0	2.2	2.8	2.8	0.2	4.4	2.9	5.2	1.2	1.5	0.7	0.5	0.9	5.5	4.1	1.0	1.7	3.2	7.3	2.8	1.4	18.6	7.6	8.1	5.3	1.7	0.8	0.5	2.8	0.3	1.9	4.0	12.0	1.1	2.0	1.8	1.4	0.8	0.6	0.7	1.4	1.5	7.9	1.5	0.8	0.3	2.7	0.9	52.8	0.8	1.7	1.7	1.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.5	0.0	49.7	184.9	2.4	0.6	0.5	0.1	0.0	13.4	27.5	0.5	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.8	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.2	2.8	2.9	5.2	2.8	1.4	1.7	0.8	12.0	2.7
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523507	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.5;CAPAN-2: 14.6;HMC-1: 67.6;RPTEC TERT1: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 50.3;monocytes: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054938	Uncertain		Approved	Microtubules	"Secreted to blood"			Microtubules	Microtubules	"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	30.9	22.1	3.4	14.6	4.7	2.0	23.3	3.0	5.4	31.4	25.8	4.4	17.1	20.6	13.0	10.3	33.3	9.6	10.7	9.9	3.8	3.2	115.1	44.4	91.5	23.5	5.5	3.4	13.5	11.6	10.9	6.7	100.8	6.7	37.6	19.5	12.0	50.6	12.9	13.9	13.0	54.0	7.9	5.6	35.8	9.5	6.0	4.6	8.3	28.2	17.7	16.1	22.4	24.0	3.4	9.5	50.3	39.5	9.3	7.0	11.9	3.3	0.1	0.0	0.0	2.4	1.8	20.5	0.0	0.1	1.0	1.6	0.0	14.6	2.1	9.8	0.0	14.4	0.0	1.8	0.2	5.2	0.0	0.0	0.4	0.3	0.1	3.8	67.6	2.4	2.3	0.4	0.0	7.4	0.0	2.4	0.0	0.0	0.4	5.1	0.0	0.1	0.7	0.0	0.9	34.1	1.3	0.0	0.1	7.5	0.3	0.1	4.1	2.2	0.3	0.0	0.0	0.0	0.2	2.6	0.3	2.6	0.2	2.2	0.0	42.4	25.6	2.7	2.3	39.5	3.1	3.2	6.4	3.5	9.5	3.4	4.7	1.8	50.3	9.3	38.3	0.6	7.0	11.9	3.4	4.7	3.0	5.4	3.8	3.2	5.5	3.4	6.7	4.6
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"			"Nuclear membrane"	"Nuclear membrane"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.7	1.4	0.0	0.0	11.5	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.6	0.0	14.5	0.0	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0	0.0	0.7	0.0	1.1	0.0	6.6	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47996895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 34.3"	"Group enriched"	"Detected in some"	6	"HeLa: 7.8;U-2197: 16.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA045817	Approved				"Intracellular and membrane"	22000	22000			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	3.6	1.5	0.5	2.2	0.3	0.1	3.3	2.7	0.5	4.8	3.0	0.5	1.5	0.9	1.8	9.3	4.7	2.2	9.5	8.2	0.1	0.1	34.3	7.1	1.8	1.9	0.4	0.5	2.5	7.0	0.3	2.3	0.9	0.8	4.9	1.6	2.7	2.3	8.5	1.7	1.7	1.8	7.1	0.7	1.5	1.9	1.8	0.0	0.6	1.1	1.0	0.8	6.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.0	7.8	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	16.7	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.7	0.5	0.1	0.1	0.4	0.5	0.8	0.0
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151945-30160934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8"	"Cell line enriched"	"Detected in single"	11	"EFO-21: 1.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 4.0"	HPA043325	Uncertain									"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	3.0	0.0	0.0	1.4	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.6;NTERA-2: 16.2;TIME: 13.6;U-2 OS: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA060514	Uncertain									"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	3.7	5.8	0.6	1.5	1.3	1.3	3.0	0.2	1.4	4.2	2.6	1.4	3.2	0.1	4.2	4.3	6.0	3.1	1.8	2.6	0.8	0.7	42.7	1.1	2.2	0.2	0.7	0.6	3.9	1.8	1.9	1.9	10.9	2.1	3.9	1.2	6.6	14.7	3.9	1.3	1.1	2.2	4.7	1.4	2.8	1.6	15.5	1.0	1.6	3.8	1.1	3.2	4.9	3.7	0.3	2.2	3.9	0.7	1.0	0.3	0.4	0.5	11.7	0.8	0.0	1.4	2.2	13.6	3.1	2.3	3.1	3.1	0.3	2.5	0.0	1.8	3.1	2.1	5.3	4.8	4.5	0.3	3.6	1.4	1.2	0.0	0.5	4.6	6.4	3.8	4.6	4.4	3.1	2.7	5.5	0.2	1.3	0.2	0.0	0.6	16.2	4.1	5.4	0.0	0.1	0.7	4.7	0.0	0.1	0.0	6.1	0.6	2.3	0.8	13.6	3.0	15.9	0.0	3.3	0.1	0.1	0.0	2.7	0.0	2.5	0.7	0.7	1.4	0.3	0.0	0.1	0.3	0.1	0.0	2.2	0.2	0.1	0.1	3.9	1.0	0.0	0.9	0.1	0.4	0.6	1.3	0.2	1.4	0.8	0.7	0.7	0.6	2.1	1.0
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.6;HEL: 32.1;U-266/70: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules				Microtubules	Microtubules	"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favourable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favourable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.1	2.7	0.8	20.6	0.0	0.0	0.9	0.0	0.2	0.5	0.2	0.4	1.9	15.5	1.6	0.5	1.4	10.7	3.3	0.8	13.2	8.1	32.1	0.8	5.8	0.8	4.4	0.6	0.6	3.2	0.1	1.1	0.5	0.3	1.9	0.0	3.6	9.3	0.1	5.9	2.8	2.9	0.4	0.4	1.7	3.9	4.9	5.8	1.9	0.6	10.8	4.4	1.9	0.0	0.0	1.5	1.7	0.5	38.0	4.5	6.7	0.3	14.3	1.9	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.2;Hep G2: 4.4;RPTEC TERT1: 15.8;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015725	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.6	0.3	0.8	1.1	0.2	0.1	0.7	0.0	0.1	0.0	0.0	8.2	0.1	0.1	3.1	0.0	0.2	0.2	0.3	0.1	1.2	1.6	0.8	0.0	4.4	0.1	0.4	0.3	0.2	0.7	0.0	0.5	0.0	0.6	0.5	0.0	0.2	1.0	2.6	0.3	0.2	1.0	0.1	0.6	15.8	0.0	0.7	0.7	0.0	0.1	1.5	0.2	0.2	0.2	0.0	0.5	0.4	0.1	5.2	2.6	0.7	0.0	1.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.0;intestine: 57.0;kidney: 22.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 35.2;HeLa: 12.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.1	0.1	1.6	4.3	7.1	0.0	0.0	0.8	3.3	0.1	23.8	6.2	0.0	40.5	0.0	6.3	0.0	1.3	26.0	0.3	5.0	2.3	22.1	0.4	0.0	0.0	4.8	1.9	0.3	2.1	0.0	5.2	0.0	3.5	0.1	20.7	1.8	0.0	0.1	0.0	0.0	57.0	0.9	10.2	0.0	11.5	0.2	3.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	35.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	7.1	0.8	2.3	5.0	2.3	4.8	1.9	3.5	3.6
VAV3		ENSG00000134215	"Vav guanine nucleotide exchange factor 3"	Q9UKW4	1	107571160-107965144	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.5;placenta: 54.4"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;RH-30: 23.0;RPTEC TERT1: 32.3;T-47d: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB002012	Uncertain									"CAB002012: "	"unprognostic (4.80e-3)"	"unprognostic (7.99e-3)"	"unprognostic (5.31e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.67e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.60e-8)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.23e-2)"	2.3	1.2	1.8	12.2	2.4	7.1	15.2	2.7	3.0	11.4	17.5	0.8	6.4	3.8	3.3	4.8	32.6	1.6	1.7	2.0	1.2	1.9	47.5	1.1	7.1	8.6	3.8	0.8	1.0	7.3	0.5	2.0	54.4	3.1	6.2	22.2	6.9	6.3	5.3	0.8	27.1	7.6	2.1	1.0	13.1	3.7	2.5	0.4	8.9	4.2	17.6	17.6	7.3	11.5	4.4	4.8	6.8	1.1	3.8	4.6	1.1	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	1.6	6.2	2.2	3.6	0.0	5.7	2.4	0.0	13.6	0.0	0.4	0.0	0.0	4.9	0.0	2.0	11.9	1.5	1.8	0.4	18.7	23.0	0.1	32.3	10.6	1.0	0.9	5.9	2.7	0.1	39.5	10.6	0.4	0.2	0.0	0.0	0.2	3.0	1.1	0.2	4.9	9.4	0.4	6.8	1.1	1.4	4.1	1.0	2.3	2.9	1.2	2.0	4.8	4.4	0.3	2.9	3.3	3.8	0.4	3.1	4.6	1.1	1.8	2.4	2.7	3.0	1.2	1.9	3.8	0.8	3.1	0.4
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 72.8"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	72.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 64.1;thyroid gland: 36.3"	"Cell line enhanced"	"Detected in some"		"A549: 9.3;EFO-21: 6.1;NTERA-2: 5.6;RPMI-8226: 15.8;RPTEC TERT1: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favourable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.7	0.2	0.1	3.0	0.8	0.6	4.9	0.3	0.8	4.6	0.2	0.1	0.1	64.1	13.1	0.8	0.1	0.1	0.1	0.5	1.3	1.5	0.9	0.8	0.1	0.2	0.1	0.3	11.2	0.4	0.1	1.1	0.6	0.1	0.1	0.1	0.2	1.1	0.1	0.1	36.3	0.4	0.5	0.6	0.1	0.2	0.0	0.1	0.0	0.2	0.8	0.1	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	3.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.1	15.8	10.3	3.3	1.8	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.3	0.5	0.0	0.1	7.3	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.5	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.4;K-562: 21.7;TIME: 21.0;WM-115: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved									"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.2	2.8	2.7	0.8	0.4	0.5	0.2	4.3	19.4	0.0	0.1	0.2	4.7	0.4	0.9	0.0	0.0	2.8	4.6	0.0	0.4	2.5	0.4	3.9	1.2	0.2	21.7	0.7	0.0	0.6	0.0	0.5	0.2	4.9	0.3	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	1.4	1.5	21.0	0.2	1.9	0.2	0.1	3.5	3.0	0.6	0.0	1.2	14.1	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2
ZNF99	"C19orf9, MGC24986"	ENSG00000213973	"Zinc finger protein 99"	A8MXY4	19	22752183-22784107	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.5;testis: 11.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;NTERA-2: 3.6"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (8.31e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.83e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.61e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.05e-3)"	"unprognostic (8.55e-2)"	0.7	0.5	1.6	0.4	2.9	1.0	1.1	1.1	2.8	0.8	0.5	0.3	0.0	0.4	1.5	1.3	0.5	0.7	0.4	0.8	1.6	0.6	5.5	0.5	0.5	1.5	0.6	1.4	0.8	0.5	0.3	0.5	0.5	2.4	0.5	0.3	0.3	0.5	0.4	0.7	0.9	0.5	0.7	0.6	0.7	0.5	11.2	0.7	0.4	0.8	0.0	0.3	0.6	0.7	1.1	1.2	2.9	0.6	0.8	0.8	0.2	0.1	0.4	0.2	0.4	0.1	0.0	2.7	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.3	0.2	0.7	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.4	3.6	0.1	0.2	0.1	0.2	0.1	0.6	0.4	0.6	0.0	0.3	0.1	0.9	0.1	0.3	0.3	0.1	1.3	0.2	0.3	0.3	0.2	0.1	0.2	0.0	1.7	0.5	0.5	0.5	0.5	0.4	0.7	0.5	0.3	0.2	1.1	0.8	0.7	2.9	0.8	0.6	1.2	0.4	0.2	1.6	2.9	1.1	2.8	1.6	0.6	0.6	1.4	2.4	0.7
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0										
